Home The Word Brain	My Amedeo FAQ Privacy About
	Explore this week’s CC Journal Club 90‑sec video • 4‑min audio • paper abstracts This week, 27 April 2025: Treatment-resistant hypertension Influenza transmission Nanoplastics in human brains Malaria elimination Chikungunya vaccine

Alzheimer's Disease

Free Subscription Articles published in J Alzheimers Dis Retrieve available abstracts of 1184 articles: HTML format

Single Articles

April 2025
1. HEINZE T, Tuchtenhagen M, Knuppel S, Weber D, et al
   EPIC-Potsdam sub-cohort study: The early role of trace elements, oxidative stress, and anthropometrics in Alzheimer's disease and dementia onset.
   J Alzheimers Dis. 2025 Apr 23:13872877251333726. doi: 10.1177/13872877251333726.
   PubMed     Abstract available
   
   
   
2. ZHANG W, Teng F, Lan X, Liu P, et al
   A novel finding relates to the involvement of ATF3/DOCK8 in Alzheimer's disease pathogenesis.
   J Alzheimers Dis. 2025 Apr 23:13872877251336266. doi: 10.1177/13872877251336266.
   PubMed     Abstract available
   
   
   
3. JEONG H, Kim D, Na S, Kim B, et al
   Repeated neuromodulation with low-intensity focused ultrasound in patients with Alzheimer's disease.
   J Alzheimers Dis. 2025 Apr 23:13872877251333614. doi: 10.1177/13872877251333614.
   PubMed     Abstract available
   
   
   
4. WEI S, Li C, Li W, Yuan F, et al
   Glial changes and gene expression in Alzheimer's disease from snRNA-Seq and spatial transcriptomics.
   J Alzheimers Dis. 2025 Apr 23:13872877251330320. doi: 10.1177/13872877251330320.
   PubMed     Abstract available
   
   
   
5. HE F, Shi WJ, Liu W, Fan JX, et al
   A mass-producible macaque model displays a durable Alzheimer-like cognitive deficit and hallmark amyloid-beta/tau/neurofilament light chain pathologies.
   J Alzheimers Dis. 2025 Apr 23:13872877251334316. doi: 10.1177/13872877251334316.
   PubMed     Abstract available
   
   
   
6. SINGH-REILLY N, Graff-Radford J, Li D, Mielke MM, et al
   Abeta(42/40) and p-tau 181 as disease biomarkers in atypical Alzheimer's disease.
   J Alzheimers Dis. 2025 Apr 23:13872877251333450. doi: 10.1177/13872877251333450.
   PubMed     Abstract available
   
   
   
7. GHANBARIAN E, Khorsand B, Petersen KK, Nallapu BT, et al
   Cerebrospinal fluid inflammatory cytokines as prognostic indicators for cognitive decline across Alzheimer's disease spectrum.
   J Alzheimers Dis. 2025 Apr 22:13872877251335915. doi: 10.1177/13872877251335915.
   PubMed     Abstract available
   
   
   
8. KSHIRSAGAR S, Deshmukh H, Reddy AP, Reddy AP, et al
   Grounding as a complementary intervention for Alzheimer's disease: Mechanisms, evidence, and potential therapeutic applications.
   J Alzheimers Dis. 2025 Apr 22:13872877251334666. doi: 10.1177/13872877251334666.
   PubMed     Abstract available
   
   
   
9. CHEN HM, Shen K, Ji L, McGrath C, et al
   Patterns and trends in the burden of Alzheimer's disease and related dementias in China (1990-2021) and predictions to 2040.
   J Alzheimers Dis. 2025 Apr 22:13872877251333108. doi: 10.1177/13872877251333108.
   PubMed     Abstract available
   
   
   
10. STAMATELOS P, Beratis IN, Hatzaki P, Economou A, et al
    Mild cognitive impairment, Alzheimer's disease dementia, and predictors of driving cessation: A 7-year longitudinal prospective study.
    J Alzheimers Dis. 2025 Apr 22:13872877251333705. doi: 10.1177/13872877251333705.
    PubMed     Abstract available
    
    
    
11. WANG S, Ni J, Wei M, Li T, et al
    Impact of obesity on neuropsychiatric symptoms in Alzheimer's disease: Insights from the ADNI cohort.
    J Alzheimers Dis. 2025 Apr 22:13872877251331974. doi: 10.1177/13872877251331974.
    PubMed     Abstract available
    
    
    
12. JAMAL R, Shaikh MA, Taleuzzaman M, Haque Z, et al
    Key biomarkers in Alzheimer's disease: Insights for diagnosis and treatment strategies.
    J Alzheimers Dis. 2025 Apr 21:13872877251330500. doi: 10.1177/13872877251330500.
    PubMed     Abstract available
    
    
    
13. MALEK J, Levchenko A, Robinson JO, Fong J, et al
    Dilemmas in diagnosing Alzheimer's disease: The peril and promise of self-fulfilling prophecies.
    J Alzheimers Dis. 2025 Apr 21:13872877251331236. doi: 10.1177/13872877251331236.
    PubMed     Abstract available
    
    
    
14. KIM H, Kulshreshtha A, Alonso A, Goldstein FC, et al
    The association between pulse wave velocity and cerebrospinal fluid biomarkers for Alzheimer's disease.
    J Alzheimers Dis. 2025 Apr 21:13872877251331235. doi: 10.1177/13872877251331235.
    PubMed     Abstract available
    
    
    
15. SUN J, Teng F, Cao Y, Pei H, et al
    Peripheral blood immune cell phenotypes and Alzheimer's disease: A mediation Mendelian randomization study.
    J Alzheimers Dis. 2025 Apr 15:13872877251330503. doi: 10.1177/13872877251330503.
    PubMed     Abstract available
    
    
    
16. ASHMAWY RE, Okesanya OJ, Ukoaka BM, Daniel FM, et al
    Exploring the efficacy and safety of lecanemab in the management of early Alzheimer's disease: A systematic review of clinical evidence.
    J Alzheimers Dis. 2025 Apr 15:13872877251331640. doi: 10.1177/13872877251331640.
    PubMed     Abstract available
    
    
    
17. SEGIET N, Poczatek G, Drzazga J, Laskowska-Wronarowicz A, et al
    Effectiveness of structured cognitive intervention among patients diagnosed with late-onset Alzheimer's disease: Report from a pilot study.
    J Alzheimers Dis. 2025 Apr 15:13872877251331184. doi: 10.1177/13872877251331184.
    PubMed     Abstract available
    
    
    
18. SAAOUD F, Liu L, Xu K, Lu Y, et al
    Alzheimer's disease as an auto-innate immune pathology with potential cell trans-differentiation and enhanced trained immunity in 3xTg-AD mouse model.
    J Alzheimers Dis. 2025 Apr 15:13872877251329583. doi: 10.1177/13872877251329583.
    PubMed     Abstract available
    
    
    
19. PARKS AL, Thacker A, Dohan D, Gomez LAR, et al
    A qualitative study of people with Alzheimer's disease in a memory clinic considering lecanemab treatment.
    J Alzheimers Dis. 2025 Apr 10:13872877251329519. doi: 10.1177/13872877251329519.
    PubMed     Abstract available
    
    
    
20. TONG H, Petyuk VA, Sendtner M, Sood A, et al
    Alzheimer's disease-related cortical proteins modify the association of brain insulin signaling with cognitive decline.
    J Alzheimers Dis. 2025 Apr 4:13872877251319463. doi: 10.1177/13872877251319463.
    PubMed     Abstract available
    
    
    
21. KARKKAINEN V, Saari T, Hannonen S, Rusanen M, et al
    Altered tear fluid protein expression in persons with mild Alzheimer's disease in proteins involved in oxidative stress, protein synthesis, and energy metabolism.
    J Alzheimers Dis. 2025 Apr 4:13872877251326868. doi: 10.1177/13872877251326868.
    PubMed     Abstract available
    
    
    
22. MARTINEZ JE, Bocanegra Y, Baena A, Langella S, et al
    Religious stress coping is associated with lower entorhinal tau pathology and better memory performance in autosomal dominant Alzheimer's disease.
    J Alzheimers Dis. 2025 Apr 3:13872877251331569. doi: 10.1177/13872877251331569.
    PubMed     Abstract available
    
    
    
23. CORDEIRO AMT, Singulani MP, Talib LL, Forlenza OV, et al
    Down syndrome and Alzheimer's disease: Oxidative stress in the neurodegenerative process.
    J Alzheimers Dis. 2025 Apr 3:13872877251326291. doi: 10.1177/13872877251326291.
    PubMed     Abstract available
    
    
    
24. DEVERKA PA, Arias JJ, Lin GA, Zwerling J, et al
    Alzheimer's disease blood-based biomarker testing: A stakeholder-informed assessment of coverage considerations.
    J Alzheimers Dis. 2025 Apr 1:13872877251329394. doi: 10.1177/13872877251329394.
    PubMed     Abstract available
    
    
    
25. WANG Y, Wu Z, Zheng Y, Wang H, et al
    Unraveling the genetic underpinnings of mitochondrial traits and associated circulating inflammatory proteins in Alzheimer's disease: Mitochondrial HtrA2-T cell CD5 negative axis.
    J Alzheimers Dis. 2025 Apr 1:13872877251329517. doi: 10.1177/13872877251329517.
    PubMed     Abstract available
    
    
    
26. ASADA T, Kakuma T, Tanaka M, Araki W, et al
    A statistical method for predicting amyloid-beta deposits from severity, extend, and ratio indices of the (99m)Tc-ECD SPECT.
    J Alzheimers Dis. 2025;104:1281-1289.
    PubMed     Abstract available
    
    
    
27. WANG J, Wang DZ, Li BH, Yang S, et al
    Elevated circulating cathepsin S levels are associated with cognitive decline and neurodegeneration in a cohort of patients reporting memory complaints.
    J Alzheimers Dis. 2025;104:1147-1153.
    PubMed     Abstract available
    
    
    
28. BECKER C, Herschung L, Gomm W, Haenisch B, et al
    Dementia diagnosis and prescription of antidementia drugs: An analysis of German claims data (2006-2016).
    J Alzheimers Dis. 2025;104:698-708.
    PubMed     Abstract available
    
    
    
29. XU S, Fan Y, Mao C, Hu Z, et al
    Multimodal magnetic resonance imaging analysis of early mild cognitive impairment.
    J Alzheimers Dis. 2025;104:1013-1027.
    PubMed     Abstract available
    
    
    
30. FURUYA Y, Sato K, Niimi Y, Ihara R, et al
    Cognitive function instrument-based anosognosia to predict amyloid status.
    J Alzheimers Dis. 2025;104:995-1000.
    PubMed     Abstract available
    
    
    March 2025
31. GONG C, Song W, Zhu Z, Yang D, et al
    APOE epsilon4 influences the dynamic functional connectivity variability and cognitive performance in Alzheimer's disease.
    J Alzheimers Dis. 2025 Mar 28:13872877251322687. doi: 10.1177/13872877251322687.
    PubMed     Abstract available
    
    
    
32. VANNINEN A, Erkkila L, Kokkola T, Selander T, et al
    Effect of ventricular volume on cerebrospinal fluid Alzheimer's disease biomarkers in patients with idiopathic normal pressure hydrocephalus.
    J Alzheimers Dis. 2025 Mar 28:13872877251329081. doi: 10.1177/13872877251329081.
    PubMed     Abstract available
    
    
    
33. BELFORT T, Nogueira ML, Gaigher J, Rangel R, et al
    Comparing patterns of impairment in social cognition between young-onset and late-onset Alzheimer's disease.
    J Alzheimers Dis. 2025 Mar 28:13872877251323046. doi: 10.1177/13872877251323046.
    PubMed     Abstract available
    
    
    
34. RUAN T, Ling Y, Wu C, Niu Y, et al
    Abnormal epigenetic modification of lysosome and lipid regulating genes in Alzheimer's disease.
    J Alzheimers Dis. 2025 Mar 28:13872877251322955. doi: 10.1177/13872877251322955.
    PubMed     Abstract available
    
    
    
35. SHEN Y, Nie Q, Xiang W, Chen S, et al
    The relationship between Alzheimer's disease and intracerebral hemorrhage based on Mendelian randomization.
    J Alzheimers Dis. 2025 Mar 28:13872877251323294. doi: 10.1177/13872877251323294.
    PubMed     Abstract available
    
    
    
36. XUE RJ, Gao PY, Chen YM, Liu Y, et al
    Associations between plasma complement C1q and cerebrospinal fluid biomarkers of Alzheimer's disease pathology in cognitively intact adults: The CABLE study.
    J Alzheimers Dis. 2025 Mar 26:13872877251322808. doi: 10.1177/13872877251322808.
    PubMed     Abstract available
    
    
    
37. WANG S, Luo G, Sun G, Zhang M, et al
    A polymorphism in the BIN1 gene influences its expression and is associated with the risk of Alzheimer's disease: An integrated analysis.
    J Alzheimers Dis. 2025 Mar 26:13872877251326273. doi: 10.1177/13872877251326273.
    PubMed     Abstract available
    
    
    
38. HOWARD KA, Massimo LM, Witrick B, Zhang L, et al
    Investigation of risk of Alzheimer's disease diagnosis and survival based on variation to life experiences used to operationalize cognitive reserve.
    J Alzheimers Dis. 2025 Mar 26:13872877251326818. doi: 10.1177/13872877251326818.
    PubMed     Abstract available
    
    
    
39. ROBERTS H, Fang Y, Quinn K, Hill T, et al
    Lifespan of male and female APP/PS1 and APP(NL-F/NL-F) mouse models of Alzheimer's disease.
    J Alzheimers Dis. 2025 Mar 26:13872877251325878. doi: 10.1177/13872877251325878.
    PubMed     Abstract available
    
    
    
40. JEONG S, Lin L, Leone AP, Hsu YH, et al
    Type 2 diabetes and late-onset Alzheimer's disease and related dementia: A longitudinal cohort study integrating polygenic risk score.
    J Alzheimers Dis. 2025 Mar 25:13872877251326107. doi: 10.1177/13872877251326107.
    PubMed     Abstract available
    
    
    
41. SCHAEFER SY, Reed AM, Duff K
    Validating a brief performance-based measure of cognition and daily functioning in amnestic mild cognitive impairment and mild Alzheimer's disease.
    J Alzheimers Dis. 2025 Mar 25:13872877251320379. doi: 10.1177/13872877251320379.
    PubMed     Abstract available
    
    
    
42. SLADE B, Williams B, Engelbrecht R, Ciorciari J, et al
    Improving executive functioning and reducing the risk of Alzheimer's disease with music therapy: A narrative review of potential neural mechanisms.
    J Alzheimers Dis. 2025 Mar 24:13872877251327762. doi: 10.1177/13872877251327762.
    PubMed     Abstract available
    
    
    
43. DE RIJKE TJ, Vasseur D, van der Flier WM, Minkman MM, et al
    Exploring interdisciplinary perspectives on the implementation of personalized medicine and patient-orchestrated care in Alzheimer's disease: A qualitative study within the ABOARD research project.
    J Alzheimers Dis. 2025 Mar 21:13872877251326166. doi: 10.1177/13872877251326166.
    PubMed     Abstract available
    
    
    
44. SORDU P, Alaylioglu M, Samanci B, Bulu E, et al
    Cerebrospinal fluid HSP90AA1, HSPA4, and STUB1/CHIP levels in Alzheimer's disease, mild cognitive impairment, and frontotemporal dementia.
    J Alzheimers Dis. 2025 Mar 21:13872877251329540. doi: 10.1177/13872877251329540.
    PubMed     Abstract available
    
    
    
45. KRAAKE S, Luppa M, Saur D, Dietzel J, et al
    Social functioning in individuals with Alzheimer's disease and the situation of caregivers.
    J Alzheimers Dis. 2025 Mar 21:13872877251326029. doi: 10.1177/13872877251326029.
    PubMed     Abstract available
    
    
    
46. WILLIAMS JP, Zhu Y, Singh RK, Beyene K, et al
    The effect of anti-seizure medications on Alzheimer's disease (AD) risk and AD-related symptoms: A scoping review.
    J Alzheimers Dis. 2025 Mar 21:13872877251324663. doi: 10.1177/13872877251324663.
    PubMed     Abstract available
    
    
    
47. ARRIOLA-INFANTE JE, Garcia-Roldan E, Garcia-Solis D, Marin-Cabanas AM, et al
    TMA-93 (binding by images): Cutoffs optimization based on Alzheimer's disease biomarkers.
    J Alzheimers Dis. 2025 Mar 21:13872877251325759. doi: 10.1177/13872877251325759.
    PubMed     Abstract available
    
    
    
48. MACIVER MB, Pearce RA
    Reduced GABA(A, slow) synaptic inhibition in Alzheimer's disease.
    J Alzheimers Dis. 2025 Mar 21:13872877251328940. doi: 10.1177/13872877251328940.
    PubMed     Abstract available
    
    
    
49. YANG B, Teymur A, Tang C, Wu T, et al
    V-set and immunoglobulin domain containing 4 as a potential predictor of Alzheimer's disease and advanced aging.
    J Alzheimers Dis. 2025 Mar 21:13872877251329463. doi: 10.1177/13872877251329463.
    PubMed     Abstract available
    
    
    
50. RICHTER N, Breidenbach L, Schmieschek MH, Heiss WD, et al
    Alzheimer-typical temporo-parietal atrophy and hypoperfusion are associated with a more significant cholinergic impairment in amnestic neurodegenerative syndromes.
    J Alzheimers Dis. 2025 Mar 21:13872877251324080. doi: 10.1177/13872877251324080.
    PubMed     Abstract available
    
    
    
51. LI F, Zheng M, Jia J
    Validate association of gene loci and establish genetic risk prediction models for late-onset Alzheimer's disease in Chinese populations.
    J Alzheimers Dis. 2025 Mar 21:13872877251326283. doi: 10.1177/13872877251326283.
    PubMed     Abstract available
    
    
    
52. XU X, Mo X, Zhang W, Liu D, et al
    Local and distant atrophy mediate the relationship between tau pathology and cognition in temporoparietal region in Alzheimer's disease.
    J Alzheimers Dis. 2025 Mar 21:13872877251322539. doi: 10.1177/13872877251322539.
    PubMed     Abstract available
    
    
    
53. ABDULLAH L, Zhou Z, Hall J, Petersen M, et al
    Association of Alzheimer's disease biomarkers with low premorbid intellectual functioning in a multi-ethnic community-dwelling cohort: A cross-sectional study of HABS-HD.
    J Alzheimers Dis. 2025 Mar 21:13872877251322966. doi: 10.1177/13872877251322966.
    PubMed     Abstract available
    
    
    
54. VASILEVA-METODIEV SZ, Spargo D, Klein EG, Quevenco FC, et al
    Diagnostic journey and management of patients with mild cognitive impairment and Alzheimer's disease dementia: A multinational, real-world survey.
    J Alzheimers Dis. 2025 Mar 20:13872877251322978. doi: 10.1177/13872877251322978.
    PubMed     Abstract available
    
    
    
55. AYAZ G, Sordu P, Kucuksezer UC, Hanagasi H, et al
    Association of glycoprotein 1b and miR-26a-5p levels with platelet function in Alzheimer's disease.
    J Alzheimers Dis. 2025 Mar 20:13872877251326204. doi: 10.1177/13872877251326204.
    PubMed     Abstract available
    
    
    
56. HU D, Chen M, Li X, Daley S, et al
    ApoE epsilon4-dependent Alteration of CXCR3 (+) CD127(+) CD4(+) T cells associates with elevated plasma neurofilament light chain in Alzheimer's disease.
    J Alzheimers Dis. 2025 Mar 20:13872877251320123. doi: 10.1177/13872877251320123.
    PubMed     Abstract available
    
    
    
57. KATONOVA A, Andel R, Jurasova V, Veverova K, et al
    Associations of KLOTHO-VS heterozygosity and alpha-Klotho protein with cerebrospinal fluid Alzheimer's disease biomarkers.
    J Alzheimers Dis. 2025 Mar 20:13872877251326199. doi: 10.1177/13872877251326199.
    PubMed     Abstract available
    
    
    
58. FUSEYA K, Mimura Y, Nakajima S, Mimura M, et al
    A systematic review and meta-analysis on the characteristics of transcranial magnetic stimulation treatment protocols for patients with Alzheimer's disease.
    J Alzheimers Dis. 2025 Mar 20:13872877251325887. doi: 10.1177/13872877251325887.
    PubMed     Abstract available
    
    
    
59. WIMO A, Handels R, Blennow K, Kirsebom KB, et al
    Cost-effectiveness of diagnosing and treating patients with early Alzheimer's disease with anti-amyloid treatment in a clinical setting.
    J Alzheimers Dis. 2025 Mar 20:13872877251323231. doi: 10.1177/13872877251323231.
    PubMed     Abstract available
    
    
    
60. ALAMI M, Zerif E, Khalil A, Hajji N, et al
    Neuroprotective effects of SGLT2 inhibitors empagliflozin and dapagliflozin on Abeta(1-42)-induced neurotoxicity and neuroinflammation in cellular models of Alzheimer's disease.
    J Alzheimers Dis. 2025 Mar 20:13872877251329474. doi: 10.1177/13872877251329474.
    PubMed     Abstract available
    
    
    
61. GUI S, Zeng F, Wu Z, Nonaka S, et al
    Lipopolysaccharides from Porphyromonas gingivalis indirectly induce neuronal GSK3beta-dependent synaptic defects and cause cognitive decline in a low-amyloid-beta-concentration environment in Alzheimer's disease.
    J Alzheimers Dis. 2025 Mar 20:13872877251326879. doi: 10.1177/13872877251326879.
    PubMed     Abstract available
    
    
    
62. LALIVE HM, Griffa A, Pini L, Rouaud O, et al
    Biomarkers do not paint the whole picture: The role of clinical expertise and advanced neuroimaging for Alzheimer's disease diagnosis.
    J Alzheimers Dis. 2025 Mar 20:13872877251328953. doi: 10.1177/13872877251328953.
    PubMed     Abstract available
    
    
    
63. MEWS MA, Naj AC, Griswold AJ, Below JE, et al
    Brain and blood transcriptome-wide association studies identify five novel genes associated with Alzheimer's disease.
    J Alzheimers Dis. 2025 Mar 20:13872877251326288. doi: 10.1177/13872877251326288.
    PubMed     Abstract available
    
    
    
64. CHEN YH, Wang ZB, Liu XP, Mao ZQ, et al
    Cerebrospinal fluid LMO4 as a synaptic biomarker linked to Alzheimer's disease pathology and cognitive decline.
    J Alzheimers Dis. 2025 Mar 19:13872877251326286. doi: 10.1177/13872877251326286.
    PubMed     Abstract available
    
    
    
65. LEI S, Liu Y
    Identifying microglia-derived NFKBIA as a potential contributor to the pathogenesis of Alzheimer's disease and age-related macular degeneration.
    J Alzheimers Dis. 2025 Mar 19:13872877251326267. doi: 10.1177/13872877251326267.
    PubMed     Abstract available
    
    
    
66. SIMMATIS LE, Russo EE, Steininger T, Riddell H, et al
    EEG biomarkers for Alzheimer's disease: A novel automated pipeline for detecting and monitoring disease progression.
    J Alzheimers Dis. 2025 Mar 18:13872877251327754. doi: 10.1177/13872877251327754.
    PubMed     Abstract available
    
    
    
67. DZIANOK P, Wojciechowski J, Wolak T, Kublik E, et al
    Alzheimer's disease-like features in resting state EEG/fMRI of cognitively intact and healthy middle-aged APOE/PICALM risk carriers.
    J Alzheimers Dis. 2025 Mar 17:13872877251317489. doi: 10.1177/13872877251317489.
    PubMed     Abstract available
    
    
    
68. ZHANG Z, Cui L, Huang L, Guan YH, et al
    Development and validation of the Chinese Naming Test (CNT): Diagnostic efficacy and correlation with Alzheimer's disease biomarkers.
    J Alzheimers Dis. 2025 Mar 17:13872877251324100. doi: 10.1177/13872877251324100.
    PubMed     Abstract available
    
    
    
69. LU Y, Li D, Yu Y, Wang Q, et al
    Cerebrospinal fluid VGF is associated with the onset and progression of Alzheimer's disease.
    J Alzheimers Dis. 2025 Mar 17:13872877251323002. doi: 10.1177/13872877251323002.
    PubMed     Abstract available
    
    
    
70. ZEISS CJ, Huttner A, Nairn AC, Arnsten A, et al
    The neuropathologic basis for translational biomarker development in the macaque model of late-onset Alzheimer's disease.
    J Alzheimers Dis. 2025 Mar 17:13872877251323787. doi: 10.1177/13872877251323787.
    PubMed     Abstract available
    
    
    
71. YANG Y, Li Y, Chen Y
    Changes in transcriptional regulation in the temporal lobe in patients with Alzheimer's disease.
    J Alzheimers Dis. 2025 Mar 17:13872877251322536. doi: 10.1177/13872877251322536.
    PubMed     Abstract available
    
    
    
72. ZHANG C, Tai Y, Kong M, Jia P, et al
    Synergistic associations of amyloid-beta and phosphorylated tau with tau aggregation and cognitive decline in Alzheimer's disease.
    J Alzheimers Dis. 2025 Mar 17:13872877251322196. doi: 10.1177/13872877251322196.
    PubMed     Abstract available
    
    
    
73. LIN YJ, Liu Y, Sheng ZH, Fu Y, et al
    The associations of cerebrospinal fluid ApoE and C1q with Alzheimer's disease biomarkers.
    J Alzheimers Dis. 2025 Mar 17:13872877251320419. doi: 10.1177/13872877251320419.
    PubMed     Abstract available
    
    
    
74. ISHIKAWA-TAKATA K, Fujiwara K, Tanaka T, Nakamura K, et al
    Associations of dietary protein and amino acid intakes with disability-adjusted life years for Alzheimer's disease in Japanese people.
    J Alzheimers Dis. 2025 Mar 14:13872877251319535. doi: 10.1177/13872877251319535.
    PubMed     Abstract available
    
    
    
75. PIERCE ME, Logue M, Sherva R, Miller M, et al
    Association of Alzheimer's disease genetic risk with age-dependent changes in plasma amyloid-beta(42:40) in Veterans.
    J Alzheimers Dis. 2025 Mar 14:13872877251321183. doi: 10.1177/13872877251321183.
    PubMed     Abstract available
    
    
    
76. WANG D, Scalici A, Wang Y, Lin H, et al
    Frequency of variants in Mendelian Alzheimer's disease genes within the Alzheimer's Disease Sequencing Project.
    J Alzheimers Dis. 2025 Mar 14:13872877251320375. doi: 10.1177/13872877251320375.
    PubMed     Abstract available
    
    
    
77. TREMBLAY C, Shakir N, Zhang N, Adler CH, et al
    Associations between neuropsychiatric symptoms and pathology in clinicopathologically defined Alzheimer's disease, Alzheimer's disease with Lewy bodies, and dementia with Lewy bodies.
    J Alzheimers Dis. 2025 Mar 14:13872877251320670. doi: 10.1177/13872877251320670.
    PubMed     Abstract available
    
    
    
78. ALVES L, Hashiguchi D, Loss CM, van Praag H, et al
    Vascular dysfunction in Alzheimer's disease: Exploring the potential of aerobic and resistance exercises as therapeutic strategies.
    J Alzheimers Dis. 2025 Mar 13:13872877251321118. doi: 10.1177/13872877251321118.
    PubMed     Abstract available
    
    
    
79. BARRETT-YOUNG A, Reuben A, Caspi A, Cheyne K, et al
    Measures of retinal health successfully capture risk for Alzheimer's disease and related dementias at midlife.
    J Alzheimers Dis. 2025 Mar 3:13872877251321114. doi: 10.1177/13872877251321114.
    PubMed     Abstract available
    
    
    
80. SHARDELL M, Chen C
    Genetic geroscience and Alzheimer's disease: The pleiotropy is the point!
    J Alzheimers Dis. 2025 Mar 3:13872877251321182. doi: 10.1177/13872877251321182.
    PubMed     Abstract available
    
    
    
81. ZEGARRA-VALDIVIA JA, Shany-Ur T, Rijpma MG, Callahan P, et al
    Validation of the Cognitive-Emotional Perspective Taking test in patients with neurodegeneration.
    J Alzheimers Dis. 2025 Mar 3:13872877251317683. doi: 10.1177/13872877251317683.
    PubMed     Abstract available
    
    
    
82. MORITO T, Watamura N, Sasaguri H, Tomita T, et al
    Experimental basis for generating nonhuman primate models of frontotemporal dementia and Alzheimer's disease.
    J Alzheimers Dis. 2025 Mar 2:13872877251321116. doi: 10.1177/13872877251321116.
    PubMed     Abstract available
    
    
    
83. WANG SY, Huang ZH, Duan R, Fu XX, et al
    IL-34/TREM2 modulates microglia-mediated inflammation and provides neuroprotection in a mouse model of sporadic Alzheimer's disease.
    J Alzheimers Dis. 2025 Mar 2:13872877251320418. doi: 10.1177/13872877251320418.
    PubMed     Abstract available
    
    
    
84. YANG J, Ding H, Li Y, Ang TFA, et al
    Association of mid-age Life's Essential 8 score with digital cognitive performance and incident Alzheimer's disease: The Framingham Heart Study.
    J Alzheimers Dis. 2025 Mar 2:13872877251317734. doi: 10.1177/13872877251317734.
    PubMed     Abstract available
    
    
    
85. BOHN L, Zheng Y, McFall GP, Andrew MK, et al
    Frailty in motion: Amnestic mild cognitive impairment and Alzheimer's disease cohorts display heterogeneity in multimorbidity classification and longitudinal transitions.
    J Alzheimers Dis. 2025 Mar 2:13872877251319547. doi: 10.1177/13872877251319547.
    PubMed     Abstract available
    
    
    
86. KIM JW, Byun MS, Yi D, Jung JH, et al
    Daily fluid intake and brain amyloid deposition: A cohort study.
    J Alzheimers Dis. 2025;104:138-149.
    PubMed     Abstract available
    
    
    
87. YANG Q, Yang H, Long W, Zuo S, et al
    Rapid cognitive assessment: Accuracy and discriminant validity of Mini-Cog and process-based Clock Drawing Test.
    J Alzheimers Dis. 2025;104:200-208.
    PubMed     Abstract available
    
    
    
88. SALMAN Y, Huyghe L, Quenon L, Ghysens O, et al
    Autopsy-proven patient with corticobasal degeneration presenting with visuo-constructive disorders as initial symptoms: How advanced MRI sequences can help clinical practice.
    J Alzheimers Dis. 2025;104:158-172.
    PubMed     Abstract available
    
    
    
89. PARK SA, An YS, Park YJ, Lee JY, et al
    Comparative analysis of Elecsys and ELISA for differentiating amyloid-PET status in a Korean memory clinic based on cerebrospinal fluid biomarkers.
    J Alzheimers Dis. 2025;104:232-244.
    PubMed     Abstract available
    
    
    
90. KUMAR WS, Bhutare SR, Sinha N, Issac TG, et al
    Bayesian network modeling of statistical dependency within cognitive domains and clinical dementia severity ratings for Western and Indian cohorts.
    J Alzheimers Dis. 2025;104:221-231.
    PubMed     Abstract available
    
    
    
91. LIGUORI C
    Obstructive sleep apnea is a common diagnosis in patients admitted at the memory clinic: Please screen for it!
    J Alzheimers Dis. 2025;104:40-42.
    PubMed     Abstract available
    
    
    
92. D'ANTONIO F, Vivacqua G, Serrentino M, Nalepa M, et al
    Salivary biomarkers for the molecular diagnosis of dementia with Lewy bodies.
    J Alzheimers Dis. 2025;104:452-462.
    PubMed     Abstract available
    
    
    
93. HAJJAR SH, Alsaad SM, AlFouzan MA, Rohaiem SN, et al
    Dementia prevalence within the Kingdom of Saudi Arabia National Guard Health System (2015-2023): An exploratory epidemiological study.
    J Alzheimers Dis. 2025;104:488-497.
    PubMed     Abstract available
    
    
    
94. ZHU S, Ni J, Long S, Teng Y, et al
    Androgen deprivation therapy and dementia risk: An updated and dose-response meta-analysis.
    J Alzheimers Dis. 2025;104:547-562.
    PubMed     Abstract available
    
    
    
95. JANG JW, Lee SH, Kim T, Lee E, et al
    Hearing loss and the risk of dementia: A longitudinal analysis of the Korean National Health Insurance Service Senior Cohort.
    J Alzheimers Dis. 2025;104:364-373.
    PubMed     Abstract available
    
    
    
96. MAYAN I, Roth H, Ghosh D, Whitson HE, et al
    Genetic and biomarker disclosure process in a memory and aging study.
    J Alzheimers Dis. 2025;104:312-318.
    PubMed     Abstract available
    
    
    February 2025
97. CHRISTIMANN G, Rocha G, Sattler JAG
    Bioactive compounds and dietary patterns in Alzheimer's disease.
    J Alzheimers Dis. 2025 Feb 26:13872877251319048. doi: 10.1177/13872877251319048.
    PubMed     Abstract available
    
    
    
98. RENTOUMI V, Vassiliou E, Pittaras N, Demiraj A, et al
    Linguistic cues for automatic assessment of Alzheimer's disease across languages.
    J Alzheimers Dis. 2025 Feb 25:13872877251319401. doi: 10.1177/13872877251319401.
    PubMed     Abstract available
    
    
    
99. BRADEN-KUHLE PN, Lacy VA, Brice KN, Bertrand ME, et al
    A Mediterranean-style diet protects against cognitive and behavioral deficits, adiposity, and Alzheimer's disease-related markers, compared to a macronutrient-matched typical American diet in C57BL/6J mice.
    J Alzheimers Dis. 2025 Feb 25:13872877251319467. doi: 10.1177/13872877251319467.
    PubMed     Abstract available
    
    
    
100. STOJANOVIC M, Millar PR, McKay NS, Aschenbrenner AJ, et al
     The associations between attentional control, episodic memory, and Alzheimer's disease biomarkers of tau and neurodegeneration.
     J Alzheimers Dis. 2025 Feb 24:13872877251316801. doi: 10.1177/13872877251316801.
     PubMed     Abstract available
     
     
     
101. ALHARBI AA, Alatwi HE, Albulaihe H, Algarzae NK, et al
     Alzheimer's disease in the Kingdom of Saudi Arabia: Current perspectives and genetic insights.
     J Alzheimers Dis. 2025 Feb 24:13872877251316122. doi: 10.1177/13872877251316122.
     PubMed     Abstract available
     
     
     
102. RANDLOVA K, Pazitny P, Kandilaki D
     Institutionalization of persons with Alzheimer's disease in the Czech and Slovak Republics.
     J Alzheimers Dis. 2025 Feb 24:13872877251317987. doi: 10.1177/13872877251317987.
     PubMed     Abstract available
     
     
     
103. WANG H, Qin N, Maimaitiaili D, Wu J, et al
     Transcranial electrical stimulation as a therapeutic strategy for Alzheimer's disease: Current uses and challenges.
     J Alzheimers Dis. 2025 Feb 24:13872877251315777. doi: 10.1177/13872877251315777.
     PubMed     Abstract available
     
     
     
104. GAO X, Sun Z, Hu J, Li Y, et al
     Identification of the enzymatic cleavage relationship between anti-aging protein alpha-Klotho and Alzheimer's disease biomarker BACE1.
     J Alzheimers Dis. 2025 Feb 24:13872877251317730. doi: 10.1177/13872877251317730.
     PubMed     Abstract available
     
     
     
105. LIN SW, Hsu YH, Yang JJ, Tu MC, et al
     A higher vertebrobasilar pulsatility index is associated with lower parietal perfusion in Alzheimer's disease.
     J Alzheimers Dis. 2025 Feb 24:13872877251314140. doi: 10.1177/13872877251314140.
     PubMed     Abstract available
     
     
     
106. DONG YT, Luo X, Zhang LL, Gong YM, et al
     Genetic colocalization of cathepsins H, D, and L1 with Alzheimer's disease: Implications for biomarker and therapeutic target discovery.
     J Alzheimers Dis. 2025 Feb 21:13872877251314058. doi: 10.1177/13872877251314058.
     PubMed     Abstract available
     
     
     
107. FIALA M, Hammock BD, Hwang SH, Whitelegge J, et al
     Inhibitors of soluble epoxide hydrolase and cGAS/STING repair defects in amyloid-beta clearance underlying vascular complications of Alzheimer's disease.
     J Alzheimers Dis. 2025 Feb 17:13872877241305965. doi: 10.1177/13872877241305965.
     PubMed     Abstract available
     
     
     
108. WEISS JN, Eber D
     Earlier diagnosis of Alzheimer's disease by dynamic light scattering spectroscopy.
     J Alzheimers Dis. 2025 Feb 16:13872877251319352. doi: 10.1177/13872877251319352.
     PubMed     Abstract available
     
     
     
109. CHEN ZQ, Wang MT, Tan CR, Huang S, et al
     Clinical relevance of plasma ADAM-17 with cognition and neurodegeneration in Alzheimer's disease.
     J Alzheimers Dis. 2025 Feb 16:13872877251317659. doi: 10.1177/13872877251317659.
     PubMed     Abstract available
     
     
     
110. MICHELUTTI M, Urso D, Tafuri B, Gnoni V, et al
     Structural covariance network patterns linked to neuropsychiatric symptoms in biologically defined Alzheimer's disease: Insights from the mild behavioral impairment checklist.
     J Alzheimers Dis. 2025 Feb 16:13872877251316794. doi: 10.1177/13872877251316794.
     PubMed     Abstract available
     
     
     
111. CLAUS JJ, Rosbergen MT, Roshchupkin GV, Ikram MA, et al
     Validation of a novel neuroimaging signature for dementia and clinical Alzheimer's disease in the population-based Rotterdam study.
     J Alzheimers Dis. 2025 Feb 16:13872877251315044. doi: 10.1177/13872877251315044.
     PubMed     Abstract available
     
     
     
112. KASAHARA H, Ikeda M, Makioka K, Nakamura T, et al
     White matter lesions rather than amyloid-beta burden are associated with cognitive decline in Alzheimer's disease.
     J Alzheimers Dis. 2025 Feb 16:13872877251316516. doi: 10.1177/13872877251316516.
     PubMed     Abstract available
     
     
     
113. PAN N, Liu S, Ge X, Zheng Y, et al
     Association of hippocampal atrophy with tau pathology of temporal regions in preclinical Alzheimer's disease.
     J Alzheimers Dis. 2025 Feb 16:13872877251314785. doi: 10.1177/13872877251314785.
     PubMed     Abstract available
     
     
     
114. XAVIER C, Pinto N
     Navigating the blurred boundary: Neuropathologic changes versus clinical symptoms in Alzheimer's disease, and its consequences for research in genetics.
     J Alzheimers Dis. 2025 Feb 16:13872877251317543. doi: 10.1177/13872877251317543.
     PubMed     Abstract available
     
     
     
115. ONIFADE IA, Umar HI, Aborode AT, Awaji AA, et al
     In silico study of selected alkaloids as dual inhibitors of beta- and gamma-secretases for Alzheimer's disease.
     J Alzheimers Dis. 2025 Feb 16:13872877241313049. doi: 10.1177/13872877241313049.
     PubMed     Abstract available
     
     
     
116. NETSYK O, Korol SV, Li JP, Birnir B, et al
     GABA-activated slow spontaneous inhibitory postsynaptic currents are decreased in dorsal hippocampal dentate gyrus granule cells in an aged mouse model of Alzheimer's disease.
     J Alzheimers Dis. 2025 Feb 16:13872877251317608. doi: 10.1177/13872877251317608.
     PubMed     Abstract available
     
     
     
117. SHENG ZH, Liu JY, Ma JY, Mi YC, et al
     Frailty increases the risk of Alzheimer's disease in non-demented individuals: A longitudinal cohort study.
     J Alzheimers Dis. 2025 Feb 16:13872877241309081. doi: 10.1177/13872877241309081.
     PubMed     Abstract available
     
     
     
118. CAI C, Kato T, Arahata Y, Takeda A, et al
     Altered functional connectivity between primary visual cortex and cerebellum in Alzheimer's disease.
     J Alzheimers Dis. 2025 Feb 16:13872877241303849. doi: 10.1177/13872877241303849.
     PubMed     Abstract available
     
     
     
119. WILLIAMS LA, Terhorst L, Williams IC, Skidmore E, et al
     Perceived risk of Alzheimer's disease: Insights into the Black and African American male perspective.
     J Alzheimers Dis. 2025 Feb 9:13872877251317151. doi: 10.1177/13872877251317151.
     PubMed     Abstract available
     
     
     
120. WEN C, Gan JH, Liu S, Lu H, et al
     Enlarged perivascular spaces correlate with blood-brain barrier leakage and cognitive impairment in Alzheimer's disease.
     J Alzheimers Dis. 2025 Feb 9:13872877251317220. doi: 10.1177/13872877251317220.
     PubMed     Abstract available
     
     
     
121. SILVA RPDS, Barbosa BJAP
     Exploring the potential of acupuncture as a complementary treatment for Alzheimer's disease: Pushing the boundaries forward.
     J Alzheimers Dis. 2025 Feb 9:13872877251316572. doi: 10.1177/13872877251316572.
     PubMed     Abstract available
     
     
     
122. TAWEEPHOL T, Pongpitakmetha T, Booncharoen K, Khieukhajee J, et al
     Short communication: Evaluating roles of plasma glial fibrillary acidic protein as Alzheimer's disease biomarker in real-world multi-center memory clinics in Thailand.
     J Alzheimers Dis. 2025 Feb 9:13872877251316546. doi: 10.1177/13872877251316546.
     PubMed     Abstract available
     
     
     
123. LU C, Zhou J
     Analysis of the causal relationship between five chosen factors and early-onset Alzheimer's disease: A Mendelian randomization study.
     J Alzheimers Dis. 2025 Feb 9:13872877241310248. doi: 10.1177/13872877241310248.
     PubMed     Abstract available
     
     
     
124. NDUKWE K, Serrano PA, Rockwell P, Xie L, et al
     Brain-penetrant histone deacetylase inhibitor RG2833 improves spatial memory in females of an Alzheimer's disease rat model.
     J Alzheimers Dis. 2025 Feb 9:13872877251314777. doi: 10.1177/13872877251314777.
     PubMed     Abstract available
     
     
     
125. TIAN Q, Dong Q, Su Z, Liu Y, et al
     Association of body weight and serum uric acid with Alzheimer's disease biomarkers and cognitive impairment.
     J Alzheimers Dis. 2025 Feb 9:13872877251315011. doi: 10.1177/13872877251315011.
     PubMed     Abstract available
     
     
     
126. PRIGATANO GP, Braga LW, McElvogue M, Coddaire K, et al
     Motor correlates of finger tapping variability in subjective memory complaints, mild cognitive impairment and probable Alzheimer's disease.
     J Alzheimers Dis. 2025 Feb 7:13872877241312984. doi: 10.1177/13872877241312984.
     PubMed     Abstract available
     
     
     
127. GUO R, Li D, Li F, Ji L, et al
     Effects of whole-head 810 nm near-infrared therapy on cognitive and neuropsychiatric symptoms in Alzheimer's disease: A pilot study.
     J Alzheimers Dis. 2025 Feb 5:13872877251313819. doi: 10.1177/13872877251313819.
     PubMed     Abstract available
     
     
     
128. RAMIREZ-GOMEZ J, Dalal S, Devara D, Sharma B, et al
     MicroRNA-based recent research developments in Alzheimer's disease.
     J Alzheimers Dis. 2025 Feb 2:13872877241313397. doi: 10.1177/13872877241313397.
     PubMed     Abstract available
     
     
     
129. KHALED M, Al-Jamal H, Matar D, Ibrahim A, et al
     Unveiling the link between APOE epsilon4, environmental factors, and Alzheimer's disease in North Lebanon: A case-control study.
     J Alzheimers Dis. 2025 Feb 2:13872877241307307. doi: 10.1177/13872877241307307.
     PubMed     Abstract available
     
     
     
130. YANG X, Wang J, Jia X, Yang Y, et al
     Microglial polarization in Alzheimer's disease: Mechanisms, implications, and therapeutic opportunities.
     J Alzheimers Dis. 2025 Feb 2:13872877241313223. doi: 10.1177/13872877241313223.
     PubMed     Abstract available
     
     
     
131. S M, Roy D, Menon AJ, G S, et al
     Exploring predementia: Understanding the characteristics of subjective cognitive decline plus from India.
     J Alzheimers Dis. 2025;103:966-973.
     PubMed     Abstract available
     
     
     
132. GE W, Yan Y, Hu Y, Lin S, et al
     Unveiling the safety profile of lecanemab: A comprehensive analysis of adverse events using FDA adverse event reporting system data.
     J Alzheimers Dis. 2025;103:844-855.
     PubMed     Abstract available
     
     
     
133. LI D, An B, Men L, Glittenberg M, et al
     The association of high-density lipoprotein cargo proteins with brain volume in older adults in the Atherosclerosis Risk in Communities (ARIC).
     J Alzheimers Dis. 2025;103:724-734.
     PubMed     Abstract available
     
     
     
134. WANG Y, Zhu L, He K, Cui L, et al
     Urinary formic acid is associated with cerebral amyloid deposition and glucose metabolism in memory clinic patients.
     J Alzheimers Dis. 2025;103:1102-1111.
     PubMed     Abstract available
     
     
     January 2025
135. ZHANG E, Dai F, Tao L, Chen Y, et al
     Immune cells: Mediators in the metabolites and Alzheimer's disease.
     J Alzheimers Dis. 2025 Jan 29:13872877241313140. doi: 10.1177/13872877241313140.
     PubMed     Abstract available
     
     
     
136. ZHANG L, An H, Zhen R, Zhang T, et al
     Di Huang Yi Zhi Fang improves cognitive function in APP/PS1 mice by inducing neuronal mitochondrial autophagy through the PINK1-parkin pathway.
     J Alzheimers Dis. 2025 Jan 28:13872877241299832. doi: 10.1177/13872877241299832.
     PubMed     Abstract available
     
     
     
137. ROVETA F, Rubino E, Marcinno A, Grassini A, et al
     Diagnostic performance of plasma biomarkers for Alzheimer's disease using a fully automated platform: A real-world clinical study.
     J Alzheimers Dis. 2025 Jan 26:13872877241313145. doi: 10.1177/13872877241313145.
     PubMed     Abstract available
     
     
     
138. ASHFORD JW
     The VA Million Veteran Program, Alzheimer's disease, and genetics: Important steps forward but many steps still to go on the march to control dementia and Alzheimer's disease.
     J Alzheimers Dis. 2025 Jan 26:13872877241313398. doi: 10.1177/13872877241313398.
     PubMed     Abstract available
     
     
     
139. SIRIWARDHANA C, Carrazana E, Liow K
     Survival disparities among Alzheimer's disease patients in Hawaii.
     J Alzheimers Dis. 2025 Jan 26:13872877251314144. doi: 10.1177/13872877251314144.
     PubMed     Abstract available
     
     
     
140. GALVIN JE, Kleiman MJ, Estes PW, Harris HM, et al
     Cognivue Clarity((R)) characterizes amyloid status and preclinical Alzheimer's disease in biomarker confirmed cohorts in the Bio-Hermes Study.
     J Alzheimers Dis. 2025 Jan 26:13872877251314117. doi: 10.1177/13872877251314117.
     PubMed     Abstract available
     
     
     
141. GILLMAN A, Bourgeat P, Cox T, Villemagne VL, et al
     Digital detector PET/CT increases Centiloid measures of amyloid in Alzheimer's disease: A head-to-head comparison of cameras.
     J Alzheimers Dis. 2025 Jan 26:13872877241313063. doi: 10.1177/13872877241313063.
     PubMed     Abstract available
     
     
     
142. TOLEA MI, Rosenfeld A, Roy SV, Besser LM, et al
     Gait, balance, and physical performance as markers of early Alzheimer's disease and related dementia risk.
     J Alzheimers Dis. 2025 Jan 26:13872877241313144. doi: 10.1177/13872877241313144.
     PubMed     Abstract available
     
     
     
143. SHAO J, Youngblood H, Yang L
     Targeting SPI1 to mitigate amyloid-beta pathology in Alzheimer's disease.
     J Alzheimers Dis. 2025 Jan 26:13872877251316593. doi: 10.1177/13872877251316593.
     PubMed     Abstract available
     
     
     
144. CROOKE PS 3RD, Tossberg JT, Aune TM
     Increased unedited Alu RNA patterns found in cortex extracellular vesicles in Alzheimer's disease resemble hippocampus vasculature Alu RNA editing patterns but not cortex Alu RNA editing patterns.
     J Alzheimers Dis. 2025 Jan 26:13872877241313054. doi: 10.1177/13872877241313054.
     PubMed     Abstract available
     
     
     
145. PETKUS AJ, Sonti AN, Montoya L, Rowe B, et al
     Sequence of decline on the NIH-toolbox cognitive battery in a predominantly Latino sample with autosomal dominant Alzheimer's disease.
     J Alzheimers Dis. 2025 Jan 26:13872877241312934. doi: 10.1177/13872877241312934.
     PubMed     Abstract available
     
     
     
146. FU XX, Wei B, Huang ZH, Duan R, et al
     Modulation of mitochondrial functions contributes to the protection of lamotrigine against Alzheimer's disease.
     J Alzheimers Dis. 2025 Jan 21:13872877251314847. doi: 10.1177/13872877251314847.
     PubMed     Abstract available
     
     
     
147. YANG H, Ning Y, Chen M, Jia J, et al
     SGLT2 inhibition, circulating biomarkers, and Alzheimer's disease: A Mendelian randomization study.
     J Alzheimers Dis. 2025 Jan 21:13872877241309674. doi: 10.1177/13872877241309674.
     PubMed     Abstract available
     
     
     
148. WANG Z, Liang Q, Lin Z, Li H, et al
     Potential role of formononetin as a novel natural agent in Alzheimer's disease and osteoporosis comorbidity.
     J Alzheimers Dis. 2025 Jan 19:13872877241299104. doi: 10.1177/13872877241299104.
     PubMed     Abstract available
     
     
     
149. KJAERGAARD D, Simonsen AH, Waldemar G, Nielsen TR, et al
     Ethnic and racial influences on blood biomarkers for Alzheimer's disease: A systematic review.
     J Alzheimers Dis. 2025 Jan 15:13872877241299047. doi: 10.1177/13872877241299047.
     PubMed     Abstract available
     
     
     
150. DAVID S, Costa AS, Hohenfeld C, Romanzetti S, et al
     Modulating effects of fitness and physical activity on Alzheimer's disease: Implications from a six-month randomized controlled sports intervention.
     J Alzheimers Dis. 2025 Jan 15:13872877241303764. doi: 10.1177/13872877241303764.
     PubMed     Abstract available
     
     
     
151. TAUFEEQ M, Choudhury A, Hussain A, Alajmi MF, et al
     Discovering potential ERK1 inhibitors from natural products for therapeutic targeting of Alzheimer's disease.
     J Alzheimers Dis. 2025 Jan 15:13872877241309592. doi: 10.1177/13872877241309592.
     PubMed     Abstract available
     
     
     
152. YANG W, Yu W, Lv Y
     Neuroprotective effects of chitinase-1 and calcitonin gene-related peptide on Alzheimer's disease by promoting lysosomal function.
     J Alzheimers Dis. 2025 Jan 15:13872877241307257. doi: 10.1177/13872877241307257.
     PubMed     Abstract available
     
     
     
153. LI Y, Sanjay AB, Manchella M, Mishra A, et al
     Effect of genetic and vascular risk factors on rates of cognitive decline in early-onset and late-onset Alzheimer's disease.
     J Alzheimers Dis. 2025 Jan 12:13872877241307321. doi: 10.1177/13872877241307321.
     PubMed     Abstract available
     
     
     
154. RUIZ-URIBE NE, Manser P, Butcher B, Li Y, et al
     Cross-sectional and prognostic associations of baseline [(18)F]GTP1 tau PET signal and white matter lesion volumes for cognitive and functional decline in prodromal-to-mild Alzheimer's disease.
     J Alzheimers Dis. 2025 Jan 12:13872877241302497. doi: 10.1177/13872877241302497.
     PubMed     Abstract available
     
     
     
155. XING H, Kant S, Kanuparthy M, Harris D, et al
     Impaired cerebral microvascular reactivity and endothelial SK channel activity in a streptozotocin-treated mouse model of Alzheimer's disease.
     J Alzheimers Dis. 2025 Jan 10:13872877241309120. doi: 10.1177/13872877241309120.
     PubMed     Abstract available
     
     
     
156. HAN X, Li Y, Wang J, Liu X, et al
     Associations between lifelong cognitive reserve, Alzheimer's disease-related plasma biomarkers, and cognitive function in dementia-free older adults: A population-based study.
     J Alzheimers Dis. 2025 Jan 10:13872877241306448. doi: 10.1177/13872877241306448.
     PubMed     Abstract available
     
     
     
157. XU F, Shi J
     Insulin signaling and oxidative stress: Bridging the gap between type 2 diabetes mellitus and Alzheimer's disease.
     J Alzheimers Dis. 2025 Jan 10:13872877241307404. doi: 10.1177/13872877241307404.
     PubMed     Abstract available
     
     
     
158. SHAH J, Krell-Roesch J, Forzani E, Knopman DS, et al
     Predicting cognitive decline from neuropsychiatric symptoms and Alzheimer's disease biomarkers: A machine learning approach to a population-based data.
     J Alzheimers Dis. 2025 Jan 10:13872877241306654. doi: 10.1177/13872877241306654.
     PubMed     Abstract available
     
     
     
159. WAN T, Wang C
     SMOC2 promotes microglia activity and neuroinflammation in Alzheimer's disease.
     J Alzheimers Dis. 2025 Jan 10:13872877241307337. doi: 10.1177/13872877241307337.
     PubMed     Abstract available
     
     
     
160. MATSUNAGA M, Tanihara S, He Y, Yatsuya H, et al
     Sex-specific association of comorbid heart failure on mortality after Alzheimer's disease diagnosis in older adults aged 75 years and above: A health insurance claims data analysis in Japan.
     J Alzheimers Dis. 2025 Jan 10:13872877241305813. doi: 10.1177/13872877241305813.
     PubMed     Abstract available
     
     
     
161. DA SILVA PINTO GM, de Souza Crepalde LO, Scalli ACAM, de Oliveira MPB, et al
     Body composition differences in older adults with and without Alzheimer's disease: A systematic review and meta-analysis of observational studies.
     J Alzheimers Dis. 2025 Jan 10:13872877241304603. doi: 10.1177/13872877241304603.
     PubMed     Abstract available
     
     
     
162. ALGHAMDI A, de Vos S, Bos JH, Schuiling-Veninga CC, et al
     A matched case-control study on polypharmacy and co-medications one year before drug treatment for Alzheimer's disease.
     J Alzheimers Dis. 2025 Jan 10:13872877241305799. doi: 10.1177/13872877241305799.
     PubMed     Abstract available
     
     
     
163. LI S, Wang Y, Liang X, Li Y, et al
     Autophagy intersection: Unraveling the role of the SNARE complex in lysosomal fusion in Alzheimer's disease.
     J Alzheimers Dis. 2025 Jan 9:13872877241307403. doi: 10.1177/13872877241307403.
     PubMed     Abstract available
     
     
     
164. BARKER-HALISKI M
     Seizing the opportunity to therapeutically address neuronal hyperexcitability in Alzheimer's disease.
     J Alzheimers Dis. 2025 Jan 9:13872877241305740. doi: 10.1177/13872877241305740.
     PubMed     Abstract available
     
     
     
165. SU S, Huang R, Liu Y
     The effects of transcranial direct current stimulation on global cognition in patients with Alzheimer's disease: An update meta-analysis.
     J Alzheimers Dis. 2025 Jan 9:13872877241298303. doi: 10.1177/13872877241298303.
     PubMed     Abstract available
     
     
     
166. WANG X, Chen L, Li W, He Z, et al
     Association of dipeptidyl peptidase-4 with Alzheimer's disease: A new therapeutic prospect.
     J Alzheimers Dis. 2025 Jan 8:13872877241304673. doi: 10.1177/13872877241304673.
     PubMed     Abstract available
     
     
     
167. GRAU-JURADO P, Mostafaei S, Xu H, Mo M, et al
     Medications and cognitive decline in Alzheimer's disease: Cohort cluster analysis of 15,428 patients.
     J Alzheimers Dis. 2025 Jan 8:13872877241307870. doi: 10.1177/13872877241307870.
     PubMed     Abstract available
     
     
     
168. GOODING DC, Van Hulle CA, Zuelsdorff M, Lewis JP, et al
     Perceptions about preclinical Alzheimer's disease biomarker collection procedure influences willingness to participate: Findings from an ethnoracially diverse study.
     J Alzheimers Dis. 2025 Jan 8:13872877241307255. doi: 10.1177/13872877241307255.
     PubMed     Abstract available
     
     
     
169. WANG P, Dong YL, Li SS, Jin Y, et al
     Integrating network pharmacology and component analysis to investigate the potential mechanisms of Sheng-Hui-Yi-Zhi decoction in the treatment of Alzheimer's disease.
     J Alzheimers Dis. 2025 Jan 8:13872877241305744. doi: 10.1177/13872877241305744.
     PubMed     Abstract available
     
     
     
170. MERRITT VC, Zhang R, Sherva R, Ly MT, et al
     Curation and validation of electronic medical record-based dementia diagnoses in the VA Million Veteran Program.
     J Alzheimers Dis. 2025;103:180-193.
     PubMed     Abstract available
     
     
     
171. IMPERIALE D, Atzori C, Angeloro DP, Murgioni A, et al
     Real-life reliability of plasma pTau181, Abeta(42)/Abeta(40), and pTau181/Abeta(42) measured by Lumipulse G600II in predicting cerebrospinal fluid amyloid status.
     J Alzheimers Dis. 2025;103:305-315.
     PubMed     Abstract available
     
     
     
172. ENGEL MG, Narayan S, Cui MH, Branch CA, et al
     Intranasal long R3 insulin-like growth factor-1 treatment promotes amyloid plaque remodeling in cerebral cortex but fails to preserve cognitive function in male 5XFAD mice.
     J Alzheimers Dis. 2025;103:113-126.
     PubMed     Abstract available
     
     
     
173. CHEN X, Lin C, He C, Li K, et al
     Icariin improves learning and memory function by enhancing HRD1-mediated ubiquitination of amyloid precursor protein in APP/PS1 mice.
     J Alzheimers Dis. 2025;103:616-626.
     PubMed     Abstract available
     
     
     
174. WITBRACHT M, Xu Y, Morgan OB, Salazar CR, et al
     Research Attitudes Questionnaire scores and retention in a recruitment registry.
     J Alzheimers Dis. 2025;103:406-418.
     PubMed     Abstract available
     
     
     
175. HEDDERICH DM, Opfer R, Kruger J, Spies L, et al
     Clinical validation of artificial intelligence-based single-subject morphometry without normative reference database.
     J Alzheimers Dis. 2025;103:542-551.
     PubMed     Abstract available
     
     
     
176. WEINSTEIN AM, Fang F, Chang CH, Cohen A, et al
     Multimodal neuroimaging biomarkers and subtle cognitive decline in a population-based cohort without dementia.
     J Alzheimers Dis. 2025;103:570-581.
     PubMed     Abstract available
     
     
     
177. LIM YY, Mills A, Norfolk M, Rosenich E, et al
     Factors influencing rates of unsupervised assessment of short-term learning in cognitively unimpaired adults.
     J Alzheimers Dis. 2025;103:441-451.
     PubMed     Abstract available
     
     
     
178. JAHANI I, Jahani A, Delrobaei M, Khadem A, et al
     Classifying cognitive impairment based on FDG-PET and combined T1-MRI and rs-fMRI: An ADNI study.
     J Alzheimers Dis. 2025;103:452-464.
     PubMed     Abstract available
     
     
     
179. WEINSTEIN AM, Gogniat MA, Butters MA
     The importance of cognitive correlates of plasma amyloid-beta 42/40.
     J Alzheimers Dis. 2025;103:353-355.
     PubMed     Abstract available
     
     
     December 2024
180. BENNETT CG, Guttmann RP, Hackney ME, Amin R, et al
     Impacts of adapted dance on mood and physical function among persons living with Alzheimer's disease.
     J Alzheimers Dis. 2024 Dec 23:13872877241298529. doi: 10.1177/13872877241298529.
     PubMed     Abstract available
     
     
     
181. HORSTKOTTER D
     Alzheimer's disease prediction and prevention in a public health perspective: Ethical considerations and collaborations beyond the biomedical paradigm.
     J Alzheimers Dis. 2024 Dec 23:13872877241308299. doi: 10.1177/13872877241308299.
     PubMed     Abstract available
     
     
     
182. VIGNOLO J, Jacus JP, Darnaud T, Cuervo-Lombard CV, et al
     Exploratory study of French healthcare workers' experiences of anosognosia in Alzheimer's disease and related disorders.
     J Alzheimers Dis. 2024 Dec 19:13872877241307045. doi: 10.1177/13872877241307045.
     PubMed     Abstract available
     
     
     
183. BOADA M, Neve A, Das B, Wojtowicz J, et al
     Long-term safety of gantenerumab in participants with Alzheimer's disease: A phase III, open-label extension study (SCarlet RoAD).
     J Alzheimers Dis. 2024 Dec 16:13872877241303644. doi: 10.1177/13872877241303644.
     PubMed     Abstract available
     
     
     
184. GARCIA-LLUCH G, Marseglia A, Royo LM, Albiach JP, et al
     Associations between antidiabetic medications and cerebrospinal fluid biomarkers of Alzheimer's disease.
     J Alzheimers Dis. 2024 Dec 16:13872877241304995. doi: 10.1177/13872877241304995.
     PubMed     Abstract available
     
     
     
185. PLUTA R, Kocki J, Bogucki J, Bogucka-Kocka A, et al
     Apolipoprotein (APOA1, APOE, CLU) genes expression in the CA3 region of the hippocampus in an ischemic model of Alzheimer's disease with survival up to 2 years.
     J Alzheimers Dis. 2024 Dec 16:13872877241303950. doi: 10.1177/13872877241303950.
     PubMed     Abstract available
     
     
     
186. NAZARETH CCG, Scalli ACAM, de Oliveira MPB, Gomes AFS, et al
     Differences in lean mass and sarcopenia between individuals with Alzheimer's disease and those without dementia: A systematic review and meta-analysis of observational studies.
     J Alzheimers Dis. 2024 Dec 16:13872877241299051. doi: 10.1177/13872877241299051.
     PubMed     Abstract available
     
     
     
187. LI D, Liu X, Yu J, Zhang Y, et al
     Item response theory for the color-picture version of Boston naming test in a Chinese sample with neurodegenerative diseases.
     J Alzheimers Dis. 2024 Dec 16:13872877241305820. doi: 10.1177/13872877241305820.
     PubMed     Abstract available
     
     
     
188. OKAFOR M, Yang Z, Vickers KL, Sanders K, et al
     Technology literacy and access to digital resources for remote assessment among adults enrolled in Alzheimer's disease research.
     J Alzheimers Dis. 2024 Dec 11:13872877241297496. doi: 10.1177/13872877241297496.
     PubMed     Abstract available
     
     
     
189. MAKI Y, Ubuka T, Yamane Y
     The importance of non-pharmacological interventions to improve cognitive reserve prior to the administration of a drug against the causative agent of Alzheimer's disease.
     J Alzheimers Dis. 2024 Dec 5:13872877241301806. doi: 10.1177/13872877241301806.
     PubMed     Abstract available
     
     
     
190. SMITH ML, Wilson AD, Knebl J, Hilsabeck RC, et al
     Utilization and perceived usefulness of monitoring technology for family caregivers of people living with Alzheimer's disease and related dementias.
     J Alzheimers Dis. 2024 Dec 5:13872877241300078. doi: 10.1177/13872877241300078.
     PubMed     Abstract available
     
     
     
191. ZENG J, Gao Z, Xiong X, Hou X, et al
     The effects of two Alzheimer's disease related genes APOE and MAPT in healthy young adults: An attentional blink study.
     J Alzheimers Dis. 2024 Dec 5:13872877241299124. doi: 10.1177/13872877241299124.
     PubMed     Abstract available
     
     
     
192. ANGELOPOULOU E, Papageorgiou SG
     Telemedicine in Alzheimer's disease and other dementias: Where we are?
     J Alzheimers Dis. 2024 Dec 5:13872877241298295. doi: 10.1177/13872877241298295.
     PubMed     Abstract available
     
     
     
193. ZHANG P, Liu Y, Jin X, Hu Z, et al
     Alzheimer's disease-like pathology induced by Porphyromonas gingivalis in middle-aged mice is mediated by NLRP3 inflammasome via the microbiota-gut-brain axis.
     J Alzheimers Dis. 2024 Dec 5:13872877241302498. doi: 10.1177/13872877241302498.
     PubMed     Abstract available
     
     
     
194. XU L, Chen K, Mueller KD, Liss J, et al
     Articulatory precision from connected speech as a marker of cognitive decline in Alzheimer's disease risk-enriched cohorts.
     J Alzheimers Dis. 2024 Dec 5:13872877241300149. doi: 10.1177/13872877241300149.
     PubMed     Abstract available
     
     
     
195. BARNES DE, Balderson BH, Shulman L, Rosenberg DE, et al
     The Systematic Multi-domain Alzheimer's Risk Reduction Trial (SMARRT) intervention: A personalized approach to dementia risk reduction.
     J Alzheimers Dis. 2024 Dec 3:13872877241296161. doi: 10.1177/13872877241296161.
     PubMed     Abstract available
     
     
     
196. TAO M, Cui L, Du Y, Liu X, et al
     Analysis of eye movement features in patients with Alzheimer's disease based on intelligent eye movement analysis and evaluation system.
     J Alzheimers Dis. 2024 Dec 1:13872877241297416. doi: 10.1177/13872877241297416.
     PubMed     Abstract available
     
     
     
197. SHIR D, Shiner T, Bregman N
     Anti-amyloid treatments for Alzheimer's disease: A study on physicians' perspectives.
     J Alzheimers Dis. 2024;102:627-632.
     PubMed     Abstract available
     
     
     
198. CANEVELLI M, Ancidoni A, Valletta M, Toccaceli Blasi M, et al
     Reporting of comorbidities and health status of participants in clinical trials testing amyloid- and tau-targeting monoclonal antibodies for Alzheimer's disease: A systematic review.
     J Alzheimers Dis. 2024;102:587-596.
     PubMed     Abstract available
     
     
     
199. KISELICA AM, Atkinas KJ, Han SD, Diaz-Orueta U, et al
     Reactions of clinical neuropsychologists to the Alzheimer's Association workgroup's draft diagnostic and staging criteria for Alzheimer's disease.
     J Alzheimers Dis. 2024;102:877-884.
     PubMed     Abstract available
     
     
     
200. OLIVER A, Wildschut T, Redhead ES, Parker MO, et al
     Benefits of nostalgic landmarks for people living with Alzheimer's disease.
     J Alzheimers Dis. 2024;102:683-702.
     PubMed     Abstract available
     
     
     
201. ANDRES P, Flores-Vazquez JF, Enriquez-Geppert S
     Associating faces with names and meals as a biomarker of early AD in cognitively healthy individuals.
     J Alzheimers Dis. 2024;102:639-641.
     PubMed     Abstract available
     
     
     
202. SOINIEMI L, Solje E, Suominen AL, Kanninen KM, et al
     The association between oral diseases and neurodegenerative disorders.
     J Alzheimers Dis. 2024;102:577-586.
     PubMed     Abstract available
     
     
     
203. PEETHAMBARAN MALLIKA A
     Tri-culture modeling of neuroinflammation, neurodegeneration, and neuroprotection.
     J Alzheimers Dis. 2024;102:742-744.
     PubMed     Abstract available
     
     
     
204. GAN J, Zeng Y, Huang G, Wang XD, et al
     The updated prevalence and risk factors of dementia in old adults in China: A cross-sectional study.
     J Alzheimers Dis. 2024;102:1209-1223.
     PubMed     Abstract available
     
     
     November 2024
205. BENKE T, Karagiannis G
     Memory anosognosia in early Alzheimer's disease: A memory clinic study.
     J Alzheimers Dis. 2024 Nov 29:13872877241302423. doi: 10.1177/13872877241302423.
     PubMed     Abstract available
     
     
     
206. CASTELLANI RJ
     Biomarker-only diagnosis of Alzheimer's disease: Not ready for prime time.
     J Alzheimers Dis. 2024 Nov 29:13872877241301805. doi: 10.1177/13872877241301805.
     PubMed     Abstract available
     
     
     
207. JUDAY TR, Holub A, Mattke S, Betts KA, et al
     Real-world diagnostic, referral, and treatment patterns in early Alzheimer's disease among community-based practices in the United States.
     J Alzheimers Dis. 2024 Nov 29:13872877241297128. doi: 10.1177/13872877241297128.
     PubMed     Abstract available
     
     
     
208. BECHI GABRIELLI G, D'Antonio F, Di Vita A, Margiotta R, et al
     Mind's eye in the Alzheimer's disease spectrum continuum.
     J Alzheimers Dis. 2024 Nov 29:13872877241299134. doi: 10.1177/13872877241299134.
     PubMed     Abstract available
     
     
     
209. UNERI A, McArdle CJ, Deng Z, Barth SH, et al
     DJ-1-mediated repression of the RNA-binding protein FMRP is predicted to impact known Alzheimer's disease-related protein networks.
     J Alzheimers Dis. 2024 Nov 29:13872877241291175. doi: 10.1177/13872877241291175.
     PubMed     Abstract available
     
     
     
210. MALIK R, Beaton D, Ahmed J, Nho K, et al
     A DAT1 gene and APOE epsilon4 interaction is associated with apathy and structural brain changes in mild cognitive impairment and Alzheimer's disease.
     J Alzheimers Dis. 2024 Nov 29:13872877241299785. doi: 10.1177/13872877241299785.
     PubMed     Abstract available
     
     
     
211. AKHTAR SN, Tran TD, Chen YH, Lu Q, et al
     Spatial and planar profiling of Rac1/Cdc42 signaling in Alzheimer's disease brain.
     J Alzheimers Dis. 2024 Nov 29:13872877241291076. doi: 10.1177/13872877241291076.
     PubMed     Abstract available
     
     
     
212. RAO S, Forns J, Danysh HE, Calingaert B, et al
     Natural history and clinical outcomes in patients with Alzheimer's disease-related psychosis by antipsychotic treatment status in the United States.
     J Alzheimers Dis. 2024 Nov 27:13872877241297361. doi: 10.1177/13872877241297361.
     PubMed     Abstract available
     
     
     
213. BERNARD MA, Boutajangout A, Debure L, Ahmed W, et al
     The relationship between anxiety and levels of Alzheimer's disease plasma biomarkers.
     J Alzheimers Dis. 2024 Nov 27:13872877241295324. doi: 10.1177/13872877241295324.
     PubMed     Abstract available
     
     
     
214. PRABHA S, Sajad M, Anjum F, Hassan MI, et al
     Investigating gene expression datasets of hippocampus tissue to discover Alzheimer's disease-associated molecular markers.
     J Alzheimers Dis. 2024 Nov 27:13872877241297335. doi: 10.1177/13872877241297335.
     PubMed     Abstract available
     
     
     
215. ORJUELA AL, Pecchio M, Cruz-Mora J, Emani LS, et al
     The role of carotenoids from red mamey fruit (Pouteria sapota) against amyloid-beta monomers in Alzheimer's disease: Computational analysis and ADMET prediction.
     J Alzheimers Dis. 2024 Nov 26:13872877241291172. doi: 10.1177/13872877241291172.
     PubMed     Abstract available
     
     
     
216. BAGHERI S, Rashno M, Salehi I, Karimi SA, et al
     Protective effects of geraniol in a male rat model of Alzheimer's disease: A behavioral, biochemical, and histological study.
     J Alzheimers Dis. 2024 Nov 25:13872877241290695. doi: 10.1177/13872877241290695.
     PubMed     Abstract available
     
     
     
217. FERRARO PM, Filippi L, Ponzano M, Signori A, et al
     Clinical and biological underpinnings of longitudinal atrophy pattern progression in Alzheimer's disease.
     J Alzheimers Dis. 2024 Nov 25:13872877241299843. doi: 10.1177/13872877241299843.
     PubMed     Abstract available
     
     
     
218. LIU W, Chen S, Rao X, Chen X, et al
     Exploring the role of miR-125b-5p as a pro-inflammatory factor in Alzheimer's disease pathology.
     J Alzheimers Dis. 2024 Nov 25:13872877241297178. doi: 10.1177/13872877241297178.
     PubMed     Abstract available
     
     
     
219. GAO Z, Zhu W, Li Y, Ye W, et al
     Identification and cognitive function prediction of Alzheimer's disease based on multivariate pattern analysis of hippocampal volumes.
     J Alzheimers Dis. 2024 Nov 25:13872877241296130. doi: 10.1177/13872877241296130.
     PubMed     Abstract available
     
     
     
220. PAN H, Wang G, Bi Z, Lai C, et al
     Identification of key neutrophil extracellular trap genes in Alzheimer's disease.
     J Alzheimers Dis. 2024 Nov 25:13872877241295374. doi: 10.1177/13872877241295374.
     PubMed     Abstract available
     
     
     
221. WEISS JN
     Dynamic light scattering of the eye in the diagnosis of Alzheimer's disease.
     J Alzheimers Dis. 2024 Nov 25:13872877241301802. doi: 10.1177/13872877241301802.
     PubMed     Abstract available
     
     
     
222. SHIBATA H, Uchida Y, Kan H, Sakurai K, et al
     Deep-learning assessment of hippocampal magnetic susceptibility in Alzheimer's disease.
     J Alzheimers Dis. 2024 Nov 25:13872877241300278. doi: 10.1177/13872877241300278.
     PubMed     Abstract available
     
     
     
223. SANTOS VD, Costa AC, Junior NC, Delaere FJ, et al
     Virtual reality interventions and their effects on the cognition of individuals with Alzheimer's disease: A systematic review and meta-analysis.
     J Alzheimers Dis. 2024 Nov 25:13872877241299037. doi: 10.1177/13872877241299037.
     PubMed     Abstract available
     
     
     
224. KOLLING LJ, Chimenti MS, Marcinkiewcz CA
     Spatial differences in gene expression across the dorsal raphe nucleus in a model of early Alzheimer's disease.
     J Alzheimers Dis. 2024 Nov 25:13872877241299119. doi: 10.1177/13872877241299119.
     PubMed     Abstract available
     
     
     
225. XIYANG Y, Gao J, Ding M, Ren X, et al
     Exacerbated mitochondrial dynamic abnormalities without evident tau pathology in rapidly progressive Alzheimer's disease.
     J Alzheimers Dis. 2024 Nov 25:13872877241295403. doi: 10.1177/13872877241295403.
     PubMed     Abstract available
     
     
     
226. BUONGIORNO M, Sanchez-Benavides G, Marzal-Espi C, Giraldo DM, et al
     Blood-brain barrier permeable beta-blockers association with Alzheimer's disease cerebrospinal fluid biomarkers levels in non-demented individuals.
     J Alzheimers Dis. 2024 Nov 25:13872877241293812. doi: 10.1177/13872877241293812.
     PubMed     Abstract available
     
     
     
227. MARTINEZ-LOPEZ S, Tabone M, Clemente-Velasco S, Gonzalez-Soltero MDR, et al
     A systematic review of lifestyle-based interventions for managing Alzheimer's disease: Insights from randomized controlled trials.
     J Alzheimers Dis. 2024 Nov 25:13872877241292829. doi: 10.1177/13872877241292829.
     PubMed     Abstract available
     
     
     
228. PAJAVAND AM, Grothe MJ, De Schotten MT, Giorgi FS, et al
     Structural white matter connectivity differences independent of gray matter loss in mild cognitive impairment with neuropsychiatric symptoms: Early indicators of Alzheimer's disease using network-based statistics.
     J Alzheimers Dis. 2024 Nov 22:13872877241288710. doi: 10.1177/13872877241288710.
     PubMed     Abstract available
     
     
     
229. WANG LY, Hu H, Sheng ZH, Hu HY, et al
     Associations among healthy lifestyle characteristics, neuroinflammation, and cerebrospinal fluid core biomarkers of Alzheimer's disease in cognitively intact adults: The CABLE study.
     J Alzheimers Dis. 2024 Nov 19:13872877241291969. doi: 10.1177/13872877241291969.
     PubMed     Abstract available
     
     
     
230. KARKKAINEN V, Hannonen S, Rusanen M, Lehtola JM, et al
     Tear fluid reflects the altered protein expressions of Alzheimer's disease patients in proteins involved in protein repair and clearance system or the regulation of cytoskeleton.
     J Alzheimers Dis. 2024 Nov 18:13872877241295315. doi: 10.1177/13872877241295315.
     PubMed     Abstract available
     
     
     
231. RIGHI D, Manco C, Pardini M, Stufano A, et al
     Investigating interleukin-8 in Alzheimer's disease: A comprehensive review.
     J Alzheimers Dis. 2024 Nov 18:13872877241298973. doi: 10.1177/13872877241298973.
     PubMed     Abstract available
     
     
     
232. SHAO K, Chen X, Yu X, Yang J, et al
     Functional connectivity changes in two cortico-hippocampal networks of Alzheimer's disease continuum and their correlations with cognition: A SILCODE study.
     J Alzheimers Dis. 2024 Nov 15:13872877241291236. doi: 10.1177/13872877241291236.
     PubMed     Abstract available
     
     
     
233. KE C, Shan S, Yu J, Wei X, et al
     Acupuncture for patients with Alzheimer's disease: An evidence map of randomized controlled trials, systematic reviews, and meta-analysis.
     J Alzheimers Dis. 2024 Nov 14:13872877241295400. doi: 10.1177/13872877241295400.
     PubMed     Abstract available
     
     
     
234. AGBOJI A, Freeman S, Banner D, Armstrong J, et al
     The prevalence and risk factors of apathy among the Canadian long-term care residents with Alzheimer's disease and related dementias.
     J Alzheimers Dis. 2024 Nov 14:JAD240370. doi: 10.3233/JAD-240370.
     PubMed     Abstract available
     
     
     
235. SCHEINMAN SB, Dong H
     The impact of sex on memory during aging and Alzheimer's disease progression: Epigenetic mechanisms.
     J Alzheimers Dis. 2024 Nov 14:13872877241288709. doi: 10.1177/13872877241288709.
     PubMed     Abstract available
     
     
     
236. CHAO SP, Lin WC, Lu CH, Wu HC, et al
     Changes in plasma biomarkers differentiate clinical stages of Alzheimer's disease using immunomagnetic reduction assays.
     J Alzheimers Dis. 2024 Nov 13:JAD240690. doi: 10.3233/JAD-240690.
     PubMed     Abstract available
     
     
     
237. SCHROEDER KM, Afonso AS, Wang H, Grace S, et al
     Demographics, comorbidities, and comedications in newly diagnosed patients with Alzheimer's disease and related dementias: Findings from United States Medicare claims data.
     J Alzheimers Dis. 2024 Nov 13:JAD231488. doi: 10.3233/JAD-231488.
     PubMed     Abstract available
     
     
     
238. BEHL S, Slomkowski M, Chen D, Chang D, et al
     Brexpiprazole for the treatment of agitation associated with dementia due to Alzheimer's disease: A 12-week, active-treatment, extension trial.
     J Alzheimers Dis. 2024 Nov 13:JAD240491. doi: 10.3233/JAD-240491.
     PubMed     Abstract available
     
     
     
239. LEWIS JM, Harris DA, Kosmatka J, Mikrut E, et al
     Single step capture and assessment of multiple plasma extracellular vesicle biomarkers in Alzheimer's disease detection.
     J Alzheimers Dis. 2024 Nov 13:13872877241291964. doi: 10.1177/13872877241291964.
     PubMed     Abstract available
     
     
     
240. MOSS DE, Perez RG
     The phospho-tau cascade, basal forebrain neurodegeneration, and dementia in Alzheimer's disease: Anti-neurodegenerative benefits of acetylcholinesterase inhibitors.
     J Alzheimers Dis. 2024 Nov 12:13872877241289602. doi: 10.1177/13872877241289602.
     PubMed     Abstract available
     
     
     
241. SUZUKI H, Tagai K, Ono M, Shimizu H, et al
     Distinct tau pathologies in the nucleus basalis of Meynert between early-onset and late-onset Alzheimer's disease patients revealed by positron emission tomography.
     J Alzheimers Dis. 2024 Nov 11:13872877241297382. doi: 10.1177/13872877241297382.
     PubMed     Abstract available
     
     
     
242. MAYR E, Rotter J, Kuhrt H, Winter K, et al
     Detection of molecular markers of ferroptosis in human Alzheimer's disease brains.
     J Alzheimers Dis. 2024 Nov 11:13872877241296563. doi: 10.1177/13872877241296563.
     PubMed     Abstract available
     
     
     
243. PAN M, Lai D, Unverzagt F, Apostolova L, et al
     Genetic variants for Alzheimer's disease and comorbid conditions.
     J Alzheimers Dis. 2024 Nov 10:13872877241289054. doi: 10.1177/13872877241289054.
     PubMed     Abstract available
     
     
     
244. MAHAJAN K, Sharma S, Gautam RK, Goyal R, et al
     Insights on therapeutic approaches of natural anti-Alzheimer's agents in the management of Alzheimer's disease: A future perspective.
     J Alzheimers Dis. 2024 Nov 10:13872877241296557. doi: 10.1177/13872877241296557.
     PubMed     Abstract available
     
     
     
245. AAZAD AA, Choudhury A, Hussain A, AlAjmi MF, et al
     Exploring phytochemical inhibitors of protein kinase C alpha for therapeutic targeting of Alzheimer's disease.
     J Alzheimers Dis. 2024 Nov 10:13872877241289620. doi: 10.1177/13872877241289620.
     PubMed     Abstract available
     
     
     
246. REN C, Wang WQ, Li HH, Li BY, et al
     Valuing the importance of sex differences in prodromal Alzheimer's disease based on structural magnetic resonance imaging.
     J Alzheimers Dis. 2024 Nov 8:13872877241289790. doi: 10.1177/13872877241289790.
     PubMed     Abstract available
     
     
     
247. GARCIA-ALBERCA JM, De La Guia P, Gris E, Mendoza S, et al
     Real-world assessment of caregiver preference and compliance to treatment with twice-weekly versus daily rivastigmine patches in Alzheimer's disease.
     J Alzheimers Dis. 2024 Nov 5:13872877241292018. doi: 10.1177/13872877241292018.
     PubMed     Abstract available
     
     
     
248. DEJAKAISAYA H, Lin R, Harutyunyan A, Chan J, et al
     Effect of ceftriaxone on the glutamate-glutamine cycle and seizure susceptibility of Tg2576 mouse model of Alzheimer's disease.
     J Alzheimers Dis. 2024 Nov 3:13872877241289053. doi: 10.1177/13872877241289053.
     PubMed     Abstract available
     
     
     
249. CHEN X, Hu F, Chi Q, Rao C, et al
     The study of Alzheimer's disease risk diagnosis based on natural killer cell marker genes in the multi-omics data.
     J Alzheimers Dis. 2024 Nov 3:13872877241295316. doi: 10.1177/13872877241295316.
     PubMed     Abstract available
     
     
     
250. GESSI S, Mirandola P, Merighi S
     Keep neuroinflammation in mind when addressing Alzheimer's disease: A microglia perspective.
     J Alzheimers Dis. 2024 Nov 3:13872877241290693. doi: 10.1177/13872877241290693.
     PubMed     Abstract available
     
     
     
251. ABDELRAOUF K, Farrag HS, El-Ganzuri MA, El-Sayed WM, et al
     A new bithiophene inhibited amyloid-beta accumulation and enhanced cognitive function in the hippocampus of aluminum-induced Alzheimer's disease in adult rats.
     J Alzheimers Dis. 2024 Nov 3:13872877241295405. doi: 10.1177/13872877241295405.
     PubMed     Abstract available
     
     
     
252. ZHAO Y, Villasante-Tezanos A, Miranda-Morales EG, Pappolla MA, et al
     Discovery of novel metabolic biomarkers in blood serum for diagnosis of Alzheimer's disease.
     J Alzheimers Dis. 2024;102:237-253.
     PubMed     Abstract available
     
     
     
253. MATIAS-GUIU JA, Alvarez-Sabin J, Botia E, Casado-Naranjo I, et al
     Perceptions of key informant neurologists before implementing anti-amyloid drugs in the Spanish departments of neurology.
     J Alzheimers Dis. 2024;102:207-217.
     PubMed     Abstract available
     
     
     
254. PAPOTTI B, Palumbo M, Adorni MP, Elviri L, et al
     Influence of APOE4 genotype on PCSK9-lipids association in cerebrospinal fluid and serum of patients in the Alzheimer's disease continuum.
     J Alzheimers Dis. 2024;102:162-172.
     PubMed     Abstract available
     
     
     
255. JURASOVA V, Andel R, Katonova A, Nolan R, et al
     Is KIBRA polymorphism associated with memory performance and cognitive impairment in Alzheimer's disease?
     J Alzheimers Dis. 2024;102:218-227.
     PubMed     Abstract available
     
     
     
256. KHAN SU, Albanyan A, Bilal M, Ullah S, et al
     A genetic programming Rician noise reduction and explainable deep learning model for Alzheimer's diseases severity prediction.
     J Alzheimers Dis. 2024;102:129-142.
     PubMed     Abstract available
     
     
     
257. ISHII K, Yamada T, Hanaoka K, Kaida H, et al
     Regional differences in glucose metabolic decline and tau deposition in the Alzheimer's continuum brain.
     J Alzheimers Dis. 2024;102:228-236.
     PubMed     Abstract available
     
     
     
258. ZHANG Z, Sheng Z, Liu J, Zhang D, et al
     The association of the triglyceride-glucose index with Alzheimer's disease and its potential mechanisms.
     J Alzheimers Dis. 2024;102:77-88.
     PubMed     Abstract available
     
     
     
259. GAO Z, Dorney I, Davis PB, Kaelber DC, et al
     Association between selective serotonin reuptake inhibitors and mortality following COVID-19 among patients with Alzheimer's disease.
     J Alzheimers Dis. 2024;102:99-109.
     PubMed     Abstract available
     
     
     
260. SERRA L, Bonarota S, Di Domenico C, Caruso G, et al
     The funnel effect of reserves prompted by leisure activities across the Alzheimer's disease continuum.
     J Alzheimers Dis. 2024;102:181-194.
     PubMed     Abstract available
     
     
     
261. KANG L, Zhang X, Guan J, Huang K, et al
     Early Alzheimer's disease diagnosis via handwriting with self-attention mechanisms.
     J Alzheimers Dis. 2024;102:173-180.
     PubMed     Abstract available
     
     
     
262. BEDER N, Belkhelfa M, Leklou H
     Involvement of inflammasomes in the pathogenesis of Alzheimer's disease.
     J Alzheimers Dis. 2024;102:11-29.
     PubMed     Abstract available
     
     
     
263. BESSER LM, Fuentes AJ, Zhang JN, O'Shea DM, et al
     Intersectionality of gender with social determinants of health and asymptomatic Alzheimer's disease neuropathology.
     J Alzheimers Dis. 2024;102:110-118.
     PubMed     Abstract available
     
     
     
264. CALVO N, McFall GP, Ramana S, Galper M, et al
     Associated risk and resilience factors of Alzheimer's disease in women with early bilateral oophorectomy: Data from the UK Biobank.
     J Alzheimers Dis. 2024;102:119-128.
     PubMed     Abstract available
     
     
     
265. LECLERC H, Lee AK, Kunicki ZJ, Alber J, et al
     Added value of inflammatory plasma biomarkers to pathologic biomarkers in predicting preclinical Alzheimer's disease.
     J Alzheimers Dis. 2024;102:89-98.
     PubMed     Abstract available
     
     
     
266. ABDULLAH L, Zhang F, Hall J, O'Bryant S, et al
     Neurofilament light and cognition in community-dwelling non-Hispanic Blacks.
     J Alzheimers Dis. 2024;102:60-66.
     PubMed     Abstract available
     
     
     
267. LIN Y, Kuo SH
     The emerging role of the cerebellum in neurodegeneration linked to cognitive impairment.
     J Alzheimers Dis. 2024;102:30-32.
     PubMed     Abstract available
     
     
     
268. LIU Z, Hu B, Tang J, Liu X, et al
     Frontiers and hotspots evolution between air pollution and Alzheimer's disease: A bibliometric analysis from 2013 to 2023.
     J Alzheimers Dis. 2024;102:257-274.
     PubMed     Abstract available
     
     
     
269. CHEN H, Wang L, Chen F, Sun W, et al
     Performance of the Benton Judgment of Line Orientation test across patients with different types of dementia.
     J Alzheimers Dis. 2024;102:437-448.
     PubMed     Abstract available
     
     
     
270. DOS SANTOS JR, Catalao CHR, Vulczak A, Azzolini AECS, et al
     Voluntary wheel running decreases amyloidogenic pathway and rescues cognition and mitochondrial energy metabolism in middle-aged female 3xTg-AD mouse model of Alzheimer's disease.
     J Alzheimers Dis. 2024;102:424-436.
     PubMed     Abstract available
     
     
     
271. TANG M, Guo JJ, Guo RX, Xu SJ, et al
     Progress of research and application of non-pharmacologic intervention in Alzheimer's disease.
     J Alzheimers Dis. 2024;102:275-294.
     PubMed     Abstract available
     
     
     
272. ZHANG X, Lv R, Sun Y, Liu TC, et al
     The safety and effectiveness of 40 Hz gamma-tACS in Alzheimer's disease: A meta-analysis.
     J Alzheimers Dis. 2024;102:295-307.
     PubMed     Abstract available
     
     
     
273. FINDLEY CA, McFadden SA, Hill T, Peck MR, et al
     Sexual dimorphism, altered hippocampal glutamatergic neurotransmission, and cognitive impairment in APP knock-in mice.
     J Alzheimers Dis. 2024;102:491-505.
     PubMed     Abstract available
     
     
     
274. CIESLA M, Toro-Serey C, Jannati A, Banks RE, et al
     Detecting functional impairment with the Digital Clock and Recall.
     J Alzheimers Dis. 2024;102:329-337.
     PubMed     Abstract available
     
     
     
275. COOK N, Driscoll I, Gaitan JM, Glittenberg M, et al
     Amyloid-beta positivity is less prevalent in cognitively unimpaired KLOTHO KL-VS heterozygotes.
     J Alzheimers Dis. 2024;102:480-490.
     PubMed     Abstract available
     
     
     September 2024
276. CHAN CK, Lane KA, Gao S, Adeoye-Olatunde OA, et al
     Referral Sources Across Racial and Ethnic Groups at Alzheimer's Disease Research Centers.
     J Alzheimers Dis. 2024 Sep 30. doi: 10.3233/JAD-240485.
     PubMed     Abstract available
     
     
     
277. WANG N, Tai HC, Tzeng IS
     Non-Pharmacological Exercise Randomized Controlled Trials in Alzheimer's Disease.
     J Alzheimers Dis. 2024 Sep 20. doi: 10.3233/JAD-240418.
     PubMed     Abstract available
     
     
     
278. DEL TREDICI K, Schon M, Feldengut S, Ghebremedhin E, et al
     Early CA2 Tau Inclusions Do Not Distinguish an Age-Related Tauopathy from Early Alzheimer's Disease.
     J Alzheimers Dis. 2024 Sep 18. doi: 10.3233/JAD-240483.
     PubMed     Abstract available
     
     
     
279. MATTKE S, Tang Y, Hanson M, von Arnim CAF, et al
     Current Capacity for Diagnosing Alzheimer's Disease in Germany and Implications for Wait Times.
     J Alzheimers Dis. 2024 Sep 17. doi: 10.3233/JAD-240728.
     PubMed     Abstract available
     
     
     
280. LIU XL, Yeerlan J, Liu Z, Bai Y, et al
     Past, Present, and Future of Liver-Brain Axis in Alzheimer's Disease: A Bibliometric Review.
     J Alzheimers Dis. 2024 Sep 17. doi: 10.3233/JAD-240688.
     PubMed     Abstract available
     
     
     
281. NOWELL J, Raza S, Livingston NR, Sivanathan S, et al
     Do Tau Deposition and Glucose Metabolism Dissociate in Alzheimer's Disease Trajectory?
     J Alzheimers Dis. 2024 Sep 17. doi: 10.3233/JAD-240434.
     PubMed     Abstract available
     
     
     
282. BABULAL GM, Zha W, Trani JF, Guerra JL, et al
     Identifying Gaps and Barriers in Alzheimer's Disease and Related Dementia Research and Management in Low- and Middle-Income Countries: A Survey of Health Professionals and Researchers.
     J Alzheimers Dis. 2024 Sep 16. doi: 10.3233/JAD-240650.
     PubMed     Abstract available
     
     
     
283. UTYRO O, Wloczkowska-Lapinska O, Jakubowski H
     Association of GLOD4 with Alzheimer's Disease in Humans and Mice.
     J Alzheimers Dis. 2024 Sep 16. doi: 10.3233/JAD-240512.
     PubMed     Abstract available
     
     
     
284. RAJAMAKI B, Braithwaite B, Hartikainen S, Tolppanen AM, et al
     Identifying Comorbidity Patterns in People with and without Alzheimer's Disease Using Latent Dirichlet Allocation.
     J Alzheimers Dis. 2024 Sep 16. doi: 10.3233/JAD-240490.
     PubMed     Abstract available
     
     
     
285. ABI-GHANEM C, Salinero AE, Smith RM, Kelly RD, et al
     Effects of Menopause and High Fat Diet on Metabolic Outcomes in a Mouse Model of Alzheimer's Disease.
     J Alzheimers Dis. 2024 Sep 16. doi: 10.3233/JAD-231332.
     PubMed     Abstract available
     
     
     
286. MENDEZ-BARRIO C, Medina-Rodriguez M, Mendoza-Vazquez G, Garcia-Roldan E, et al
     Prodromal Alzheimer's Disease: Global Cognition, Cue Efficiency, and Cerebrospinal Fluid Neurofilament Light Values Predict Short-Term Conversion to Dementia.
     J Alzheimers Dis. 2024 Sep 14. doi: 10.3233/JAD-240689.
     PubMed     Abstract available
     
     
     
287. PARK J, Oh JP, Ku K, Jin Y, et al
     Preventing Donepezil-Induced Adverse Effects Through N-acetylcysteine Co-Administration.
     J Alzheimers Dis. 2024 Sep 13. doi: 10.3233/JAD-240709.
     PubMed     Abstract available
     
     
     
288. MANAKKADAN A, Krishnan D, Rui Xia Ang S, Sajikumar S, et al
     Slow Release of Hydrogen Sulfide in CA1 Hippocampal Neurons Rescues Long-Term Synaptic Plasticity and Associativity in an Amyloid-beta Induced Model of Alzheimer's Disease.
     J Alzheimers Dis. 2024 Sep 13. doi: 10.3233/JAD-240456.
     PubMed     Abstract available
     
     
     
289. SCHICKTANZ S, Alpinar-Segawa Z, Ulitsa N, Perry J, et al
     Moving Towards Ethical-Practical Recommendations for Alzheimer's Disease Prediction: Addressing Interindividual, Interprofessional, and Societal Aspects.
     J Alzheimers Dis. 2024 Sep 13. doi: 10.3233/JAD-231137.
     PubMed     Abstract available
     
     
     
290. VYHNALEK M, Laczo M, Laczo J
     Diagnosis of Alzheimer's Disease in Clinical Practice: Time to Incorporate Biomarkers?
     J Alzheimers Dis. 2024 Sep 12. doi: 10.3233/JAD-240660.
     PubMed     Abstract available
     
     
     
291. WANG T, Yan S, Shan Y, Xing Y, et al
     Altered Neuronal Activity Patterns of the Prefrontal Cortex in Alzheimer's Disease After Transcranial Alternating Current Stimulation: A Resting-State fMRI Study.
     J Alzheimers Dis. 2024 Sep 12. doi: 10.3233/JAD-240400.
     PubMed     Abstract available
     
     
     
292. SPENCER FSE, Elsworthy RJ, Breen L, Bishop J, et al
     The Relationship Between Physical Activity and Non-Modifiable Risk Factors on Alzheimer's Disease and Brain Health Markers: A UK Biobank Study.
     J Alzheimers Dis. 2024 Sep 12. doi: 10.3233/JAD-240269.
     PubMed     Abstract available
     
     
     
293. WANG Q, Fu M, Gao L, Yuan X, et al
     A Drug Repositioning Approach Reveals Ergotamine May Be a Potential Drug for the Treatment of Alzheimer's Disease.
     J Alzheimers Dis. 2024 Sep 12. doi: 10.3233/JAD-240235.
     PubMed     Abstract available
     
     
     
294. SELIGMANN B, Camiolo S, Hernandez M, Yeakley JM, et al
     Molecular Gene Expression Testing to Identify Alzheimer's Disease with High Accuracy from Fingerstick Blood.
     J Alzheimers Dis. 2024 Sep 11. doi: 10.3233/JAD-240174.
     PubMed     Abstract available
     
     
     
295. BOLSHAKOV AP, Gerasimov K, Dobryakova YV
     Alzheimer's Disease: An Attempt of Total Recall.
     J Alzheimers Dis. 2024 Sep 7. doi: 10.3233/JAD-240620.
     PubMed     Abstract available
     
     
     
296. LIU S, Maruff P, Fedyashov V, Masters CL, et al
     A Data-Driven Cognitive Composite Sensitive to Amyloid-beta for Preclinical Alzheimer's Disease.
     J Alzheimers Dis. 2024 Sep 6. doi: 10.3233/JAD-231319.
     PubMed     Abstract available
     
     
     
297. BUTLER T, Tey SR, Galvin JE, Perry G, et al
     Endocrine Dyscrasia in the Etiology and Therapy of Alzheimer's Disease.
     J Alzheimers Dis. 2024 Sep 4. doi: 10.3233/JAD-240334.
     PubMed     Abstract available
     
     
     
298. GUO H, Sun S, Yang Y, Ma R, et al
     A Novel Score to Predict Individual Risk for Future Alzheimer's Disease: A Longitudinal Study of the ADNI Cohort.
     J Alzheimers Dis. 2024 Sep 3. doi: 10.3233/JAD-240532.
     PubMed     Abstract available
     
     
     
299. GUO F, Tan MS, Hu H, Ou YN, et al
     sTREM2 Mediates the Correlation Between BIN1 Gene Polymorphism and Tau Pathology in Alzheimer's Disease.
     J Alzheimers Dis. 2024 Sep 3. doi: 10.3233/JAD-240372.
     PubMed     Abstract available
     
     
     
300. CARDOSO R, Teunissen CE, Oliveira CR
     Enhancing Alzheimer's Disease Diagnosis and Care by Focusing on Plasma Biomarkers for Identifying Mild Cognitive Impairment.
     J Alzheimers Dis. 2024 Sep 2. doi: 10.3233/JAD-240724.
     PubMed     Abstract available
     
     
     
301. ZHANG X, You J, Qao Q, Qi X, et al
     Correlation Between the Fractional Amplitude of Low-Frequency Fluctuation and Cognitive Defects in Alzheimer's Disease.
     J Alzheimers Dis. 2024 Sep 2. doi: 10.3233/JAD-231040.
     PubMed     Abstract available
     
     
     August 2024
302. KRESHPA W, Raffa S, Girtler N, Brugnolo A, et al
     Limbic Network Derangement Mediates Unawareness of Apathy in Mild Cognitive Impairment due to Alzheimer's Disease: Clues from [18F]FDG PET Voxel-Wise Analysis.
     J Alzheimers Dis. 2024 Aug 31. doi: 10.3233/JAD-240430.
     PubMed     Abstract available
     
     
     
303. ZHAO H, Yuan H, Wang E
     Causal Effects of Kidney Function and Chronic Kidney Disease on Alzheimer's Disease by Analyzing Large-Scale Genome-Wide Association Study Datasets.
     J Alzheimers Dis. 2024 Aug 30. doi: 10.3233/JAD-240807.
     PubMed     Abstract available
     
     
     
304. GIUDICESSI A, McDowell CP, Martinez JE, Baena A, et al
     Cognitive Outcomes in Autosomal-Dominant Alzheimer's Disease: A Comprehensive Review from a Colombian Kindred with the Presenilin-1 E280A Mutation.
     J Alzheimers Dis. 2024 Aug 30. doi: 10.3233/JAD-240360.
     PubMed     Abstract available
     
     
     
305. HANYU H, Koyama Y, Umekida K, Watanabe S, et al
     Path Integration Detects Prodromal Alzheimer's Disease and Predicts Cognitive Decline.
     J Alzheimers Dis. 2024 Aug 30. doi: 10.3233/JAD-240347.
     PubMed     Abstract available
     
     
     
306. CHEN Y, Ji X, Bao Z
     Identification of the Shared Gene Signatures Between Alzheimer's Disease and Diabetes-Associated Cognitive Dysfunction by Bioinformatics Analysis Combined with Biological Experiment.
     J Alzheimers Dis. 2024 Aug 29. doi: 10.3233/JAD-240353.
     PubMed     Abstract available
     
     
     
307. MACCIONI RB, Prieto R
     Understanding the Human Being from a Quantum Perspective: Lessons to Elucidate Alzheimer's Disease Pathogenesis.
     J Alzheimers Dis. 2024 Aug 28. doi: 10.3233/JAD-240864.
     PubMed    
     
     
     
308. NAGATA T, Nakajima S, Kito S, Shinagawa S, et al
     The Association Between Distinct Delusional Ideations and Depressive Symptoms in Alzheimer's Disease: A Re-Analysis of CATIE-AD.
     J Alzheimers Dis. 2024 Aug 28. doi: 10.3233/JAD-240702.
     PubMed     Abstract available
     
     
     
309. GUTIERREZ J, Kurz C, Sandoval C, Edmonds R, et al
     Impact of Preanalytical Procedures on Complement Biomarkers in Cerebrospinal Fluid and Plasma from Controls and Alzheimer's Disease Patients.
     J Alzheimers Dis. 2024 Aug 28. doi: 10.3233/JAD-240287.
     PubMed     Abstract available
     
     
     
310. HUYNH ALH, Wang Y, Ma L, Low YLC, et al
     A Comparison of an Australian Observational Longitudinal Alzheimer's Disease Cohort to Community-Based Australian Data.
     J Alzheimers Dis. 2024 Aug 28. doi: 10.3233/JAD-240241.
     PubMed     Abstract available
     
     
     
311. SOUZA NAP, Simoes Neto JP, Dourado MCN
     The Relationship Between Decision-Making Capacity and Awareness in People with Young-Onset Alzheimer's Disease.
     J Alzheimers Dis. 2024 Aug 26. doi: 10.3233/JAD-231324.
     PubMed     Abstract available
     
     
     
312. GIAQUINTO F, Lorenzini P, Salvi E, Carnevale G, et al
     The Profile of the Italian Centers for Cognitive Disorders and Dementia in the Context of New Drugs in Alzheimer's Disease.
     J Alzheimers Dis. 2024 Aug 24. doi: 10.3233/JAD-240594.
     PubMed     Abstract available
     
     
     
313. SUN W, Chen Y, Yang Y, Wang P, et al
     Characteristics and Transcriptomic Analysis of Cholinergic Neurons Derived from Induced Pluripotent Stem Cells with APP Mutation in Alzheimer's Disease.
     J Alzheimers Dis. 2024 Aug 24. doi: 10.3233/JAD-240299.
     PubMed     Abstract available
     
     
     
314. SILVA-RUDBERG JA, Mecca AP
     Diffusion Imaging of Gray Matter Microstructure in Alzheimer's Disease.
     J Alzheimers Dis. 2024 Aug 23. doi: 10.3233/JAD-240673.
     PubMed     Abstract available
     
     
     
315. PERREIRA KM, Hotz VJ, Duke NN, Aiello AE, et al
     The Add Health Parent Study: A Biosocial Resource for the Study of Multigenerational Racial/Ethnic Disparities in Alzheimer's Disease and Alzheimer's Disease-Related Dementias.
     J Alzheimers Dis. 2024 Aug 23. doi: 10.3233/JAD-240201.
     PubMed     Abstract available
     
     
     
316. WEI W, Jiang Y, Hu G, He Y, et al
     Recent Advances of Mitochondrial Alterations in Alzheimer's Disease: A Perspective of Mitochondrial Basic Events.
     J Alzheimers Dis. 2024 Aug 23. doi: 10.3233/JAD-240092.
     PubMed     Abstract available
     
     
     
317. CHEN J, Yang J, Shen D, Wang X, et al
     A Predictive Model of the Progression to Alzheimer's Disease in Patients with Mild Cognitive Impairment Based on the MRI Enlarged Perivascular Spaces.
     J Alzheimers Dis. 2024 Aug 22. doi: 10.3233/JAD-240523.
     PubMed     Abstract available
     
     
     
318. JANN K, Cen S, Santos M, Aksman L, et al
     Effect of Genetic Risk on the Relationship Between rs-fMRI Complexity and Tau and Amyloid PET in Alzheimer's Disease.
     J Alzheimers Dis. 2024 Aug 22. doi: 10.3233/JAD-240459.
     PubMed     Abstract available
     
     
     
319. NATARAJ A, Kala A, Pena SLP, Jezek K, et al
     Impaired Dynamics of Positional and Contextual Neural Coding in an Alzheimer's Disease Rat Model.
     J Alzheimers Dis. 2024 Aug 22. doi: 10.3233/JAD-231386.
     PubMed     Abstract available
     
     
     
320. UH K, Monarch K, Reese ED, Rodriguez K, et al
     Impaired Skeletal Development by Disruption of Presenilin-1 in Pigs and Generation of Novel Pig Models for Alzheimer's Disease.
     J Alzheimers Dis. 2024 Aug 21. doi: 10.3233/JAD-231297.
     PubMed     Abstract available
     
     
     
321. QI H, Zhu X, Ren Y, Zhang X, et al
     A Study of Assisted Screening for Alzheimer's Disease Based on Handwriting and Gait Analysis.
     J Alzheimers Dis. 2024 Aug 17. doi: 10.3233/JAD-240362.
     PubMed     Abstract available
     
     
     
322. NEVE A, Das B, Wojtowicz J, Huang Z, et al
     Long-Term Safety of Gantenerumab in Participants with Alzheimer's Disease: A Phase III, Double-Blind, and Open-Label Extension Study (Marguerite RoAD).
     J Alzheimers Dis. 2024 Aug 17. doi: 10.3233/JAD-240221.
     PubMed     Abstract available
     
     
     
323. AVELAR-PEREIRA B, Phillips CM, Hosseini SMH
     Convergence of Accelerated Brain Volume Decline in Normal Aging and Alzheimer's Disease Pathology.
     J Alzheimers Dis. 2024 Aug 17. doi: 10.3233/JAD-231458.
     PubMed     Abstract available
     
     
     
324. ILARDI CR, Menichelli A, Michelutti M, Cattaruzza T, et al
     On the Clinimetrics of the Montreal Cognitive Assessment: Cutoff Analysis in Patients with Mild Cognitive Impairment due to Alzheimer's Disease.
     J Alzheimers Dis. 2024 Aug 12. doi: 10.3233/JAD-240339.
     PubMed     Abstract available
     
     
     
325. KOHLER K, Macheda T, Hobbs MM, Maisel MT, et al
     Exposure to Lead in Drinking Water Causes Cognitive Impairment via an Alzheimer's Disease Gene-Dependent Mechanism in Adult Mice.
     J Alzheimers Dis. 2024 Aug 8. doi: 10.3233/JAD-240640.
     PubMed     Abstract available
     
     
     
326. DUITS FH, Nilsson J, Zetterberg H, Blennow K, et al
     Serial Cerebrospinal Fluid Sampling Reveals Trajectories of Potential Synaptic Biomarkers in Early Stages of Alzheimer's Disease.
     J Alzheimers Dis. 2024 Aug 8. doi: 10.3233/JAD-240610.
     PubMed     Abstract available
     
     
     
327. KALTSA M, Tsolaki A, Lazarou I, Mittas I, et al
     Assessing the Linguistic Capacity Across Alzheimer's Disease and Its Preclinical Stages: Evidence from Narrative Macrostructure in Elderly Speakers of Greek.
     J Alzheimers Dis. 2024 Aug 8. doi: 10.3233/JAD-240496.
     PubMed     Abstract available
     
     
     
328. L'ESPERANCE OJ, McGhee J, Davidson G, Niraula S, et al
     Functional Connectivity Favors Aberrant Visual Network c-Fos Expression Accompanied by Cortical Synapse Loss in a Mouse Model of Alzheimer's Disease.
     J Alzheimers Dis. 2024 Aug 7. doi: 10.3233/JAD-240776.
     PubMed     Abstract available
     
     
     
329. WING JJ, Rajczyk JI, Burke JF
     Geographic Variation of Prevalence of Alzheimer's Disease and Related Dementias in Central Appalachia.
     J Alzheimers Dis. 2024 Aug 7. doi: 10.3233/JAD-240528.
     PubMed     Abstract available
     
     
     
330. GRANT WB
     A Brief History of the Progress in Our Understanding of Genetics and Lifestyle, Especially Diet, in the Risk of Alzheimer's Disease.
     J Alzheimers Dis. 2024 Aug 6. doi: 10.3233/JAD-240658.
     PubMed     Abstract available
     
     
     
331. BUCHMAN AS, Yu L, Oveisgharan S, Zammit AR, et al
     Parkinson's Disease and Other Alzheimer's Disease and Related Dementia Pathologies and the Progression of Parkinsonism in Older Adults.
     J Alzheimers Dis. 2024 Aug 6. doi: 10.3233/JAD-240593.
     PubMed     Abstract available
     
     
     
332. RUSTAMZADEH A, Tafakhori A, Ariaei A, Heydari M, et al
     Targeting Caspases 3/6 and Cathepsins L/B May Decrease Laminopathy-Induced Apoptosis in Alzheimer's Disease.
     J Alzheimers Dis. 2024 Aug 5. doi: 10.3233/JAD-240413.
     PubMed     Abstract available
     
     
     
333. ORIA RB, Smith CJ, Ashford JW, Vitek MP, et al
     Pros and Cons of APOE4 Homozygosity and Effects on Neuroplasticity, Malnutrition, and Infections in Early Life Adversity, Alzheimer's Disease, and Alzheimer's Prevention.
     J Alzheimers Dis. 2024 Aug 1. doi: 10.3233/JAD-240888.
     PubMed     Abstract available
     
     
     
334. HAN BL, Ma LZ, Han SL, Mi YC, et al
     Explore the Role of Frailty as a Contributor to the Association Between AT(N) Profiles and Cognition in Alzheimer's Disease.
     J Alzheimers Dis. 2024 Aug 1. doi: 10.3233/JAD-231489.
     PubMed     Abstract available
     
     
     July 2024
335. IBAN-ARIAS R, Wang SH, Soares Dias Portela A, Yang EJ, et al
     Exposure to the World Center Particulate Matter Alters the Gut-Brain Axis in Early Onset Alzheimer's Disease Mice.
     J Alzheimers Dis. 2024 Jul 30. doi: 10.3233/JAD-240635.
     PubMed     Abstract available
     
     
     
336. WANG H, Li J, Tu W, Wang Z, et al
     Identification of Blood Biomarkers Related to Energy Metabolism and Construction of Diagnostic Prediction Model Based on Three Independent Alzheimer's Disease Cohorts.
     J Alzheimers Dis. 2024 Jul 29. doi: 10.3233/JAD-240301.
     PubMed     Abstract available
     
     
     
337. KASHIBAYASHI T, Kanemoto H, Takahashi R, Fujito R, et al
     Neural Basis of Agitated Behaviors in Patients with Amnestic Mild Cognitive Impairment and Alzheimer's Disease.
     J Alzheimers Dis. 2024 Jul 27. doi: 10.3233/JAD-240256.
     PubMed     Abstract available
     
     
     
338. BOCCARDI V, Ruggiero C, Cecchetti R, Mecocci P, et al
     Geroscience and the Fight Against Alzheimer's Disease: Between Myth and Reality.
     J Alzheimers Dis. 2024 Jul 26. doi: 10.3233/JAD-240582.
     PubMed     Abstract available
     
     
     
339. WANG W, Zhao F, Torres S, Harris PLR, et al
     Space-Like Irradiation Exacerbated Cognitive Deficits and Amyloid Pathology in CRND8 Mouse Model of Alzheimer's Disease.
     J Alzheimers Dis. 2024 Jul 26. doi: 10.3233/JAD-240570.
     PubMed     Abstract available
     
     
     
340. LEE JH, Jia J, Ji Y, Kandiah N, et al
     A Framework for Best Practices and Readiness in the Advent of Anti-Amyloid Therapy for Early Alzheimer's Disease in Asia.
     J Alzheimers Dis. 2024 Jul 23. doi: 10.3233/JAD-240684.
     PubMed     Abstract available
     
     
     
341. LIU Y, Xu W, Yang P, Liu X, et al
     Revealing Molecular Patterns of Alzheimer's Disease Risk Gene Expression Signatures in COVID-19 Brains.
     J Alzheimers Dis. 2024 Jul 23. doi: 10.3233/JAD-240609.
     PubMed     Abstract available
     
     
     
342. AVILA J
     Delaying Brain Aging or Decreasing Tau Levels as Strategies to Prevent Alzheimer's Disease: In Memoriam of Mark A. Smith.
     J Alzheimers Dis. 2024 Jul 20. doi: 10.3233/JAD-240500.
     PubMed     Abstract available
     
     
     
343. LIU Y, He B, Du K, Zheng J, et al
     Periphery Biomarkers Predicting Conversion of Type 2 Diabetes to Pre-Alzheimer-Like Cognitive Decline: A Multicenter Follow-Up Study.
     J Alzheimers Dis. 2024 Jul 19. doi: 10.3233/JAD-240455.
     PubMed     Abstract available
     
     
     
344. BUTTERFIELD DA
     Activation of the Neuronal Cell Cycle in Brains in Amnestic Mild Cognitive Impairment: Early Involvement in the Progression of Alzheimer's Disease.
     J Alzheimers Dis. 2024 Jul 12. doi: 10.3233/JAD-240615.
     PubMed     Abstract available
     
     
     
345. MANDAL PK, Maroon JC, Samkaria A, Arora Y, et al
     Iron Chelators and Alzheimer's Disease Clinical Trials.
     J Alzheimers Dis. 2024 Jul 12. doi: 10.3233/JAD-240605.
     PubMed     Abstract available
     
     
     
346. AMARAL-CARVALHO V, Bento Lima-Silva T, Inacio Mariano L, Cruz de Souza L, et al
     Improved Accuracy of the Addenbrooke's Cognitive Examination-Revised in the Diagnosis of Mild Cognitive Impairment, Mild Dementia Due to Alzheimer's Disease and Behavioral Variant Frontotemporal Dementia Using Mokken Scale Analysis.
     J Alzheimers Dis. 2024 Jul 12. doi: 10.3233/JAD-240554.
     PubMed     Abstract available
     
     
     
347. WANG RT, Sun Z, Tan CC, Tan L, et al
     Dynamic Features of Body Mass Index in Late Life Predict Cognitive Trajectories and Alzheimer's Disease: A Longitudinal Study.
     J Alzheimers Dis. 2024 Jul 12. doi: 10.3233/JAD-240292.
     PubMed     Abstract available
     
     
     
348. BOCTI C
     Is Simpler Always Better? The Case for Going Beyond the Amyloid Hypothesis in Alzheimer's Disease.
     J Alzheimers Dis. 2024 Jul 9. doi: 10.3233/JAD-240488.
     PubMed     Abstract available
     
     
     
349. ELMAN JA, Schork NJ, Rangan AV
     Exploring the Genetic Heterogeneity of Alzheimer's Disease: Evidence for Genetic Subtypes.
     J Alzheimers Dis. 2024 Jul 8. doi: 10.3233/JAD-231252.
     PubMed     Abstract available
     
     
     
350. REIVE BS, Lau V, Sanchez-Lafuente CL, Henri-Bhargava A, et al
     The Inflammation-Induced Dysregulation of Reelin Homeostasis Hypothesis of Alzheimer's Disease.
     J Alzheimers Dis. 2024 Jul 5. doi: 10.3233/JAD-240088.
     PubMed     Abstract available
     
     
     
351. PORTAL B, Sodergren M, Pares I Borrell T, Giraud R, et al
     Early Astrocytic Dysfunction Is Associated with Mistuned Synapses as well as Anxiety and Depressive-Like Behavior in the AppNL-F Mouse Model of Alzheimer's Disease.
     J Alzheimers Dis. 2024 Jul 4. doi: 10.3233/JAD-231461.
     PubMed     Abstract available
     
     
     
352. 
     Erratum to: Tubastatin A/ACY-1215 Improves Cognition in Alzheimer's Disease Transgenic Mice.
     J Alzheimers Dis. 2024 Jul 2. doi: 10.3233/JAD-249014.
     PubMed    
     
     
     June 2024
353. JIN H, Yang Q, Chen G, Zhang W, et al
     Effects of Hepatorenal Function on Urinary Alzheimer-Associated Neuronal Thread Protein: A Laboratory-Based Cross-Sectional Study Among the Older Chinese Population.
     J Alzheimers Dis. 2024 Jun 29. doi: 10.3233/JAD-240148.
     PubMed     Abstract available
     
     
     
354. ZHANG YH, Zhao P, Gao HL, Zhong ML, et al
     Screening Targets and Therapeutic Drugs for Alzheimer's Disease Based on Deep Learning Model and Molecular Docking.
     J Alzheimers Dis. 2024 Jun 29. doi: 10.3233/JAD-231389.
     PubMed     Abstract available
     
     
     
355. 
     Erratum to: Insulin-Related Biomarkers in Cerebrospinal Fluid in Mild Cognitive Impairment and Alzheimer's Disease: A Systematic Review.
     J Alzheimers Dis. 2024 Jun 28. doi: 10.3233/JAD-249011.
     PubMed    
     
     
     
356. GARCIA-MARTINEZ M, Pozueta-Cantudo A, Lage C, Martinez-Dubarbie F, et al
     LAM Test: A New Cognitive Marker for Early Detection in Preclinical Alzheimer's Disease.
     J Alzheimers Dis. 2024 Jun 28. doi: 10.3233/JAD-240067.
     PubMed     Abstract available
     
     
     
357. ZHUANG X, Cordes D, Bender AR, Nandy R, et al
     Classifying Alzheimer's Disease Neuropathology Using Clinical and MRI Measurements.
     J Alzheimers Dis. 2024 Jun 28. doi: 10.3233/JAD-231321.
     PubMed     Abstract available
     
     
     
358. PUZZO D
     Beyond Amyloid-beta: Reevaluating Its Physiological Role to Find Safe Therapies Against Alzheimer's Disease.
     J Alzheimers Dis. 2024 Jun 27. doi: 10.3233/JAD-240406.
     PubMed     Abstract available
     
     
     
359. COIMBRA JRM, Resende R, Custodio JBA, Salvador JAR, et al
     BACE1 Inhibitors for Alzheimer's Disease: Current Challenges and Future Perspectives.
     J Alzheimers Dis. 2024 Jun 22. doi: 10.3233/JAD-240146.
     PubMed     Abstract available
     
     
     
360. SAKHAROVA T, Mao S, Osadchuk M
     Updated Models of Alzheimer's Disease with Deep Neural Networks.
     J Alzheimers Dis. 2024 Jun 21. doi: 10.3233/JAD-240183.
     PubMed     Abstract available
     
     
     
361. PERRY G, Castellani R
     Alzheimer's Disease: Are We There Yet?
     J Alzheimers Dis. 2024 Jun 20. doi: 10.3233/JAD-249012.
     PubMed    
     
     
     
362. LOBUE C, McClintock SM, Chiang HS, Helphrey J, et al
     A Critical Review of Noninvasive Brain Stimulation Technologies in Alzheimer's Dementia and Primary Progressive Aphasia.
     J Alzheimers Dis. 2024 Jun 20. doi: 10.3233/JAD-240230.
     PubMed     Abstract available
     
     
     
363. HU Y, Wang X, Zhao Z, Liu M, et al
     The Downregulation of ITGAX Exacerbates Amyloid-beta Plaque Deposition in Alzheimer's Disease by Increasing Polarization of M1 Microglia.
     J Alzheimers Dis. 2024 Jun 20. doi: 10.3233/JAD-240118.
     PubMed     Abstract available
     
     
     
364. GARERI P, Cotroneo AM, Montella R, Gaglianone M, et al
     Citicoline: A Cholinergic Precursor with a Pivotal Role in Dementia and Alzheimer's Disease.
     J Alzheimers Dis. 2024 Jun 15. doi: 10.3233/JAD-240497.
     PubMed     Abstract available
     
     
     
365. DESAI S, Chen IY, Hom C, Doran E, et al
     Insomnia Symptoms Are Associated with Measures of Functional Deterioration and Dementia Status in Adults with Down Syndrome at High Risk for Alzheimer's Disease.
     J Alzheimers Dis. 2024 Jun 14. doi: 10.3233/JAD-220750.
     PubMed     Abstract available
     
     
     
366. CABALLERO HS, McFall GP, Gee M, MacDonald S, et al
     Cognitive Speed in Neurodegenerative Disease: Comparing Mean Rate and Inconsistency Within and Across the Alzheimer's and Lewy Body Spectra in the COMPASS-ND Study.
     J Alzheimers Dis. 2024 Jun 12. doi: 10.3233/JAD-240210.
     PubMed     Abstract available
     
     
     
367. CHEN X, Walton K, Brodaty H, Chalton K, et al
     Polyphenols and Diets as Current and Potential Nutrition Senotherapeutics in Alzheimer's Disease: Findings from Clinical Trials.
     J Alzheimers Dis. 2024 Jun 12. doi: 10.3233/JAD-231222.
     PubMed     Abstract available
     
     
     
368. CANDEIAS E, Pereira-Santos AR, Empadinhas N, Cardoso SM, et al
     The Gut-Brain Axis in Alzheimer's and Parkinson's Diseases: The Catalytic Role of Mitochondria.
     J Alzheimers Dis. 2024 Jun 8. doi: 10.3233/JAD-240524.
     PubMed     Abstract available
     
     
     
369. SHAMSI A, Furkan M, Khan MS, Yadav DK, et al
     Computational Screening of Repurposed Drugs for HMG-CoA Synthase 2 in Alzheimer's Disease.
     J Alzheimers Dis. 2024 Jun 8. doi: 10.3233/JAD-240376.
     PubMed     Abstract available
     
     
     
370. CHANDLER JM, Ye W, Mi X, Doty EG, et al
     Potential Impact of Slowing Disease Progression in Early Symptomatic Alzheimer's Disease on Patient Quality of Life, Caregiver Time, and Total Societal Costs: Estimates Based on Findings from GERAS-US Study.
     J Alzheimers Dis. 2024 Jun 8. doi: 10.3233/JAD-231166.
     PubMed     Abstract available
     
     
     
371. LALIVE HM, Griffa A, Carlier S, Nasuti M, et al
     Amnestic Syndrome in Memory Clinics: Similar Morphological Brain Patterns in Older Adults with and without Alzheimer's Disease.
     J Alzheimers Dis. 2024 Jun 7. doi: 10.3233/JAD-240026.
     PubMed     Abstract available
     
     
     
372. CHEN YH, Wang ZB, Liu XP, Mao ZQ, et al
     Plasma Insulin Predicts Early Amyloid-beta Pathology Changes in Alzheimer's Disease.
     J Alzheimers Dis. 2024 Jun 5. doi: 10.3233/JAD-240289.
     PubMed     Abstract available
     
     
     
373. LI D, Xie Q, Xie J, Ni M, et al
     Cerebrospinal Fluid Proteomics Identifies Potential Biomarkers for Early-Onset Alzheimer's Disease.
     J Alzheimers Dis. 2024 Jun 5. doi: 10.3233/JAD-240022.
     PubMed     Abstract available
     
     
     
374. LI JG, Mutreja Y, Servili M, Leone A, et al
     The Anti-Neuroinflammatory Effect of Extra-Virgin Olive Oil in the Triple Transgenic Mouse Model of Alzheimer's Disease.
     J Alzheimers Dis. 2024 Jun 4. doi: 10.3233/JAD-240374.
     PubMed     Abstract available
     
     
     
375. 
     Erratum to: Self-Reported Late-Life Hypertension Is Associated with a Healthy Cognitive Status and Reduced Alzheimer's Disease Pathology Burden.
     J Alzheimers Dis. 2024 Jun 3. doi: 10.3233/JAD-249010.
     PubMed    
     
     
     
376. SUN CK, Guo F, Ou YN, Zhang MZ, et al
     Association Between Carotid Plaque and Alzheimer's Disease Cerebrospinal Fluid Biomarkers and Cognitive Function in Cognitively Intact Adults: The CABLE Study.
     J Alzheimers Dis. 2024 Jun 1. doi: 10.3233/JAD-240131.
     PubMed     Abstract available
     
     
     
377. LIANG X, Wang Y, Li S, Fan J, et al
     Enhancing Rab7 Activity by Inhibiting TBC1D5 Expression Improves Mitophagy in Alzheimer's Disease Models.
     J Alzheimers Dis. 2024 Jun 1. doi: 10.3233/JAD-231300.
     PubMed     Abstract available
     
     
     
378. FUKUI Y, Tadokoro K, Hamada M, Asada K, et al
     A Novel Peptidome Technology for the Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease by Selected Reaction Monitoring.
     J Alzheimers Dis. 2024 Jun 1. doi: 10.3233/JAD-230915.
     PubMed     Abstract available
     
     
     May 2024
379. TAYLOR J, Jaros M, Chen C, Harrison J, et al
     Plasma pTau181 Predicts Clinical Progression in a Phase 2 Randomized Controlled Trial of the 11beta-HSD1 Inhibitor Xanamem(R) for Mild Alzheimer's Disease.
     J Alzheimers Dis. 2024 May 31. doi: 10.3233/JAD-231456.
     PubMed     Abstract available
     
     
     
380. CANTERO-FORTIZ Y, Cano A, Boada M
     Unraveling the Tau Puzzle: A Brief Discussion on Biomarkers in Alzheimer's Disease.
     J Alzheimers Dis. 2024 May 30. doi: 10.3233/JAD-240055.
     PubMed     Abstract available
     
     
     
381. ZHAO A, Balcer LJ, Himali JJ, O'Donnell A, et al
     Association of Loneliness with Functional Connectivity MRI, Amyloid-beta PET, and Tau PET Neuroimaging Markers of Vulnerability for Alzheimer's Disease.
     J Alzheimers Dis. 2024 May 28. doi: 10.3233/JAD-231425.
     PubMed     Abstract available
     
     
     
382. ILBOUDO Y, Yoshiji S, Lu T, Butler-Laporte G, et al
     Vitamin D, Cognition, and Alzheimer's Disease: Observational and Two-Sample Mendelian Randomization Studies.
     J Alzheimers Dis. 2024 May 27. doi: 10.3233/JAD-221223.
     PubMed     Abstract available
     
     
     
383. DUCHESNE S, Rousseau LS, Belzile-Marsolais F, Welch LA, et al
     A Scoping Review of Alzheimers Disease Hypotheses: An Array of Uni- and Multi-Factorial Theories.
     J Alzheimers Dis. 2024 May 24. doi: 10.3233/JAD-230772.
     PubMed     Abstract available
     
     
     
384. GENG Z, Wu Y, Liu J, Zhan Y, et al
     A Study on the Effect of Executive Control Network Functional Connection on the Therapeutic Efficacy of Repetitive Transcranial Magnetic Stimulation in Alzheimer's Disease.
     J Alzheimers Dis. 2024 May 24. doi: 10.3233/JAD-231449.
     PubMed     Abstract available
     
     
     
385. AGUILAR BJ, Jasuja GK, Li X, Shishova E, et al
     Prevalence of Mild Cognitive Impairment and Alzheimer's Disease Identified in Veterans in the United States.
     J Alzheimers Dis. 2024 May 23. doi: 10.3233/JAD-240027.
     PubMed     Abstract available
     
     
     
386. HERMES S, Cady J, Armentrout S, O'Connor J, et al
     Epistatic Features and Machine Learning Improve Alzheimer's Disease Risk Prediction Over Polygenic Risk Scores.
     J Alzheimers Dis. 2024 May 23. doi: 10.3233/JAD-230236.
     PubMed     Abstract available
     
     
     
387. STARMANS NLP, Kappelle LJ, Muller M, Staals J, et al
     Blood Pressure Variability and Plasma Biomarkers of Neuronal Injury and Alzheimer's Disease: A Clinic-Based Study of Patients with Diseases Along the Heart-Brain Axis.
     J Alzheimers Dis. 2024 May 21. doi: 10.3233/JAD-240119.
     PubMed     Abstract available
     
     
     
388. CHAI YL, Strohm L, Zhu Y, Chia RSL, et al
     Extracellular Vesicle-Enriched miRNA-Biomarkers Show Improved Utility for Detecting Alzheimer's Disease Dementia and Medial Temporal Atrophy.
     J Alzheimers Dis. 2024 May 21. doi: 10.3233/JAD-230572.
     PubMed     Abstract available
     
     
     
389. NING M, An L, Dong L, Zhu R, et al
     Causal Associations Between Gut Microbiota, Gut Microbiota-Derived Metabolites, and Alzheimer's Disease: A Multivariable Mendelian Randomization Study.
     J Alzheimers Dis. 2024 May 20. doi: 10.3233/JAD-240082.
     PubMed     Abstract available
     
     
     
390. PRZYBYSZEWSKI AW, Chudzik A
     How to Cure Alzheimer's Disease.
     J Alzheimers Dis. 2024 May 18. doi: 10.3233/JAD-240231.
     PubMed     Abstract available
     
     
     
391. GAMM S, Ummel D, Vasil N, Grenier S, et al
     Getting Insight to the Lived Emotional Experience of People with Alzheimer's Disease Shortly After Diagnosis: A Phenomenological Approach.
     J Alzheimers Dis. 2024 May 18. doi: 10.3233/JAD-231403.
     PubMed     Abstract available
     
     
     
392. ZENG B, Tang C, Wang J, Yang Q, et al
     Pharmacologic and Nutritional Interventions for Early Alzheimer's Disease: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials.
     J Alzheimers Dis. 2024 May 17. doi: 10.3233/JAD-240161.
     PubMed     Abstract available
     
     
     
393. PLUTA R, Bogucka-Kocka A, Bogucki J, Kocki J, et al
     Apoptosis, Autophagy, and Mitophagy Genes in the CA3 Area in an Ischemic Model of Alzheimer's Disease with 2-Year Survival.
     J Alzheimers Dis. 2024 May 16. doi: 10.3233/JAD-240401.
     PubMed     Abstract available
     
     
     
394. COSTANTINI E, Carrarini C, Calisi D, De Rosa M, et al
     Search in the Periphery for Potential Inflammatory Biomarkers of Dementia with Lewy Bodies and Alzheimer's Disease.
     J Alzheimers Dis. 2024 May 16. doi: 10.3233/JAD-231471.
     PubMed     Abstract available
     
     
     
395. KURIHARA M, Kondo S, Ohse K, Nojima H, et al
     Relationship Between Cerebrospinal Fluid Alzheimer's Disease Biomarker Values Measured via Lumipulse Assays and Conventional ELISA: Single-Center Experience and Systematic Review.
     J Alzheimers Dis. 2024 May 15. doi: 10.3233/JAD-240185.
     PubMed     Abstract available
     
     
     
396. WEGNER P, Balabin H, Ay MC, Bauermeister S, et al
     Semantic Harmonization of Alzheimer's Disease Datasets Using AD-Mapper.
     J Alzheimers Dis. 2024 May 15. doi: 10.3233/JAD-240116.
     PubMed     Abstract available
     
     
     
397. NAKAYA M, Sato N, Matsuda H, Maikusa N, et al
     Assessment of Gray Matter Microstructural Alterations in Alzheimer's Disease by Free Water Imaging.
     J Alzheimers Dis. 2024 May 15. doi: 10.3233/JAD-231416.
     PubMed     Abstract available
     
     
     
398. STAM CJ, de Haan W
     Network Hyperexcitability in Early-Stage Alzheimer's Disease: Evaluation of Functional Connectivity Biomarkers in a Computational Disease Model.
     J Alzheimers Dis. 2024 May 15. doi: 10.3233/JAD-230825.
     PubMed     Abstract available
     
     
     
399. MCINTIRE LB
     Prognostic Power? Do the Plasma Biomarkers, Neurofilament Light and Phospho-Tau 181, Improve Prediction of Progression to Alzheimer's Disease Using a Machine Learning Approach in the ADNI Cohort?
     J Alzheimers Dis. 2024 May 14. doi: 10.3233/JAD-240126.
     PubMed     Abstract available
     
     
     
400. IRFAN B, Ankouni G, Reader J, Seraji-Bozorgzad N, et al
     Alzheimer's Disease and Related Dementias in Muslim Women: Recommendations for Culturally Sensitive Care.
     J Alzheimers Dis. 2024 May 13. doi: 10.3233/JAD-240064.
     PubMed     Abstract available
     
     
     
401. ZAKRZEWSKI JJ, Davis JD, Gemelli ZT, Korthauer LE, et al
     Understanding Health Beliefs and Health Behaviors in Older Adults at Risk for Alzheimer's Disease.
     J Alzheimers Dis. 2024 May 13. doi: 10.3233/JAD-230977.
     PubMed     Abstract available
     
     
     
402. SATO K, Niimi Y, Ihara R, Suzuki K, et al
     Simplifying Alzheimer's Disease Monitoring: A Novel Machine-Learning Approach to Estimate the Clinical Dementia Rating Sum of Box Changes Using the Mini-Mental State Examination and Functional Activities Questionnaire.
     J Alzheimers Dis. 2024 May 11. doi: 10.3233/JAD-231426.
     PubMed     Abstract available
     
     
     
403. CHONG JSX, Tan YJ, Koh AJ, Ting SKS, et al
     Plasma Neurofilament Light Relates to Divergent Default and Salience Network Connectivity in Alzheimer's Disease and Behavioral Variant Frontotemporal Dementia.
     J Alzheimers Dis. 2024 May 11. doi: 10.3233/JAD-231251.
     PubMed     Abstract available
     
     
     
404. GUO ZX, Liu F, Wang FY, Ou YN, et al
     CAIDE Score, Alzheimer's Disease Pathology, and Cognition in Cognitively Normal Adults: The CABLE Study.
     J Alzheimers Dis. 2024 May 10. doi: 10.3233/JAD-240005.
     PubMed     Abstract available
     
     
     
405. MCLAREN AMR, Kawaja MD
     Olfactory Dysfunction and Alzheimer's Disease: A Review.
     J Alzheimers Dis. 2024 May 10. doi: 10.3233/JAD-231377.
     PubMed     Abstract available
     
     
     
406. WU C, Ruan T, Yuan Y, Xu C, et al
     Alterations in Synaptic Connectivity and Synaptic Transmission in Alzheimer's Disease with High Physical Activity.
     J Alzheimers Dis. 2024 May 10. doi: 10.3233/JAD-240123.
     PubMed     Abstract available
     
     
     
407. ZUPANIC E, Emersic A, Wimo A, Winblad B, et al
     Slovenian Memory Clinic Organization with the Introduction of Potential New Alzheimer's Disease Treatment.
     J Alzheimers Dis. 2024 May 9. doi: 10.3233/JAD-240190.
     PubMed     Abstract available
     
     
     
408. XIE L, Raj Y, Varathan P, He B, et al
     Deep Trans-Omic Network Fusion for Molecular Mechanism of Alzheimer's Disease.
     J Alzheimers Dis. 2024 May 9. doi: 10.3233/JAD-240098.
     PubMed     Abstract available
     
     
     
409. ZHU M, Liu Y, Chen C, Chen H, et al
     TLR4/Rac1/NLRP3 Pathway Mediates Amyloid-beta-Induced Neuroinflammation in Alzheimer's Disease.
     J Alzheimers Dis. 2024 May 8. doi: 10.3233/JAD-240012.
     PubMed     Abstract available
     
     
     
410. GIRALDO-BERRIO D, Jimenez-Del-Rio M, Velez-Pardo C
     Sildenafil Reverses the Neuropathological Alzheimer's Disease Phenotype in Cholinergic-Like Neurons Carrying the Presenilin 1 E280A Mutation.
     J Alzheimers Dis. 2024 May 8. doi: 10.3233/JAD-231169.
     PubMed     Abstract available
     
     
     April 2024
411. XU J, Chen Y, Shi Y, Sun A, et al
     Associations Between Neuroinflammation-Related Conditions and Alzheimer's Disease: A Study of US Insurance Claims Data.
     J Alzheimers Dis. 2024 Apr 30. doi: 10.3233/JAD-231286.
     PubMed     Abstract available
     
     
     
412. WU B, Chen M, Meng L, Tian Q, et al
     Osteoclasts Link Dysregulated Peripheral Degradation Processes and Accelerated Progression in Alzheimer's Disease.
     J Alzheimers Dis. 2024 Apr 29. doi: 10.3233/JAD-240096.
     PubMed     Abstract available
     
     
     
413. LI Y, Yang Z, Zhang Y, Liu F, et al
     Genetic Screening of Patients with Sporadic Alzheimer's Disease and Frontotemporal Lobar Degeneration in the Chinese Population.
     J Alzheimers Dis. 2024 Apr 29. doi: 10.3233/JAD-231361.
     PubMed     Abstract available
     
     
     
414. GALE SA
     Language and Meaning: Asymptomatic Alzheimer's Disease in the Clinic and Society.
     J Alzheimers Dis. 2024 Apr 27. doi: 10.3233/JAD-240195.
     PubMed     Abstract available
     
     
     
415. OHNO M
     A Strategy for Allowing Earlier Diagnosis and Rigorous Evaluation of BACE1 Inhibitors in Preclinical Alzheimer's Disease.
     J Alzheimers Dis. 2024 Apr 27. doi: 10.3233/JAD-231451.
     PubMed     Abstract available
     
     
     
416. HORVATH A, Quinlan P, Eckerstrom C, Aberg ND, et al
     The Associations Between Serum Insulin-like Growth Factor-I, Brain White Matter Volumes, and Cognition in Mild Cognitive Impairment and Alzheimer's Disease.
     J Alzheimers Dis. 2024 Apr 27. doi: 10.3233/JAD-231026.
     PubMed     Abstract available
     
     
     
417. 
     Erratum to: Loss in PKC Epsilon Causes Downregulation of MnSOD and BDNF Expression in Neurons of Alzheimer's Disease Hippocampus.
     J Alzheimers Dis. 2024 Apr 26. doi: 10.3233/JAD-249008.
     PubMed    
     
     
     
418. UM YH, Wang SM, Kang DW, Kim S, et al
     Impact of Apolipoprotein E4 on the Locus Coeruleus Functional Connectivity in Preclinical Alzheimer's Disease.
     J Alzheimers Dis. 2024 Apr 26. doi: 10.3233/JAD-240065.
     PubMed     Abstract available
     
     
     
419. ELGHANAM Y, Purja S, Kim EY
     Biomarkers as Endpoints in Clinical Trials for Alzheimer's Disease.
     J Alzheimers Dis. 2024 Apr 26. doi: 10.3233/JAD-240008.
     PubMed     Abstract available
     
     
     
420. DURAN T, Gaussoin SA, Latham LA, Rundle MM, et al
     Examining a Preclinical Alzheimer's Cognitive Composite for Telehealth Administration for Reliability Between In-Person and Remote Cognitive Testing with Neuroimaging Biomarkers.
     J Alzheimers Dis. 2024 Apr 26. doi: 10.3233/JAD-231435.
     PubMed     Abstract available
     
     
     
421. GARCIA-CARLOS CA, Basurto-Islas G, Perry G, Mondragon-Rodriguez S, et al
     Meta-Analysis in Transgenic Alzheimer's Disease Mouse Models Reveals Opposite Brain Network Effects of Amyloid-beta and Phosphorylated Tau Proteins.
     J Alzheimers Dis. 2024 Apr 26. doi: 10.3233/JAD-231365.
     PubMed     Abstract available
     
     
     
422. MEMON A, Moore JA, Kang C, Ismail Z, et al
     Visual Functions Are Associated with Biomarker Changes in Alzheimer's Disease.
     J Alzheimers Dis. 2024 Apr 26. doi: 10.3233/JAD-231084.
     PubMed     Abstract available
     
     
     
423. LIU M, Ma N, Yang X, Sun M, et al
     The Association of Circulating Glucagon-Like Peptide-1 with Cognitive Functions and Biomarkers in Alzheimer's Disease.
     J Alzheimers Dis. 2024 Apr 25. doi: 10.3233/JAD-240001.
     PubMed     Abstract available
     
     
     
424. NGO S, Jackson AJ, Manivannan M, Young JC, et al
     Real World Financial Mismanagement in Alzheimer's Disease, Frontotemporal Dementia, and Primary Progressive Aphasia.
     J Alzheimers Dis. 2024 Apr 24. doi: 10.3233/JAD-231021.
     PubMed     Abstract available
     
     
     
425. HUANG Z
     Evidence that Alzheimer's Disease Is a Disease of Competitive Synaptic Plasticity Gone Awry.
     J Alzheimers Dis. 2024 Apr 21. doi: 10.3233/JAD-240042.
     PubMed     Abstract available
     
     
     
426. DUFF K, Hammers DB, Koppelmans V, King JB, et al
     Short-Term Practice Effects on Cognitive Tests Across the Late Life Cognitive Spectrum and How They Compare to Biomarkers of Alzheimer's Disease.
     J Alzheimers Dis. 2024 Apr 21. doi: 10.3233/JAD-231392.
     PubMed     Abstract available
     
     
     
427. CHU Y, Xie Q, Meng R, Leng B, et al
     Evaluation of the Quality and Readability of Online Information about Alzheimer's Disease in China.
     J Alzheimers Dis. 2024 Apr 21. doi: 10.3233/JAD-231339.
     PubMed     Abstract available
     
     
     
428. CETINSOY O, Anyanwu I, Krishnanand H, Natarajan G, et al
     Gene Association Study of the Urokinase Plasminogen Activator and Its Receptor Gene in Alzheimer's Disease.
     J Alzheimers Dis. 2024 Apr 20. doi: 10.3233/JAD-231383.
     PubMed     Abstract available
     
     
     
429. KIM D, Jamrasi P, Li X, Ahn S, et al
     Effects of Exercise on Urinary AD7c-NTP (Alzheimer-Associated Neuronal Thread Protein) Levels and Cognitive Function Among Active Korean Elderly: A Randomized Controlled Trial.
     J Alzheimers Dis. 2024 Apr 20. doi: 10.3233/JAD-230946.
     PubMed     Abstract available
     
     
     
430. BUTLER T, Wang X, Chiang G, Xi K, et al
     Reduction in Constitutively Activated Auditory Brainstem Microglia in Aging and Alzheimer's Disease.
     J Alzheimers Dis. 2024 Apr 19. doi: 10.3233/JAD-231312.
     PubMed     Abstract available
     
     
     
431. KIM M, Song YS, Han K, Bae YJ, et al
     Impaired Glymphatic Flow on Diffusion Tensor MRI as a Marker of Neurodegeneration in Alzheimer's Disease: Correlation with Gray Matter Volume Loss and Cognitive Decline Independent of Cerebral Amyloid Deposition.
     J Alzheimers Dis. 2024 Apr 19. doi: 10.3233/JAD-231131.
     PubMed     Abstract available
     
     
     
432. CAI J, Xie D, Kong F, Zhai Z, et al
     Effect and Mechanism of Rapamycin on Cognitive Deficits in Animal Models of Alzheimer's Disease: A Systematic Review and Meta-analysis of Preclinical Studies.
     J Alzheimers Dis. 2024 Apr 17. doi: 10.3233/JAD-231249.
     PubMed     Abstract available
     
     
     
433. SIGHINOLFI G, Mitolo M, Pizzagalli F, Stanzani-Maserati M, et al
     Sulcal Morphometry Predicts Mild Cognitive Impairment Conversion to Alzheimer's Disease.
     J Alzheimers Dis. 2024 Apr 17. doi: 10.3233/JAD-231192.
     PubMed     Abstract available
     
     
     
434. CHANDRASEKARAN G, Xie SX
     Improving Regression Analysis with Imputation in a Longitudinal Study of Alzheimer's Disease.
     J Alzheimers Dis. 2024 Apr 17. doi: 10.3233/JAD-231047.
     PubMed     Abstract available
     
     
     
435. DAS S
     Omics Approaches in Alzheimer's Disease Research.
     J Alzheimers Dis. 2024 Apr 16. doi: 10.3233/JAD-240272.
     PubMed    
     
     
     
436. TAHAMI MONFARED AA, Khachatryan A, Hummel N, Kopiec A, et al
     Assessing Quality of Life, Economic Burden, and Independence Across the Alzheimer's Disease Continuum Using Patient-Caregiver Dyad Surveys.
     J Alzheimers Dis. 2024 Apr 16. doi: 10.3233/JAD-231259.
     PubMed     Abstract available
     
     
     
437. CHOI YY, Lee JJ, Te Nijenhuis J, Choi KY, et al
     Multi-Ethnic Norms for Volumes of Subcortical and Lobar Brain Structures Measured by Neuro I: Ethnicity May Improve the Diagnosis of Alzheimer's Disease1.
     J Alzheimers Dis. 2024 Apr 16. doi: 10.3233/JAD-231182.
     PubMed     Abstract available
     
     
     
438. YOO HS, Kim HK, Lee JH, Chun JH, et al
     Association of Basal Forebrain Volume with Amyloid, Tau, and Cognition in Alzheimer's Disease.
     J Alzheimers Dis. 2024 Apr 16. doi: 10.3233/JAD-230975.
     PubMed     Abstract available
     
     
     
439. KHALED M, Al-Jamal H, Tajer L, El-Mir R, et al
     Alzheimer's Disease in Lebanon: Exploring Genetic and Environmental Risk Factors-A Comprehensive Review.
     J Alzheimers Dis. 2024 Apr 12. doi: 10.3233/JAD-231432.
     PubMed     Abstract available
     
     
     
440. ETEKOCHAY MO, Amaravadhi AR, Gonzalez GV, Atanasov AG, et al
     Unveiling New Strategies Facilitating the Implementation of Artificial Intelligence in Neuroimaging for the Early Detection of Alzheimer's Disease.
     J Alzheimers Dis. 2024 Apr 12. doi: 10.3233/JAD-231135.
     PubMed     Abstract available
     
     
     
441. DORADO-MARTINEZ C, Montiel-Flores E, Ordonez-Librado JL, Gutierrez-Valdez AL, et al
     Histological and Memory Alterations in an Innovative Alzheimer's Disease Animal Model by Vanadium Pentoxide Inhalation.
     J Alzheimers Dis. 2024 Apr 12. doi: 10.3233/JAD-230818.
     PubMed     Abstract available
     
     
     
442. BINI J
     The Importance of PET Imaging to Understanding Whole-Body Cortisol Metabolism in Alzheimer's Disease.
     J Alzheimers Dis. 2024 Apr 11. doi: 10.3233/JAD-231463.
     PubMed     Abstract available
     
     
     
443. BECKERS E, Riphagen JM, Van Egroo M, Bennett DA, et al
     Sparse Asymmetry in Locus Coeruleus Pathology in Alzheimer's Disease.
     J Alzheimers Dis. 2024 Apr 11. doi: 10.3233/JAD-231328.
     PubMed     Abstract available
     
     
     
444. SACHDEVA P, Narayanan KB, Sinha JK, Gupta S, et al
     Recent Advances in Drug Delivery Systems Targeting Insulin Signalling for the Treatment of Alzheimer's Disease.
     J Alzheimers Dis. 2024 Apr 6. doi: 10.3233/JAD-231181.
     PubMed     Abstract available
     
     
     
445. WIDJAYA MA, Lee SD, Cheng WC, Wu BT, et al
     Effects of Exercise Training on Immune-Related Genes and Pathways in the Cortex of Animal Models of Alzheimer's Disease: A Systematic Review.
     J Alzheimers Dis. 2024 Apr 5. doi: 10.3233/JAD-230803.
     PubMed     Abstract available
     
     
     
446. ACQUARONE E, Argyrousi EK, Arancio O, Watterson DM, et al
     The 5HT2b Receptor in Alzheimer's Disease: Increased Levels in Patient Brains and Antagonist Attenuation of Amyloid and Tau Induced Dysfunction.
     J Alzheimers Dis. 2024 Apr 3. doi: 10.3233/JAD-240063.
     PubMed     Abstract available
     
     
     
447. AREA-GOMEZ E, Schon EA
     Towards a Unitary Hypothesis of Alzheimer's Disease Pathogenesis.
     J Alzheimers Dis. 2024 Apr 3. doi: 10.3233/JAD-231318.
     PubMed     Abstract available
     
     
     
448. DAUAR MT, Picard C, Labonte A, Breitner J, et al
     Contactin 5 and Apolipoproteins Interplay in Alzheimer's Disease.
     J Alzheimers Dis. 2024 Apr 3. doi: 10.3233/JAD-231003.
     PubMed     Abstract available
     
     
     March 2024
449. BRAGAZZI NL, Boulares A, Garbarino S
     Could the Historical Transition from Segmented to Monophasic Sleep Explain the Modern Insurgence of Alzheimer's Disease and Related Dementias?
     J Alzheimers Dis. 2024 Mar 30. doi: 10.3233/JAD-240154.
     PubMed     Abstract available
     
     
     
450. MORENO-RODRIGUEZ M, Perez SE, Martinez-Gardeazabal J, Manuel I, et al
     Frontal Cortex Lipid Alterations During the Onset of Alzheimer's Disease.
     J Alzheimers Dis. 2024 Mar 30. doi: 10.3233/JAD-231485.
     PubMed     Abstract available
     
     
     
451. MUELLER SG
     Traumatic Brain Injury and Post-Traumatic Stress Disorder and Their Influence on Development and Pattern of Alzheimer's Disease Pathology in Later Life.
     J Alzheimers Dis. 2024 Mar 29. doi: 10.3233/JAD-231183.
     PubMed     Abstract available
     
     
     
452. MATTSSON P, Cselenyi Z, Forsberg Moren A, Freund-Levi Y, et al
     High Contrast PET Imaging of Subcortical and Allocortical Amyloid-beta in Early Alzheimer's Disease Using [11C]AZD2184.
     J Alzheimers Dis. 2024 Mar 29. doi: 10.3233/JAD-231013.
     PubMed     Abstract available
     
     
     
453. ROBINSON AC, Bin Rizwan T, Davidson YS, Minshull J, et al
     Self-Reported Late-Life Hypertension Is Associated with a Healthy Cognitive Status and Reduced Alzheimer's Disease Pathology Burden.
     J Alzheimers Dis. 2024 Mar 25. doi: 10.3233/JAD-231429.
     PubMed     Abstract available
     
     
     
454. VIJAYAN M, Reddy PH
     Unveiling the Role of Novel miRNA PC-5P-12969 in Alleviating Alzheimer's Disease.
     J Alzheimers Dis. 2024 Mar 25. doi: 10.3233/JAD-231281.
     PubMed     Abstract available
     
     
     
455. GELFO F, Petrosini L, Mandolesi L, Landolfo E, et al
     Land/Water Aerobic Activities: Two Sides of the Same Coin. A Comparative Analysis on the Effects in Cognition of Alzheimer's Disease.
     J Alzheimers Dis. 2024 Mar 25. doi: 10.3233/JAD-231279.
     PubMed     Abstract available
     
     
     
456. LOVE RWB
     Aniracetam: An Evidence-Based Model for Preventing the Accumulation of Amyloid-beta Plaques in Alzheimer's Disease.
     J Alzheimers Dis. 2024 Mar 25. doi: 10.3233/JAD-231247.
     PubMed     Abstract available
     
     
     
457. LI Y, Xu X, Wang P, Chen X, et al
     Association of Cancer History with Lifetime Risk of Dementia and Alzheimer's Disease.
     J Alzheimers Dis. 2024 Mar 22. doi: 10.3233/JAD-231223.
     PubMed     Abstract available
     
     
     
458. MATTKE S, Jun H, Chu S, Hanson M, et al
     Disparities in Access to Diagnostic Evaluation for Alzheimer's Disease in Individuals Dually Eligible for Medicare and Medicaid: A Modeling Study.
     J Alzheimers Dis. 2024 Mar 22. doi: 10.3233/JAD-231134.
     PubMed     Abstract available
     
     
     
459. ZHANG M, Qu Y, Li Q, Gu C, et al
     Correlation Between Prefrontal Functional Connectivity and the Degree of Cognitive Impairment in Alzheimer's Disease: A Functional Near-Infrared Spectroscopy Study.
     J Alzheimers Dis. 2024 Mar 21. doi: 10.3233/JAD-230648.
     PubMed     Abstract available
     
     
     
460. CUMMINGS J
     "Landscape of Phase 2 Trials in Alzheimer's Disease": Perspective on Adaptive Trials.
     J Alzheimers Dis. 2024 Mar 20. doi: 10.3233/JAD-240145.
     PubMed     Abstract available
     
     
     
461. SHUI L, Shibata D, Chan KCG, Zhang W, et al
     Longitudinal Relationship Between Brain Atrophy Patterns, Cognitive Decline, and Cerebrospinal Fluid Biomarkers in Alzheimer's Disease Explored by Orthonormal Projective Non-Negative Matrix Factorization.
     J Alzheimers Dis. 2024 Mar 20. doi: 10.3233/JAD-231149.
     PubMed     Abstract available
     
     
     
462. POLIS B, Samson AO
     Addressing the Discrepancies Between Animal Models and Human Alzheimer's Disease Pathology: Implications for Translational Research.
     J Alzheimers Dis. 2024 Mar 19. doi: 10.3233/JAD-240058.
     PubMed     Abstract available
     
     
     
463. ZHONG P, Cao Q, Yan Z
     Distinct and Convergent Alterations of Entorhinal Cortical Circuits in Two Mouse Models for Alzheimer's Disease and Related Disorders.
     J Alzheimers Dis. 2024 Mar 14. doi: 10.3233/JAD-231413.
     PubMed     Abstract available
     
     
     
464. SOARES MARTINS T, Ferreira M, Magalhaes S, Leandro K, et al
     FTIR Spectroscopy and Blood-Derived Extracellular Vesicles Duo in Alzheimer's Disease.
     J Alzheimers Dis. 2024 Mar 14. doi: 10.3233/JAD-231239.
     PubMed     Abstract available
     
     
     
465. ALJASSABI A, Zieneldien T, Kim J, Regmi D, et al
     Alzheimer's Disease Immunotherapy: Current Strategies and Future Prospects.
     J Alzheimers Dis. 2024 Mar 14. doi: 10.3233/JAD-231163.
     PubMed     Abstract available
     
     
     
466. ZHANG X, Gomez L, Below JE, Naj AC, et al
     An X Chromosome Transcriptome Wide Association Study Implicates ARMCX6 in Alzheimer's Disease.
     J Alzheimers Dis. 2024 Mar 14. doi: 10.3233/JAD-231075.
     PubMed     Abstract available
     
     
     
467. SHEN Z, Yang X, Lan Y, Chen G, et al
     The Neuro-Inflammatory Microenvironment: An Important Regulator of Stem Cell Survival in Alzheimer's Disease.
     J Alzheimers Dis. 2024 Mar 13. doi: 10.3233/JAD-231159.
     PubMed     Abstract available
     
     
     
468. RAMADAN FA, Arani G, Jafri A, Thompson T, et al
     Mendelian Randomization of Blood Metabolites Suggests Circulating Glutamine Protects Against Late-Onset Alzheimer's Disease.
     J Alzheimers Dis. 2024 Mar 13. doi: 10.3233/JAD-231063.
     PubMed     Abstract available
     
     
     
469. BROOKS WH
     Polyamine Dysregulation and Nucleolar Disruption in Alzheimer's Disease.
     J Alzheimers Dis. 2024 Mar 12. doi: 10.3233/JAD-231184.
     PubMed     Abstract available
     
     
     
470. CAO J, Tang Y, Chen S, Yu S, et al
     The Hippocampal Subfield Volume Reduction and Plasma Biomarker Changes in Mild Cognitive Impairment and Alzheimer's Disease.
     J Alzheimers Dis. 2024 Mar 12. doi: 10.3233/JAD-231114.
     PubMed     Abstract available
     
     
     
471. TRIEU C, van Harten AC, Leeuwis AE, Exalto LG, et al
     Alzheimer's Disease and Cognitive Decline in Patients with Cardiovascular Diseases Along the Heart-Brain Axis.
     J Alzheimers Dis. 2024 Mar 12. doi: 10.3233/JAD-231096.
     PubMed     Abstract available
     
     
     
472. ZHAI M, Zhang Y, Yan D, Wang Y, et al
     Genetic Insights into the Association and Causality Between Blood Metabolites and Alzheimer's Disease.
     J Alzheimers Dis. 2024 Mar 12. doi: 10.3233/JAD-230985.
     PubMed     Abstract available
     
     
     
473. CESANA BM, Bergh S, Ciccone A, Cognat E, et al
     Predictors of Nursing Home Placement in a Cohort of European People with Alzheimer's Disease and Other Dementia Cases Enrolled in SCU-B or Non SCU-B Centers: The RECage Study.
     J Alzheimers Dis. 2024 Mar 12. doi: 10.3233/JAD-230878.
     PubMed     Abstract available
     
     
     
474. CABRERA-LEON Y, Baez PG, Fernandez-Lopez P, Suarez-Araujo CP, et al
     Neural Computation-Based Methods for the Early Diagnosis and Prognosis of Alzheimer's Disease Not Using Neuroimaging Biomarkers: A Systematic Review.
     J Alzheimers Dis. 2024 Mar 10. doi: 10.3233/JAD-231271.
     PubMed     Abstract available
     
     
     
475. TERAO I, Kodama W
     Comparative Efficacy, Tolerability, and Acceptability of Donanemab, Lecanemab, Aducanumab, Melatonin, and Aerobic Exercise for a Short Time on Cognitive Function in Mild Cognitive Impairment and Mild Alzheimer's Disease: A Systematic Review and Networ
     J Alzheimers Dis. 2024 Mar 6. doi: 10.3233/JAD-230911.
     PubMed     Abstract available
     
     
     
476. MANDAL PK
     Pro-Oxidants and Antioxidants Imbalance in Alzheimer's Disease.
     J Alzheimers Dis. 2024 Mar 4. doi: 10.3233/JAD-240217.
     PubMed    
     
     
     
477. 
     Retraction to: Potential Mechanisms Linking Cholesterol to Alzheimer's Disease-like Pathology in Rabbit Brain, Hippocampal Organotypic Slices, and Skeletal Muscle.
     J Alzheimers Dis. 2024 Mar 1. doi: 10.3233/JAD-239016.
     PubMed    
     
     
     
478. GOHEL D, Zhang P, Gupta AK, Li Y, et al
     Sildenafil as a Candidate Drug for Alzheimer's Disease: Real-World Patient Data Observation and Mechanistic Observations from Patient-Induced Pluripotent Stem Cell-Derived Neurons.
     J Alzheimers Dis. 2024 Mar 1. doi: 10.3233/JAD-231391.
     PubMed     Abstract available
     
     
     
479. YANG J, Liu X, Oveisgharan S, Zammit AR, et al
     Inferring Alzheimer's Disease Pathologic Traits from Clinical Measures in Living Adults.
     J Alzheimers Dis. 2024 Mar 1. doi: 10.3233/JAD-230639.
     PubMed     Abstract available
     
     
     February 2024
480. WANG CS, Chen PS, Tsai TY, Hou NT, et al
     Cognitive Effect of Transcranial Direct Current Stimulation on Left Dorsolateral Prefrontal Cortex in Mild Alzheimer's Disease: A Randomized, Double-Blind, Cross-Over Small-Scale Exploratory Study.
     J Alzheimers Dis. 2024 Feb 28. doi: 10.3233/JAD-240002.
     PubMed     Abstract available
     
     
     
481. LI S, Lan X, Liu Y, Zhou J, et al
     Unlocking the Potential of Repetitive Transcranial Magnetic Stimulation in Alzheimer's Disease: A Meta-Analysis of Randomized Clinical Trials to Optimize Intervention Strategies.
     J Alzheimers Dis. 2024 Feb 28. doi: 10.3233/JAD-231031.
     PubMed     Abstract available
     
     
     
482. LU TV, Grill JD, Gillen DL
     Study Partner Type and Adverse Event Reporting in Mild-to-Moderate Alzheimer's Disease Clinical Trials.
     J Alzheimers Dis. 2024 Feb 26. doi: 10.3233/JAD-231283.
     PubMed     Abstract available
     
     
     
483. SIGURDSSON EM
     Tau Immunotherapies for Alzheimer's Disease and Related Tauopathies: Status of Trials and Insights from Preclinical Studies.
     J Alzheimers Dis. 2024 Feb 26. doi: 10.3233/JAD-231238.
     PubMed     Abstract available
     
     
     
484. GARCIA-ALBERCA JM, de Rojas I, Sanchez-Mejias E, Garrido-Martin D, et al
     An Insertion Within SIRPbeta1 Shows a Dual Effect Over Alzheimer's Disease Cognitive Decline Altering the Microglial Response.
     J Alzheimers Dis. 2024 Feb 26. doi: 10.3233/JAD-231150.
     PubMed     Abstract available
     
     
     
485. CHI HC, Ma LZ, Wang ZB, Sheng ZH, et al
     Associations of Frailty with Neuropsychiatric Symptoms of Alzheimer's Disease: A Longitudinal Study.
     J Alzheimers Dis. 2024 Feb 26. doi: 10.3233/JAD-231111.
     PubMed     Abstract available
     
     
     
486. ROSSI E, Marrosu F, Saba L
     Music Therapy as a Complementary Treatment in Patients with Dementia Associated to Alzheimer's Disease: A Systematic Review.
     J Alzheimers Dis. 2024 Feb 26. doi: 10.3233/JAD-230852.
     PubMed     Abstract available
     
     
     
487. NJOMBORO P, Lekhutlile T
     The Effect of Apathy and Depressive Syndromes on Functional Outcomes in Alzheimer's Disease.
     J Alzheimers Dis. 2024 Feb 26. doi: 10.3233/JAD-230426.
     PubMed     Abstract available
     
     
     
488. VERWAERDE P, Estrella C, Burlet S, Barrier M, et al
     First-In-Human Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of AZP2006, A Synthetic Compound for the Treatment of Alzheimer's Disease and Related Diseases.
     J Alzheimers Dis. 2024 Feb 26. doi: 10.3233/JAD-220883.
     PubMed     Abstract available
     
     
     
489. KUMARI S, Kaur P, Singh AK, Ashar MS, et al
     Quantification of COX-2 Level in Alzheimer's Disease Patients to Develop Potential Blood-Based Biomarker for Early Diagnosis and Therapeutic Target.
     J Alzheimers Dis. 2024 Feb 24. doi: 10.3233/JAD-231445.
     PubMed     Abstract available
     
     
     
490. KAVOOSI S, Shahraki A, Sheervalilou R
     Identification of microRNA-mRNA Regulatory Networks with Therapeutic Values in Alzheimer's Disease by Bioinformatics Analysis.
     J Alzheimers Dis. 2024 Feb 24. doi: 10.3233/JAD-230966.
     PubMed     Abstract available
     
     
     
491. SABBIR MG
     Cholinergic Receptor Muscarinic 1 Co-Localized with Mitochondria in Cultured Dorsal Root Ganglion Neurons, and Its Deletion Disrupted Mitochondrial Ultrastructure in Peripheral Neurons: Implications in Alzheimer's Disease.
     J Alzheimers Dis. 2024 Feb 24. doi: 10.3233/JAD-230883.
     PubMed     Abstract available
     
     
     
492. CULIBRK RA, Ebbert KA, Yeisley DJ, Chen R, et al
     Impact of Suramin on Key Pathological Features of Sporadic Alzheimer's Disease-Derived Forebrain Neurons.
     J Alzheimers Dis. 2024 Feb 24. doi: 10.3233/JAD-230600.
     PubMed     Abstract available
     
     
     
493. KAMEYAMA H, Tagai K, Takasaki E, Kashibayashi T, et al
     Examining Frontal Lobe Asymmetry and Its Potential Role in Aggressive Behaviors in Early Alzheimer's Disease.
     J Alzheimers Dis. 2024 Feb 23. doi: 10.3233/JAD-231306.
     PubMed     Abstract available
     
     
     
494. VAISHNAV N, Gonzalez R, Karunungan K, Tyler A, et al
     Creating an Unprotected Class: Addressing Legal Risks in the Era of Biologically-Defined Alzheimer's Disease.
     J Alzheimers Dis. 2024 Feb 23. doi: 10.3233/JAD-230067.
     PubMed     Abstract available
     
     
     
495. ADAMS JA, Uryash A, Lopez JR
     Harnessing Passive Pulsatile Shear Stress for Alzheimer's Disease Prevention and Intervention.
     J Alzheimers Dis. 2024 Feb 22. doi: 10.3233/JAD-231010.
     PubMed     Abstract available
     
     
     
496. RAPOS PEREIRA F, George N, Dalla Barba G, Dubois B, et al
     The Memory Binding Test Detects Early Subtle Episodic Memory Decline in Preclinical Alzheimer's Disease: A Longitudinal Study.
     J Alzheimers Dis. 2024 Feb 22. doi: 10.3233/JAD-230921.
     PubMed     Abstract available
     
     
     
497. COGRAM P, Garduno BM, Ren B, Xu X, et al
     First International Conference on Unconventional Animal Models of Alzheimer's Disease and Aging.
     J Alzheimers Dis. 2024 Feb 20. doi: 10.3233/JAD-249004.
     PubMed     Abstract available
     
     
     
498. ACHARYA NK, Grossman HC, Clifford PM, Levin EC, et al
     A Chronic Increase in Blood-Brain Barrier Permeability Facilitates Intraneuronal Deposition of Exogenous Bloodborne Amyloid-Beta1-42 Peptide in the Brain and Leads to Alzheimer's Disease-Relevant Cognitive Changes in a Mouse Model.
     J Alzheimers Dis. 2024 Feb 20. doi: 10.3233/JAD-231028.
     PubMed     Abstract available
     
     
     
499. CZUCZWAR SAJ, Kocki J, Miziak B, Bogucki J, et al
     Alpha-, Beta-, and Gamma-Secretase, Amyloid Precursor Protein, and Tau Protein Genes in the Hippocampal CA3 Subfield in an Ischemic Model of Alzheimer's Disease with Survival up to 2 Years.
     J Alzheimers Dis. 2024 Feb 19. doi: 10.3233/JAD-231333.
     PubMed     Abstract available
     
     
     
500. RAJABLI F, Seixas AA, Akgun B, Adams LD, et al
     African Ancestry Individuals with Higher Educational Attainment are Resilient to Alzheimer's Disease Measured by pTau181.
     J Alzheimers Dis. 2024 Feb 19. doi: 10.3233/JAD-231116.
     PubMed     Abstract available
     
     
     
501. SUN H, Li P, Gao L, Yang J, et al
     Altered Motor Activity Patterns within 10-Minute Timescale Predict Incident Clinical Alzheimer's Disease.
     J Alzheimers Dis. 2024 Feb 19. doi: 10.3233/JAD-230928.
     PubMed     Abstract available
     
     
     
502. NELSON D, Thompson KJ, Wang L, Wang Z, et al
     Pericyte Control of Gene Expression in the Blood-Brain Barrier Endothelium: Implications for Alzheimer's Disease.
     J Alzheimers Dis. 2024 Feb 19. doi: 10.3233/JAD-230907.
     PubMed     Abstract available
     
     
     
503. GILLS JL, Bubu OM
     Obstructive Sleep Apnea and Alzheimer's Disease Pathology: Is Sleep Architecture the Missing Key?
     J Alzheimers Dis. 2024 Feb 14. doi: 10.3233/JAD-231385.
     PubMed     Abstract available
     
     
     
504. KIM SA, Maeda M, Murata F, Fujii T, et al
     Impact of Concurrent Visual and Hearing Impairment on Incident Alzheimer's Disease: The LIFE Study.
     J Alzheimers Dis. 2024 Feb 14. doi: 10.3233/JAD-230806.
     PubMed     Abstract available
     
     
     
505. JU IG, Lee S, Kim SH, Im H, et al
     Trichosanthis Semen Exerts Neuroprotective Effects in Alzheimer's Disease Models by Inhibiting Amyloid-beta Accumulation and Regulating the Akt and ERK Signaling Pathways.
     J Alzheimers Dis. 2024 Feb 13. doi: 10.3233/JAD-231124.
     PubMed     Abstract available
     
     
     
506. LI Z, Fan Z, Zhang Q
     The Associations of Phosphorylated Tau 181 and Tau 231 Levels in Plasma and Cerebrospinal Fluid with Cognitive Function in Alzheimer's Disease: A Systematic Review and Meta-Analysis.
     J Alzheimers Dis. 2024 Feb 7. doi: 10.3233/JAD-230799.
     PubMed     Abstract available
     
     
     
507. GEPHINE L, Roux CM, Freret T, Boulouard M, et al
     Vulnerability of Spatial Pattern Separation in 5xFAD Alzheimer's Disease Mouse Model.
     J Alzheimers Dis. 2024 Feb 2. doi: 10.3233/JAD-231112.
     PubMed     Abstract available
     
     
     
508. DE LA MONTE SM, Tong M
     Agent Orange Herbicidal Toxin-Initiation of Alzheimer-Type Neurodegeneration.
     J Alzheimers Dis. 2024 Feb 2. doi: 10.3233/JAD-230881.
     PubMed     Abstract available
     
     
     
509. GIULIETTI MV, Fabbietti P, Spatuzzi R, Vespa A, et al
     Effects of Mindfulness Based Interventions in Adults and Older Adults Caregivers of Patients with Early Stage Alzheimer's Disease: A Randomized Pilot Study.
     J Alzheimers Dis. 2024 Feb 2. doi: 10.3233/JAD-230284.
     PubMed     Abstract available
     
     
     January 2024
510. MONE P, De Luca A, Kansakar U, Santulli G, et al
     Leukocytes and Endothelial Cells Participate in the Pathogenesis of Alzheimer's Disease: Identifying New Biomarkers Mirroring Metabolic Alterations.
     J Alzheimers Dis. 2024 Jan 31. doi: 10.3233/JAD-231464.
     PubMed     Abstract available
     
     
     
511. ZHANG X, Haeri M, Swerdlow RH, Wang N, et al
     Loss of Adaptive DNA Breaks in Alzheimer's Disease Brains.
     J Alzheimers Dis. 2024 Jan 31. doi: 10.3233/JAD-231303.
     PubMed     Abstract available
     
     
     
512. SIBLE IJ, Nation DA
     Blood Pressure Variability and Plasma Alzheimer's Disease Biomarkers in the SPRINT Trial.
     J Alzheimers Dis. 2024 Jan 31. doi: 10.3233/JAD-230930.
     PubMed     Abstract available
     
     
     
513. NOORI A, Jayakumar R, Moturi V, Li Z, et al
     Alzheimer DataLENS: An Open Data Analytics Portal for Alzheimer's Disease Research.
     J Alzheimers Dis. 2024 Jan 31. doi: 10.3233/JAD-230884.
     PubMed     Abstract available
     
     
     
514. WHEELER KV, Irimia A, Braskie MN
     Using Neuroimaging to Study Cerebral Amyloid Angiopathy and Its Relationship to Alzheimer's Disease.
     J Alzheimers Dis. 2024 Jan 31. doi: 10.3233/JAD-230553.
     PubMed     Abstract available
     
     
     
515. JIAO L, Jing Z, Zhang W, Su X, et al
     Codon Pattern and Context Analysis in Genes Triggering Alzheimer's Disease and Latent Tau Protein Aggregation Post-Anesthesia Exhibited Unique Molecular Patterns Associated with Functional Aspects.
     J Alzheimers Dis. 2024 Jan 30. doi: 10.3233/JAD-231142.
     PubMed     Abstract available
     
     
     
516. NG PY, Zhang C, Li H, Baker DJ, et al
     Senescence Targeting Methods Impact Alzheimer's Disease Features in 3xTg Mice.
     J Alzheimers Dis. 2024 Jan 30. doi: 10.3233/JAD-230465.
     PubMed     Abstract available
     
     
     
517. CABAN-HOLT A, Cuccaro ML, Lloyd SL, Starks TD, et al
     Attitudes and Perceptions about Brain Donation Among African Americans: Implications for Recruitment into Alzheimer's Disease Research.
     J Alzheimers Dis. 2024 Jan 29. doi: 10.3233/JAD-230461.
     PubMed     Abstract available
     
     
     
518. BELKHELFA M, Bekrar S, Rezaig L, Beder N, et al
     Neuroinflammatory Responses Occur in Brain Lesions During Alzheimer's Disease: Postmortem Case Report.
     J Alzheimers Dis. 2024 Jan 23. doi: 10.3233/JAD-230910.
     PubMed     Abstract available
     
     
     
519. WEI G, Tian X, Yang H, Luo Y, et al
     Adjunct Methods for Alzheimer's Disease Detection: A Review of Auditory Evoked Potentials.
     J Alzheimers Dis. 2024 Jan 23. doi: 10.3233/JAD-230822.
     PubMed     Abstract available
     
     
     
520. TAKASE H, Hamanaka G, Hoshino T, Ohtomo R, et al
     Transcriptomic Profiling Reveals Neuroinflammation in the Corpus Callosum of a Transgenic Mouse Model of Alzheimer's Disease.
     J Alzheimers Dis. 2024 Jan 22. doi: 10.3233/JAD-231049.
     PubMed     Abstract available
     
     
     
521. OKINAKA Y, Shinagawa Y, Claussen C, Gul S, et al
     RNA Analysis of Circulating Leukocytes in Patients with Alzheimer's Disease.
     J Alzheimers Dis. 2024 Jan 22. doi: 10.3233/JAD-230874.
     PubMed     Abstract available
     
     
     
522. SAEED A, Alharazi T, Alshaghdali K, Rezgui R, et al
     Targeting GluR3 in Depression and Alzheimer's Disease: Novel Compounds and Therapeutic Prospects.
     J Alzheimers Dis. 2024 Jan 22. doi: 10.3233/JAD-230821.
     PubMed     Abstract available
     
     
     
523. VILLEMAGNE VL, Dore V, Chong L, Kassiou M, et al
     Brain 11beta-Hydroxysteroid Dehydrogenase Type 1 Occupancy by Xanamem Assessed by PET in Alzheimer's Disease and Cognitively Normal Individuals.
     J Alzheimers Dis. 2024 Jan 19. doi: 10.3233/JAD-220542.
     PubMed     Abstract available
     
     
     
524. ZHOU J, Zhao M, Yang Z, Chen L, et al
     Exploring the Value of MRI Measurement of Hippocampal Volume for Predicting the Occurrence and Progression of Alzheimer's Disease Based on Artificial Intelligence Deep Learning Technology and Evidence-Based Medicine Meta-Analysis.
     J Alzheimers Dis. 2024 Jan 18. doi: 10.3233/JAD-230733.
     PubMed     Abstract available
     
     
     
525. GORHAM IK, Reid DM, Sun J, Zhou Z, et al
     Blood-Based mtDNA Quantification Indicates Population-Specific Differences Associated with Alzheimer's Disease-Related Risk.
     J Alzheimers Dis. 2024 Jan 16. doi: 10.3233/JAD-230880.
     PubMed     Abstract available
     
     
     
526. KURANO M, Saito Y, Yatomi Y
     Comprehensive Analysis of Metabolites in Postmortem Brains of Patients with Alzheimer's Disease.
     J Alzheimers Dis. 2024 Jan 13. doi: 10.3233/JAD-230942.
     PubMed     Abstract available
     
     
     
527. CHEN M, Wang F, Lei H, Yang Z, et al
     In Silico Insights into Micro-Mechanism Understanding of Extracts of Taxus Chinensis Fruits Against Alzheimer's Disease.
     J Alzheimers Dis. 2024 Jan 12. doi: 10.3233/JAD-231066.
     PubMed     Abstract available
     
     
     
528. FORT-AZNAR L, Molina-Porcel L, Ramos-Campoy O, Esteller D, et al
     Misfolded alpha-Synuclein in Autosomal Dominant Alzheimer's Disease.
     J Alzheimers Dis. 2024 Jan 12. doi: 10.3233/JAD-230919.
     PubMed     Abstract available
     
     
     
529. SMITH HS, Robinson JO, Levchenko A, Pereira S, et al
     Research Participants' Perspectives on Precision Diagnostics for Alzheimer's Disease.
     J Alzheimers Dis. 2024 Jan 12. doi: 10.3233/JAD-230609.
     PubMed     Abstract available
     
     
     
530. HAN Y, Huang C, Pan Y, Gu X, et al
     Single Cell Sequencing Technology and Its Application in Alzheimer's Disease.
     J Alzheimers Dis. 2024 Jan 8. doi: 10.3233/JAD-230861.
     PubMed     Abstract available
     
     
     
531. WU LY, Chong JR, Chong JPC, Hilal S, et al
     Serum Placental Growth Factor as a Marker of Cerebrovascular Disease Burden in Alzheimer's Disease.
     J Alzheimers Dis. 2024 Jan 8. doi: 10.3233/JAD-230811.
     PubMed     Abstract available
     
     
     
532. ZHANG C, Lei X, Ma W, Long J, et al
     Diagnosis Framework for Probable Alzheimer's Disease and Mild Cognitive Impairment Based on Multi-Dimensional Emotion Features.
     J Alzheimers Dis. 2024 Jan 5. doi: 10.3233/JAD-230703.
     PubMed     Abstract available
     
     
     
533. STONE J, Mitrofanis J, Johnstone DM, Robinson SR, et al
     The Catastrophe of Intracerebral Hemorrhage Drives the Capillary-Hemorrhage Dementias, Including Alzheimer's Disease.
     J Alzheimers Dis. 2024 Jan 5. doi: 10.3233/JAD-231202.
     PubMed     Abstract available
     
     
     
534. SAFIEH M, Liraz O, Ovadia M, Michaelson D, et al
     The Role of Impaired Receptor Trafficking in Mediating the Pathological Effects of APOE4 in Alzheimer's Disease.
     J Alzheimers Dis. 2024 Jan 5. doi: 10.3233/JAD-230514.
     PubMed     Abstract available
     
     
     
535. FAN X, Cai Y, Zhao L, Liu W, et al
     Machine Learning-Derived MRI-Based Neurodegeneration Biomarker for Alzheimer's Disease: A Multi-Database Validation Study.
     J Alzheimers Dis. 2024 Jan 4. doi: 10.3233/JAD-230574.
     PubMed     Abstract available
     
     
     
536. VALENTIN-ESCALERA J, Leclerc M, Calon F
     High-Fat Diets in Animal Models of Alzheimer's Disease: How Can Eating Too Much Fat Increase Alzheimer's Disease Risk?
     J Alzheimers Dis. 2024 Jan 4. doi: 10.3233/JAD-230118.
     PubMed     Abstract available
     
     
     
537. SELLES MC, Oliveira MM
     The Oxytocin Puzzle: Unlocking Alzheimer's Disease.
     J Alzheimers Dis. 2024 Jan 3. doi: 10.3233/JAD-231127.
     PubMed     Abstract available
     
     
     
538. LI J, Yang M, Wei R, Cao Y, et al
     The Predictive Ability of Blood Neurofilament Light Chain in Predicting Cognitive Decline in the Alzheimer's Disease Continuum: A Systematic Review and Meta-Analysis.
     J Alzheimers Dis. 2024 Jan 2. doi: 10.3233/JAD-231080.
     PubMed     Abstract available
     
     
     
539. NADEAU PA, Jobin B, Boller B
     Erratum to: Diagnostic Sensitivity and Specificity of Cognitive Tests for Mild Cognitive Impairment and Alzheimer's Disease in Patients with Down Syndrome: A Systematic Review and Meta-Analysis.
     J Alzheimers Dis. 2024;97:521.
     PubMed    
     
     
     
540. 
     The Journal of Alzheimer's Disease Is Happy to Announce the Appointment of Paula I. Moreira, PhD, as Co-Editor-in-Chief of the Journal.
     J Alzheimers Dis. 2024;97:1.
     PubMed    
     
     
     
541. ANGELIDOU IA, Stocker H, Beyreuther K, Teichmann B, et al
     Validation of the "Perceptions Regarding pRE-Symptomatic Alzheimer's Disease Screening" (PRE-ADS) Questionnaire in the German Population: Attitudes, Motivations, and Barriers to Pre-Symptomatic Dementia Screening.
     J Alzheimers Dis. 2024;97:309-325.
     PubMed     Abstract available
     
     
     
542. ZENG Y, Cao S, Pang K, Tang J, et al
     Causal Association Between Sepsis and Neurodegenerative Diseases: A Bidirectional Two-Sample Mendelian Randomization Study.
     J Alzheimers Dis. 2024;97:229-237.
     PubMed     Abstract available
     
     
     
543. DE SIMONE MS, Spalletta G, Vecchio D, Bassi A, et al
     The Role of the Anterior Thalamic Nuclei in the Genesis of Memory Disorders in Alzheimer's Disease: An Exploratory Study.
     J Alzheimers Dis. 2024;97:507-519.
     PubMed     Abstract available
     
     
     
544. ALSHAHERI DURAZO A, Weigand AJ, Bangen KJ, Membreno R, et al
     Type 2 Diabetes Moderates the Association Between Amyloid and 1-Year Change in Everyday Functioning in Older Veterans.
     J Alzheimers Dis. 2024;97:219-228.
     PubMed     Abstract available
     
     
     
545. LOBUE C, Stopschinski BE, Saez Calveras N, Douglas PM, et al
     Blood Markers in Relation to a History of Traumatic Brain Injury Across Stages of Cognitive Impairment in a Diverse Cohort.
     J Alzheimers Dis. 2024;97:345-358.
     PubMed     Abstract available
     
     
     
546. GUO Y, Sun Y, Li M, Qi WY, et al
     Amyloid Pathology Modulates the Associations of Neuropsychiatric Symptoms with Cognitive Impairments and Neurodegeneration in Non-Demented Elderly.
     J Alzheimers Dis. 2024;97:471-484.
     PubMed     Abstract available
     
     
     
547. LAPEYRE L, Piret J, Rheaume C, Pons V, et al
     Herpes Simplex Virus 1 Infection Does Not Increase Amyloid-beta Pathology in APP/PS1 Mice.
     J Alzheimers Dis. 2024;97:171-178.
     PubMed     Abstract available
     
     
     
548. MARTIN J, Reid N, Ward DD, King S, et al
     Investigating Sex Differences in Risk and Protective Factors in the Progression of Mild Cognitive Impairment to Dementia: A Systematic Review.
     J Alzheimers Dis. 2024;97:101-119.
     PubMed     Abstract available
     
     
     
549. YANG M, Gan J, Liu S, Yang Y, et al
     Associations Between Plasma Orexin-A Level and Constipation in Cognitive Impairment.
     J Alzheimers Dis. 2024;97:409-419.
     PubMed     Abstract available
     
     
     
550. KIM REY, Lee M, Kang DW, Wang SM, et al
     Increased Likelihood of Dementia with Coexisting Atrophy of Multiple Regions of Interest.
     J Alzheimers Dis. 2024;97:259-271.
     PubMed     Abstract available
     
     
     
551. NA S, Lee C, Ho S, Hong YJ, et al
     A Longitudinal Study on Memory Enhancement in Subjective Cognitive Decline Patients: Clinical and Neuroimaging Perspectives.
     J Alzheimers Dis. 2024;97:193-204.
     PubMed     Abstract available
     
     
     
552. POSSEMIS N, Ter Huurne D, Banning L, Gruters A, et al
     The Reliability and Clinical Validation of Automatically-Derived Verbal Memory Features of the Verbal Learning Test in Early Diagnostics of Cognitive Impairment.
     J Alzheimers Dis. 2024;97:179-191.
     PubMed     Abstract available
     
     
     
553. BRUNO JL, Shaw JS, Hosseini SMH
     Toward Personalized Cognitive Training in Older Adults: A Pilot Investigation of the Effects of Baseline Performance and Age on Cognitive Training Outcomes.
     J Alzheimers Dis. 2024;97:327-343.
     PubMed     Abstract available
     
     
     
554. DE LA PERRELLE L
     Health Care Is Not Enough to Prevent Dementia.
     J Alzheimers Dis. 2024;97:951-952.
     PubMed     Abstract available
     
     
     
555. DIGMA LA, Winer JR, Greicius MD
     Substantial Doubt Remains about the Efficacy of Anti-Amyloid Antibodies.
     J Alzheimers Dis. 2024;97:567-572.
     PubMed     Abstract available
     
     
     
556. FRENTZ I, van Arendonk J, Leeuwis AE, Vernooij MW, et al
     Interaction Between Arteriosclerosis and Amyloid-beta on Cognitive Function.
     J Alzheimers Dis. 2024;97:953-961.
     PubMed     Abstract available
     
     
     
557. MATERS J, van der Steen JT, de Vugt ME, Bakker C, et al
     Palliative Care in Nursing Home Residents with Young-Onset Dementia: Professional and Family Caregiver Perspectives.
     J Alzheimers Dis. 2024;97:573-586.
     PubMed     Abstract available
     
     
     
558. SCHRODER VE, Skrozic A, Erz D, Kaysen A, et al
     Programme Dementia Prevention (pdp): A Nationwide Program for Personalized Prevention in Luxembourg.
     J Alzheimers Dis. 2024;97:791-804.
     PubMed     Abstract available
     
     
     
559. DINGLE SE, Milte CM, Daly RM, Torres SJ, et al
     Attitudes and Considerations for Multidomain Lifestyle Approaches to Dementia Prevention: A Qualitative Study.
     J Alzheimers Dis. 2024;97:939-949.
     PubMed     Abstract available
     
     
     
560. KOSEL F, Hartley MR, Franklin TB
     Aberrant Cortical Activity in 5xFAD Mice in Response to Social and Non-Social Olfactory Stimuli.
     J Alzheimers Dis. 2024;97:659-677.
     PubMed     Abstract available
     
     
     
561. REHMAN H, Ang TFA, Tao Q, Espenilla AL, et al
     Comparison of Commonly Measured Plasma and Cerebrospinal Fluid Proteins and Their Significance for the Characterization of Cognitive Impairment Status.
     J Alzheimers Dis. 2024;97:621-633.
     PubMed     Abstract available
     
     
     
562. REN J, Yu Y, Wang Y, Dong Y, et al
     Association Between Urinary Glyphosate Exposure and Cognitive Impairment in Older Adults from NHANES 2013-2014.
     J Alzheimers Dis. 2024;97:609-620.
     PubMed     Abstract available
     
     
     
563. MAZZOLA P, Zanetti M, Ferraguzzi G, Villa ML, et al
     Shifting the Paradigm of Nursing Home Care for People with Dementia: The Italian Experience of Il Paese Ritrovato and the Impact of SARS-CoV-2.
     J Alzheimers Dis. 2024;97:741-752.
     PubMed     Abstract available
     
     
     
564. BRITZ J, Ojo E, Haque N, Dhukhwa A, et al
     Sex-Dependent Effects of Chronic Circadian Disruption in AbetaPP/PS1 Mice.
     J Alzheimers Dis. 2024;97:855-870.
     PubMed     Abstract available
     
     
     
565. GURJAR P, Khan AA, Alanazi AM, Vasil'ev VG, et al
     Molecular Dissection of Herpes Simplex Virus Type 1 to Elucidate Molecular Mechanisms Behind Latency and Comparison of Its Codon Usage Patterns with Genes Modulated During Alzheimer's Disease as a Part of Host-Pathogen Interaction.
     J Alzheimers Dis. 2024;97:1111-1123.
     PubMed     Abstract available
     
     
     
566. SCHWINNE M, Alonso A, Roberts BR, Hickle S, et al
     The Association of Alzheimer's Disease-Related Blood-Based Biomarkers with Cognitive Screening Test Performance in the Congolese Population in Kinshasa.
     J Alzheimers Dis. 2024;97:1353-1363.
     PubMed     Abstract available
     
     
     
567. ASIAMAH EA, Feng B, Guo R, Yaxing X, et al
     The Contributions of the Endolysosomal Compartment and Autophagy to APOEvarepsilon4 Allele-Mediated Increase in Alzheimer's Disease Risk.
     J Alzheimers Dis. 2024;97:1007-1031.
     PubMed     Abstract available
     
     
     
568. PLASSMAN BL, Ford CB, Smith VA, DePasquale N, et al
     Elevated Amyloid-beta PET Scan and Cognitive and Functional Decline in Mild Cognitive Impairment and Dementia of Uncertain Etiology.
     J Alzheimers Dis. 2024;97:1161-1171.
     PubMed     Abstract available
     
     
     
569. ROBILLARD JM, Masellis M, Martin SE, Khachaturian AS, et al
     The Return of Biomarker Results in Research: Balancing Complexity, Precision, and Ethical Responsibility.
     J Alzheimers Dis. 2024;97:1083-1090.
     PubMed     Abstract available
     
     
     
570. PANZAVOLTA A, Cerami C, Marcone A, Zamboni M, et al
     Diagnostic Performance of Socio-Emotional Informant-Based Questionnaires for the Clinical Detection of the Behavioral Variant of Frontotemporal Dementia.
     J Alzheimers Dis. 2024;97:1249-1260.
     PubMed     Abstract available
     
     
     
571. OKAHASHI S, Noguchi T, Ishihara M, Osawa A, et al
     Dyadic Art Appreciation and Self-Expression Program (NCGG-ART) for People with Dementia or Mild Cognitive Impairment and Their Family Caregivers: A Feasibility Study.
     J Alzheimers Dis. 2024;97:1435-1448.
     PubMed     Abstract available
     
     
     
572. DU P, Zhang X, Lian X, Holscher C, et al
     O-GlcNAcylation and Its Roles in Neurodegenerative Diseases.
     J Alzheimers Dis. 2024;97:1051-1068.
     PubMed     Abstract available
     
     
     
573. SHANG L, Dong L, Huang X, Chu S, et al
     Comorbidity of Dementia: A Cross-Sectional Study of PUMCH Dementia Cohort.
     J Alzheimers Dis. 2024;97:1313-1322.
     PubMed     Abstract available
     
     
     
574. ALEGRET M, Garcia-Gutierrez F, Munoz N, Espinosa A, et al
     FACEmemory(R), an Innovative Online Platform for Episodic Memory Pre-Screening: Findings from the First 3,000 Participants.
     J Alzheimers Dis. 2024;97:1173-1187.
     PubMed     Abstract available
     
     
     
575. MARIN-MARIN L, Renau-Lagranja J, Avila C, Costumero V, et al
     Depression and Agitation Factors Are Related to Regional Brain Atrophy and Faster Longitudinal Cognitive Decline in Mild Cognitive Impairment.
     J Alzheimers Dis. 2024;97:1341-1351.
     PubMed     Abstract available
     
     
     
576. TSENG YT, Chang YL, Chiu YS
     Assessment of Language Function in Older Mandarin-Speaking Adults with Mild Cognitive Impairment using Multifaceted Language Tests.
     J Alzheimers Dis. 2024;97:1189-1209.
     PubMed     Abstract available
     
     
     
577. KARAYIANNIS CC, Srikanth V, Beare R, Mehta H, et al
     Type 2 Diabetes and Biomarkers of Brain Structure, Perfusion, Metabolism, and Function in Late Mid-Life: A Multimodal Discordant Twin Study.
     J Alzheimers Dis. 2024;97:1223-1233.
     PubMed     Abstract available
     
     
     
578. ZAWISLAK-FORNAGIEL K, Ledwon D, Bugdol M, Grazynska A, et al
     Quantitative EEG Spectral and Connectivity Analysis for Cognitive Decline in Amnestic Mild Cognitive Impairment.
     J Alzheimers Dis. 2024;97:1235-1247.
     PubMed     Abstract available
     
     
     
579. FERINI-STRAMBI L
     Which Are the Most Reliable Sleep Parameters that Predict Cognitive Decline and Alzheimer's Disease?
     J Alzheimers Dis. 2024;97:1641-1643.
     PubMed     Abstract available
     
     
     
580. KANG J, Park M, Kim T
     Vitamin D Reduces GABA-Positive Astrocytes in the 5xFAD Mouse Model of Alzheimer's Disease.
     J Alzheimers Dis. 2024;97:1939-1950.
     PubMed     Abstract available
     
     
     
581. GROECHEL RC, Liu AC, Koton S, Kucharska-Newton AM, et al
     Associations Between Mid-Life Psychosocial Measures and Estimated Late Life Amyloid Burden: The Atherosclerosis Risk in Communities (ARIC)-PET Study.
     J Alzheimers Dis. 2024;97:1901-1911.
     PubMed     Abstract available
     
     
     
582. BACHAND AM, Dell LD
     Can Incorrect Analysis of Time-Dependent Exposure Explain Associations between PM2.5 Exposure and Risk of Dementia?
     J Alzheimers Dis. 2024;97:1931-1937.
     PubMed     Abstract available
     
     
     
583. VERMEULEN RJ, Roudijk B, Govers TM, Rovers MM, et al
     Prognostic Information on Progression to Dementia: Quantification of the Impact on Quality of Life.
     J Alzheimers Dis. 2024;97:1829-1840.
     PubMed     Abstract available
     
     
     
584. HARRIS JL, Wang X, Christian SK, Novikova L, et al
     Traumatic Brain Injury Alters the Trajectory of Age-Related Mitochondrial Change.
     J Alzheimers Dis. 2024;97:1793-1806.
     PubMed     Abstract available
     
     
     
585. VALENCIA-OLVERA AC, Balu D, Moore A, Shah M, et al
     APOE2 Heterozygosity Reduces Hippocampal Soluble Amyloid-beta42 Levels in Non-Hyperlipidemic Mice.
     J Alzheimers Dis. 2024;97:1629-1639.
     PubMed     Abstract available
     
     
     
586. ZHANG S, Ai H, Wang J, Liu T, et al
     Reduced Prefrontal-Thalamic Theta Flow During Working Memory Retrieval in APP/PS1 Mice.
     J Alzheimers Dis. 2024;97:1737-1749.
     PubMed     Abstract available
     
     
     
587. DAI Y, Hsu YC, Fernandes BS, Zhang K, et al
     Disentangling Accelerated Cognitive Decline from the Normal Aging Process and Unraveling Its Genetic Components: A Neuroimaging-Based Deep Learning Approach.
     J Alzheimers Dis. 2024;97:1807-1827.
     PubMed     Abstract available
     
     
     
588. HEIKKINEN AL, Paajanen TI, Hanninen T, Tikkanen V, et al
     Neuropsychological Profiles, Etiologies, and Medical Comorbidities in Early-Onset Dementia and Cognitive Impairment: A Memory Outpatient Clinic Cohort Study.
     J Alzheimers Dis. 2024;97:1765-1776.
     PubMed     Abstract available
     
     
     
589. VESTIN E, Bostrom G, Olsson J, Elgh F, et al
     Herpes Simplex Viral Infection Doubles the Risk of Dementia in a Contemporary Cohort of Older Adults: A Prospective Study.
     J Alzheimers Dis. 2024;97:1841-1850.
     PubMed     Abstract available
     
     
     
590. ARMSTRONG MJ, Barnes LL
     Under-Diagnosis of Dementia with Lewy Bodies in Individuals Racialized as Black: Hypotheses Regarding Potential Contributors.
     J Alzheimers Dis. 2024;97:1571-1580.
     PubMed     Abstract available
     
     
     
591. CUI X, Wang J, Wu B, Zhao Q, et al
     Interventions for Persons with Young-Onset Dementia and Their Families: A Scoping Review.
     J Alzheimers Dis. 2024;97:1519-1531.
     PubMed     Abstract available
     
     
     
592. FINCH CE, Burstein SM
     Dementia in the Ancient Greco-Roman World Was Minimally Mentioned.
     J Alzheimers Dis. 2024;97:1581-1588.
     PubMed     Abstract available
     
     
     
593. SIAFARIKAS N
     Neuropsychiatric and Cognitive Symptoms: Two Sides of the Same Coin?
     J Alzheimers Dis. 2024;98:75-78.
     PubMed     Abstract available
     
     
     
594. MATSUZONO K, Mashiko T, Koide R, Yoshizumi H, et al
     Comparison of Prognosis and Cognitive Function of Holistic Neurological Disease: Tochigi Neurological Disease Cohort Study.
     J Alzheimers Dis. 2024;98:275-285.
     PubMed     Abstract available
     
     
     
595. NALLAPU BT, Petersen KK, Lipton RB, Davatzikos C, et al
     Plasma Biomarkers as Predictors of Progression to Dementia in Individuals with Mild Cognitive Impairment.
     J Alzheimers Dis. 2024;98:231-246.
     PubMed     Abstract available
     
     
     
596. PRABHAKARAN D, Grant C, Pedraza O, Caselli R, et al
     Machine Learning Predicts Conversion from Normal Aging to Mild Cognitive Impairment Using Medical History, APOE Genotype, and Neuropsychological Assessment.
     J Alzheimers Dis. 2024;98:83-94.
     PubMed     Abstract available
     
     
     
597. ROSS JP, Post SG, Scheinfeld L
     Lucidity in the Deeply Forgetful: A Scoping Review.
     J Alzheimers Dis. 2024;98:3-11.
     PubMed     Abstract available
     
     
     
598. PUTIGNANO S, Forgione L, Fusco M, Giacummo A, et al
     Early Detection Screening of Cognitive Decline in Patients Over 60 Years: ELDERCARE Study.
     J Alzheimers Dis. 2024;98:145-150.
     PubMed     Abstract available
     
     
     
599. BALLENGER J, George DR, Whitehouse PJ
     Digging Deeper: What Can We Really Learn about Dementia from History?
     J Alzheimers Dis. 2024;98:417-419.
     PubMed     Abstract available
     
     
     
600. ORR ME
     A Need for Refined Senescence Biomarkers and Measures of Senolytics in the Brain.
     J Alzheimers Dis. 2024;98:411-415.
     PubMed     Abstract available
     
     
     
601. SHIMADA H, Doi T, Tsutsumimoto K, Makino K, et al
     Elevated Risk of Dementia Diagnosis in Older Adults with Low Frequencies and Durations of Social Conversation.
     J Alzheimers Dis. 2024;98:659-669.
     PubMed     Abstract available
     
     
     
602. ZHANG XX, Wang HR, Meng-Wei, Hu YZ, et al
     Association of Vitamin D Levels with Risk of Cognitive Impairment and Dementia: A Systematic Review and Meta-Analysis of Prospective Studies.
     J Alzheimers Dis. 2024;98:373-385.
     PubMed     Abstract available
     
     
     
603. WANG J, Leong IT, Johnson MK, Pei Y, et al
     What Matters to Chinese and Korean American Dementia Caregivers: Navigating Cultural Influences in Dementia Care from Caregivers' Perspectives.
     J Alzheimers Dis. 2024;98:519-538.
     PubMed     Abstract available
     
     
     
604. VERA R, Hong N, Jiang B, Liang G, et al
     Effects of Intranasal Dantrolene Nanoparticles on Brain Concentration and Behavior in PS19 Tau Transgenic Mice.
     J Alzheimers Dis. 2024;98:549-562.
     PubMed     Abstract available
     
     
     
605. GREENBLATT CL, Lathe R
     Vaccines and Dementia: Part II. Efficacy of BCG and Other Vaccines Against Dementia.
     J Alzheimers Dis. 2024;98:361-372.
     PubMed     Abstract available
     
     
     
606. WANG Y, Wang S, Wu J, Liu X, et al
     Causal Association Between Allergic Diseases and Dementia: Evidence from Multivariate Mendelian Randomization Study.
     J Alzheimers Dis. 2024;98:505-517.
     PubMed     Abstract available
     
     
     
607. PARKER DC, Whitson HE, Smith PJ, Kraus VB, et al
     Anti-CMV IgG Seropositivity is Associated with Plasma Biomarker Evidence of Amyloid-beta Accumulation.
     J Alzheimers Dis. 2024;98:593-600.
     PubMed     Abstract available
     
     
     
608. HAN SL, Ou YN, Han BL, Guo HH, et al
     Total Tau Protein Mediates the Association of Ischemic Cerebrovascular Disease with Cognitive Decline.
     J Alzheimers Dis. 2024;98:1133-1143.
     PubMed     Abstract available
     
     
     
609. COGUT V, McNeely TL, Bussian TJ, Graves SI, et al
     Caloric Restriction Improves Spatial Learning Deficits in Tau Mice.
     J Alzheimers Dis. 2024;98:925-940.
     PubMed     Abstract available
     
     
     
610. TSENG WI, Hsu YC, Huang LK, Hong CT, et al
     Brain Age Is Associated with Cognitive Outcomes of Cholinesterase Inhibitor Treatment in Patients with Mild Cognitive Impairment.
     J Alzheimers Dis. 2024;98:1095-1106.
     PubMed     Abstract available
     
     
     
611. MARTINEZ-DUBARBIE F, Lopez-Garcia S, Lage C, Di Molfetta G, et al
     Plasma Phosphorylated Tau 231 Increases at One-Year Intervals in Cognitively Unimpaired Subjects.
     J Alzheimers Dis. 2024;98:1029-1042.
     PubMed     Abstract available
     
     
     
612. O'SHEA DM, Camacho S, Ezzeddine R, Besser L, et al
     The Mediating Role of Cortical Atrophy on the Relationship between the Resilience Index and Cognitive Function: Findings from the Healthy Brain Initiative.
     J Alzheimers Dis. 2024;98:1017-1027.
     PubMed     Abstract available
     
     
     
613. PODGER L, Stewart WF, Serrano D, Lipton RB, et al
     Application of a Novel Endpoint Staging Framework: Proof of Concept in the AMBAR Study.
     J Alzheimers Dis. 2024;98:1079-1094.
     PubMed     Abstract available
     
     
     
614. CEYZERIAT K, Jaques E, Gloria Y, Badina A, et al
     Low-Dose Radiation Therapy Impacts Microglial Inflammatory Response without Modulating Amyloid Load in Female TgF344-AD Rats.
     J Alzheimers Dis. 2024;98:1001-1016.
     PubMed     Abstract available
     
     
     
615. PAPADIMITRIOU A, Dawson AZ, Thorgerson A, Bhandari S, et al
     Understanding the Relationship Between Wealth and Cognitive Function by Race/Ethnicity Among Older United States Adults with Diabetes.
     J Alzheimers Dis. 2024;98:1145-1155.
     PubMed     Abstract available
     
     
     
616. SANCHEZ-SOBLECHERO A, Lopez-Garcia S, Lage C, Fernandez-Matarrubia M, et al
     Where Should I Draw the Line: PET-Driven, Data-Driven, or Manufacturer Cut-Off?
     J Alzheimers Dis. 2024;98:957-967.
     PubMed     Abstract available
     
     
     
617. BERGAMINO M, Keeling E, McElvogue M, Schaefer SY, et al
     White Matter Microstructure Analysis in Subjective Memory Complaints and Cognitive Impairment: Insights from Diffusion Kurtosis Imaging and Free-Water DTI.
     J Alzheimers Dis. 2024;98:863-884.
     PubMed     Abstract available
     
     
     
618. 
     Erratum to: Ubiquitin Specific Protease 13 Regulates Tau Accumulation and Clearance in Models of Alzheimer's Disease.
     J Alzheimers Dis. 2024;98:1543-1546.
     PubMed    
     
     
     
619. JANBEK J, Laursen TM, Frimodt-Moller N, Magyari M, et al
     Risk of Major Types of Dementias Following Hospital-Diagnosed Infections and Autoimmune Diseases.
     J Alzheimers Dis. 2024;98:1503-1514.
     PubMed     Abstract available
     
     
     
620. CHEN Y, Su Y, Wu J, Chen K, et al
     Combining Blood-Based Biomarkers and Structural MRI Measurements to Distinguish Persons with and without Significant Amyloid Plaques.
     J Alzheimers Dis. 2024;98:1415-1426.
     PubMed     Abstract available
     
     
     
621. GALANKIN TL, Bespalov AY, Moebius HY
     Clusterization of Behavioral and Psychological Symptoms of Dementia as Assessed by Neuropsychiatric Inventory: A Case Against the Use of Principal Component Analysis.
     J Alzheimers Dis. 2024;98:1483-1491.
     PubMed     Abstract available
     
     
     
622. HOJJATI SH, Chiang GC, Butler TA, de Leon M, et al
     Remote Associations Between Tau and Cortical Amyloid-beta Are Stage-Dependent.
     J Alzheimers Dis. 2024;98:1467-1482.
     PubMed     Abstract available
     
     
     
623. CALDERON-GARCIDUENAS L, Ayala A, Mukherjee PS
     2024 United States Elections: Air Pollution, Neurodegeneration, Neuropsychiatric, and Neurodevelopmental Disorders. Who Cares?
     J Alzheimers Dis. 2024;98:1277-1282.
     PubMed     Abstract available
     
     
     
624. SYED RA, Hayat M, Qaiser H, Uzair M, et al
     Aging-Related Protein Alterations in the Brain.
     J Alzheimers Dis. 2024;99.
     PubMed     Abstract available
     
     
     
625. ALROUJI M, Yasmin S, Furkan M, Alhumaydhi FA, et al
     Unveiling the Molecular Interactions Between Human Transferrin and Limonene: Natural Compounds in Alzheimer's Disease Therapeutics.
     J Alzheimers Dis. 2024;99:333-343.
     PubMed     Abstract available
     
     
     
626. MORROW CB, Pontone GM
     Exploring Psychosis in Neurodegenerative Dementia: Connecting Symptoms to Neurobiology.
     J Alzheimers Dis. 2024;99:101-103.
     PubMed     Abstract available
     
     
     
627. CRESSOT C, Vrillon A, Lilamand M, Francisque H, et al
     Psychosis in Neurodegenerative Dementias: A Systematic Comparative Review.
     J Alzheimers Dis. 2024;99:85-99.
     PubMed     Abstract available
     
     
     
628. ESPAY AJ, Herrup K, Imbimbo BP, Kepp KP, et al
     Recalibrating the Risk-Benefit Profiles of Lecanemab and Donanemab: Scales, Immunoreactivity, and Changes in Amyloid-beta42.
     J Alzheimers Dis. 2024;99:877-881.
     PubMed     Abstract available
     
     
     
629. TAVARES-JUNIOR JWL, Ciurleo GCV, Feitosa EAAF, Oria RB, et al
     The Clinical Aspects of COVID and Alzheimer's Disease: A Round-Up of Where Things Stand and Are Headed.
     J Alzheimers Dis. 2024;99:1159-1171.
     PubMed     Abstract available
     
     
     
630. SUGANUMA T, Hatori S, Chen CK, Hori S, et al
     Caffeoylquinic Acid Mitigates Neuronal Loss and Cognitive Decline in 5XFAD Mice Without Reducing the Amyloid-beta Plaque Burden.
     J Alzheimers Dis. 2024;99:1285-1301.
     PubMed     Abstract available
     
     
     
631. WANG T, Zhang W, Maclin JMA, Xu H, et al
     Novel Panel of Long Noncoding RNAs as Diagnostic Biomarkers for Amnestic Mild Cognitive Impairment in Peripheral Blood.
     J Alzheimers Dis. 2024;99:1385-1396.
     PubMed     Abstract available
     
     
     
632. XIONG R, Li B, Yu H, Fan T, et al
     Urolithin A Inhibits Anterior Basolateral Amygdala to Ventral Hippocampal CA1 Circuit to Ameliorate Amyloid-beta-Impaired Social Ability.
     J Alzheimers Dis. 2024;99:1303-1316.
     PubMed     Abstract available
     
     
     
633. LEE CS, Ferguson AN, Gibbons LE, Walker R, et al
     Eye Adult Changes in Thought (Eye ACT) Study: Design and Report on the Inaugural Cohort.
     J Alzheimers Dis. 2024;100:309-320.
     PubMed     Abstract available
     
     
     
634. MENG H, Lv X, Zhang R, Feng Y, et al
     Occurrence and Risk Factors for Cognitive Decline Shared by Couples: A Systematic Review and Meta-Analysis.
     J Alzheimers Dis. 2024;100:29-40.
     PubMed     Abstract available
     
     
     
635. GIBBONS LE, Mobley T, Mayeda ER, Lee CS, et al
     How Generalizable Are Findings from a Community-Based Prospective Cohort Study? Extending Estimates from the Adult Changes in Thought Study to Its Source Population.
     J Alzheimers Dis. 2024;100:163-174.
     PubMed     Abstract available
     
     
     
636. SHI Q, Liu WS, Liu F, Zeng YX, et al
     The Etiology of Rapidly Progressive Dementia: A 3-Year Retrospective Study in a Tertiary Hospital in China.
     J Alzheimers Dis. 2024;100:77-85.
     PubMed     Abstract available
     
     
     
637. SANNEMANN L, Bartels C, Brosseron F, Buerger K, et al
     Symptomatic Clusters Related to Amyloid Positivity in Cognitively Unimpaired Individuals.
     J Alzheimers Dis. 2024;100:193-205.
     PubMed     Abstract available
     
     
     
638. ZUKOWSKI LA, Brinkerhoff SA, Levin I, Herter TM, et al
     Amyloid-beta Deposition Predicts Grocery Shopping Performance in Older Adults Without Cognitive Impairment.
     J Alzheimers Dis. 2024;100:53-75.
     PubMed     Abstract available
     
     
     
639. 
     Robert Rissman, PhD, is the recipient of the 2024 Alzheimer Award.
     J Alzheimers Dis. 2024;100:377-378.
     PubMed    
     
     
     
640. KRIZANOVIC N, Jokisch M, Jockel KH, Schmidt B, et al
     Sex-Specific Differences in Serum Kallikrein-8 (KLK8): An Exploratory Study.
     J Alzheimers Dis. 2024;100:495-507.
     PubMed     Abstract available
     
     
     
641. HOWARD E, Moody JN, Prieto S, Hayes JP, et al
     Higher Cerebrospinal Fluid Levels of Amyloid-beta40 Following Traumatic Brain Injury Relate to Confrontation Naming Performance.
     J Alzheimers Dis. 2024;100:539-550.
     PubMed     Abstract available
     
     
     
642. HE Q, Wang W, Xiong Y, Tao C, et al
     Potential Biomarkers in Cerebrospinal Fluid and Plasma for Dementia.
     J Alzheimers Dis. 2024;100:603-611.
     PubMed     Abstract available
     
     
     
643. LOEFFLER DA
     Approaches for Increasing Cerebral Efflux of Amyloid-beta in Experimental Systems.
     J Alzheimers Dis. 2024;100:379-411.
     PubMed     Abstract available
     
     
     
644. LENG F, Hinz R, Gentleman S, Dani M, et al
     Combined Neuroinflammation and Amyloid PET Markers in Predicting Disease Progression in Cognitively Impaired Subjects.
     J Alzheimers Dis. 2024;100:973-986.
     PubMed     Abstract available
     
     
     
645. FRANK B, Walsh M, Hurley L, Groh J, et al
     Cognition Mediates the Association Between Cerebrospinal Fluid Biomarkers of Amyloid and P-Tau and Neuropsychiatric Symptoms.
     J Alzheimers Dis. 2024;100:1055-1073.
     PubMed     Abstract available
     
     
     
646. FU J, Wei Q, Chen X, Lai X, et al
     Analysis of the Association Between Pathogen Exposure and the Risk of Dementia.
     J Alzheimers Dis. 2024;100:961-972.
     PubMed     Abstract available
     
     
     
647. SCHWERTHOFFER D, Haselwarter T, Grimmer T
     Obstructive Sleep Apnea Among Patients with Mild Cognitive Impairment.
     J Alzheimers Dis. 2024;100:809-823.
     PubMed     Abstract available
     
     
     
648. YU W, Zhuang S, Zhan M, Chen Y, et al
     Deubiquitinating Enzyme USP19 Regulates Ferroptosis and Mitochondrial Damage in SH-SY5Y Cells by Targeting the NOX4 Protein.
     J Alzheimers Dis. 2024;100:799-808.
     PubMed     Abstract available
     
     
     
649. DENG C, Cai Q, Zhang J, Chang K, et al
     Generation and Characterization of a Novel Knockin Mouse Model Expressing PSEN1 D385A: Implications for Investigating Herbal Drug Effects in gamma-Secretase Activity.
     J Alzheimers Dis. 2024;100:825-841.
     PubMed     Abstract available
     
     
     
650. MACE RA, Lyons C, Cohen JE, Ritchie C, et al
     Optimizing the Implementation of a Lifestyle Dementia Prevention Intervention for Older Patients in an Academic Healthcare System.
     J Alzheimers Dis. 2024;100:1237-1259.
     PubMed     Abstract available
     
     
     
651. LEPPING RJ, Hess BJ, Taylor JM, Hanson-Abromeit D, et al
     Inconsistent Music-Based Intervention Reporting in Dementia Studies: A Systematic Mapping Review.
     J Alzheimers Dis. 2024;100:1145-1159.
     PubMed     Abstract available
     
     
     
652. MARIN A, Turk KW, Schiloski K, Vives-Rodriguez A, et al
     The Use of Event Related Potentials to Predict Amyloid PET Status Among Patients from a Memory Disorders Clinic.
     J Alzheimers Dis. 2024;100:1195-1208.
     PubMed     Abstract available
     
     
     
653. FROMM D, Dalton SG, Brick A, Olaiya G, et al
     The Case of the Cookie Jar: Differences in Typical Language Use in Dementia.
     J Alzheimers Dis. 2024;100:1417-1434.
     PubMed     Abstract available
     
     
     
654. CORREIA SC, Perry G, Moreira PI
     Fueling Alzheimer's Disease: Where Does Immunometabolism Stand?
     J Alzheimers Dis. 2024;100.
     PubMed     Abstract available
     
     
     
655. PETERSEN ME, Zhang F, Hall JR, Julovich D, et al
     Characterization of Ptau181 Among a Diverse Community-Based Cohort: A HABS-HD Study.
     J Alzheimers Dis. 2024;100.
     PubMed     Abstract available
     
     
     
656. ARENDASH GW, Lin X, Cao C
     Enhanced Brain Clearance of Tau and Amyloid-beta in Alzheimer's Disease Patients by Transcranial Radiofrequency Wave Treatment: A Central Role of Vascular Endothelial Growth Factor (VEGF).
     J Alzheimers Dis. 2024;100.
     PubMed     Abstract available
     
     
     
657. POUDEL P, Frost SM, Eslick S, Sohrabi HR, et al
     Hyperspectral Retinal Imaging as a Non-Invasive Marker to Determine Brain Amyloid Status.
     J Alzheimers Dis. 2024;100.
     PubMed     Abstract available
     
     
     
658. GOGOLA A, Cohen AD, Snitz B, Minhas D, et al
     Implementation and Assessment of Tau Thresholds in Non-Demented Individuals as Predictors of Cognitive Decline in Tau Imaging Studies.
     J Alzheimers Dis. 2024;100.
     PubMed     Abstract available
     
     
     
659. LEINENGA G, Padmanabhan P, Gotz J
     Improving Cognition Without Clearing Amyloid: Effects of Tau and Ultrasound Neuromodulation.
     J Alzheimers Dis. 2024;100.
     PubMed     Abstract available
     
     
     
660. PERRY G
     JAD's Glorious 100 Volumes.
     J Alzheimers Dis. 2024;100.
     PubMed    
     
     
     
661. ALLDRED MJ, Pidikiti H, Ibrahim KW, Lee SH, et al
     Hippocampal CA1 Pyramidal Neurons Display Sublayer and Circuitry Dependent Degenerative Expression Profiles in Aged Female Down Syndrome Mice.
     J Alzheimers Dis. 2024;100.
     PubMed     Abstract available
     
     
     
662. ZHANG J, Zhang Y, Zhang Y, Yao J, et al
     The Association of Brain Insulin Resistance with Anesthesia/Surgery-Induced Cognitive Deterioration Is Female-Specific in 5XFAD Transgenic Mice.
     J Alzheimers Dis. 2024;101:183-195.
     PubMed     Abstract available
     
     
     
663. LASTUKA A, Bliss E, Breshock MR, Iannucci VC, et al
     Societal Costs of Dementia: 204 Countries, 2000-2019.
     J Alzheimers Dis. 2024;101:277-292.
     PubMed     Abstract available
     
     
     
664. ZHANG Y, Li Y, Song S, Li Z, et al
     Predicting Conversion Time from Mild Cognitive Impairment to Dementia with Interval-Censored Models.
     J Alzheimers Dis. 2024;101:147-157.
     PubMed     Abstract available
     
     
     
665. SATERNOS H, Hamlett ED, Guzman S, Head E, et al
     Unique Pathology in the Locus Coeruleus of Individuals with Down Syndrome.
     J Alzheimers Dis. 2024;101:541-561.
     PubMed     Abstract available
     
     
     
666. ALLE MC, Joseph C, Antoine P
     Involuntary Autobiographical Memory in Alzheimer's Disease: A Double-Edged Way of Remembering the Past?
     J Alzheimers Dis. 2024;101:961-969.
     PubMed     Abstract available
     
     
     
667. SAIDO TC
     Obituary for the late Yasuo Ihara.
     J Alzheimers Dis. 2024;101:1027-1028.
     PubMed    
     
     
     
668. PEREIRA HR, Diogo VS, Prata D, Ferreira HA, et al
     Detecting Amyloid Positivity Using Morphometric Magnetic Resonance Imaging.
     J Alzheimers Dis. 2024;101:1293-1305.
     PubMed     Abstract available
     
     
     
669. LINGENBERG A, Herrmann FR, Armand S, Peron J, et al
     Forget About Memory: Disentangling the Amnestic Syndrome in Idiopathic Normal Pressure Hydrocephalus.
     J Alzheimers Dis. 2024;101:1205-1216.
     PubMed     Abstract available
     
     
     
670. BECKMANN MN
     Did Reagan Decline?
     J Alzheimers Dis. 2024;101:1261-1266.
     PubMed     Abstract available
     
     
     
671. WANG J, Xu L, Chen X, Wu J, et al
     Correlation Analysis of ApoB, ApoA1, and ApoB/ApoA1 with Cortical Morphology in Patients with Memory Complaints.
     J Alzheimers Dis. 2024;101:1137-1150.
     PubMed     Abstract available
     
     
     
672. SATO K, Niimi Y, Ihara R, Iwata A, et al
     Adverse Events as a Cause of Unblinding of Allocated Arms in Anti-Amyloid Therapy Trials: A Meta-Analysis of the Predictive Value.
     J Alzheimers Dis. 2024;101:1127-1132.
     PubMed     Abstract available
     
     
     
673. HAMEDANI M, Caneva S, Mancardi GL, Ali PA, et al
     Toward Quantitative Neurology: Sensors to Assess Motor Deficits in Dementia.
     J Alzheimers Dis. 2024;101:1083-1106.
     PubMed     Abstract available
     
     
     
674. MOREIRA PI, Avila J, Galimberti D, Pappolla MA, et al
     Therapeutic Trials in Alzheimer's Disease: Where Are We Now?
     J Alzheimers Dis. 2024;101.
     PubMed    
     
     
     
675. SAYFULLAEVA J, McLoughlin J, Kwakowsky A
     Hormone Replacement Therapy and Alzheimer's Disease: Current State of Knowledge and Implications for Clinical Use.
     J Alzheimers Dis. 2024;101.
     PubMed     Abstract available
     
     
     
676. CROOK H, Edison P
     Incretin Mimetics as Potential Disease Modifying Treatment for Alzheimer's Disease.
     J Alzheimers Dis. 2024;101.
     PubMed     Abstract available
     
     
     
677. BROWN A, Bayley PJ
     The Therapeutic Potential of Yoga for Alzheimer's Disease: A Critical Review.
     J Alzheimers Dis. 2024;101.
     PubMed     Abstract available
     
     
     
678. ROBERTS JA, Varma VR, Jones A, Thambisetty M, et al
     Drug Repurposing for Effective Alzheimer's Disease Medicines: Existing Methods and Novel Pharmacoepidemiological Approaches.
     J Alzheimers Dis. 2024;101.
     PubMed     Abstract available
     
     
     
679. PAPPOLLA MA, Martins RN, Poeggeler B, Omar RA, et al
     Oxidative Stress in Alzheimer's Disease: The Shortcomings of Antioxidant Therapies.
     J Alzheimers Dis. 2024;101.
     PubMed     Abstract available
     
     
     
680. TUSZYNSKI MH
     Growth Factor Gene Therapy for Alzheimer's Disease.
     J Alzheimers Dis. 2024;101.
     PubMed     Abstract available
     
     
     
681. TAHMI M, Benitez R, Luchsinger JA
     Metformin as a Potential Prevention Strategy for Alzheimer's Disease and Alzheimer's Disease Related Dementias.
     J Alzheimers Dis. 2024;101.
     PubMed     Abstract available
     
     
     
682. SUN MK, Alkon DL
     Treating Alzheimer's Disease: Focusing on Neurodegenerative Consequences.
     J Alzheimers Dis. 2024;101.
     PubMed     Abstract available
     
     
     
683. PAPPOLLA MA, Refolo L, Sambamurti K, Zambon D, et al
     Hypercholesterolemia and Alzheimer's Disease: Unraveling the Connection and Assessing the Efficacy of Lipid-Lowering Therapies.
     J Alzheimers Dis. 2024;101.
     PubMed     Abstract available
     
     
     
684. TRIUMBARI EKA, Chiaravalloti A, Schillaci O, Mercuri NB, et al
     Positron Emission Tomography/Computed Tomography Imaging in Therapeutic Clinical Trials in Alzheimer's Disease: An Overview of the Current State of the Art of Research.
     J Alzheimers Dis. 2024;101.
     PubMed     Abstract available
     
     
     
685. VINA J, Borras C, Mas-Bargues C
     Genistein, A Phytoestrogen, Delays the Transition to Dementia in Prodromal Alzheimer's Disease Patients.
     J Alzheimers Dis. 2024;101.
     PubMed     Abstract available
     
     
     
686. HOILUND-CARLSEN PF, Alavi A, Barrio JR
     PET/CT/MRI in Clinical Trials of Alzheimer's Disease.
     J Alzheimers Dis. 2024;101.
     PubMed     Abstract available
     
     
     
687. NOORDA K, Noorda K, Sabbagh MN, Bertelson J, et al
     Amyloid-Directed Antibodies: Past, Present, and Future.
     J Alzheimers Dis. 2024;101.
     PubMed     Abstract available
     
     
     
688. GABUZYAN R, Lee C, Nygaard HB
     Ketogenic Approaches for the Treatment of Alzheimer's Disease.
     J Alzheimers Dis. 2024;101.
     PubMed     Abstract available
     
     
     
689. DU B, Chen K, Wang W, Lei P, et al
     Targeting Metals in Alzheimer's Disease: An Update.
     J Alzheimers Dis. 2024;101.
     PubMed     Abstract available
     
     
     
690. MEIJER L, Chretien E, Ravel D
     Leucettinib-21, a DYRK1A Kinase Inhibitor as Clinical Drug Candidate for Alzheimer's Disease and Down Syndrome.
     J Alzheimers Dis. 2024;101.
     PubMed     Abstract available
     
     
     
691. DE LA MONTE SM
     Conquering Insulin Network Dysfunctions in Alzheimer's Disease: Where Are We Today?
     J Alzheimers Dis. 2024;101.
     PubMed     Abstract available
     
     
     
692. YASSINE HN, Carrasco AS, Badie DS
     Designing Newer Omega-3 Supplementation Trials for Cognitive Outcomes: A Systematic Review Guided Analysis.
     J Alzheimers Dis. 2024;101.
     PubMed     Abstract available
     
     
     
693. KUCK MJ, Begde A, Hawkins K, Hogervorst E, et al
     Alzheimer's Disease and (Phyto) Estrogen Treatment: Modification of Effects by Age, Type of Treatment, and Duration of Use.
     J Alzheimers Dis. 2024;101.
     PubMed     Abstract available
     
     
     
694. MORATO X, Tartari JP, Pytel V, Boada M, et al
     Pharmacodynamic and Clinical Effects of Ginkgo Biloba Extract EGb 761 and Its Phytochemical Components in Alzheimer's Disease.
     J Alzheimers Dis. 2024;101.
     PubMed     Abstract available
     
     
     
695. ALGHAMDI M, Braidy N
     Supplementation with NAD+ Precursors for Treating Alzheimer's Disease: A Metabolic Approach.
     J Alzheimers Dis. 2024;101.
     PubMed     Abstract available
     
     
     
696. ALGHAMDI M, Braidy N
     Functional Magnetic Resonance Imaging in Alzheimer's Disease Drug Trials: A Mini-Review.
     J Alzheimers Dis. 2024;101.
     PubMed     Abstract available
     
     
     
697. WATKINS EA, Vassar R
     BACE Inhibitor Clinical Trials for Alzheimer's Disease.
     J Alzheimers Dis. 2024;101.
     PubMed     Abstract available
     
     
     
698. LI H, Xiang Q, Ren R, Wang G, et al
     Acupuncture as a Complementary Therapy for Alzheimer's Disease.
     J Alzheimers Dis. 2024;101.
     PubMed     Abstract available
     
     
     
699. FELDMAN HH, Messer K, Qiu Y, Sabbagh M, et al
     Varoglutamstat: Inhibiting Glutaminyl Cyclase as a Novel Target of Therapy in Early Alzheimer's Disease.
     J Alzheimers Dis. 2024;101.
     PubMed     Abstract available
     
     
     
700. CURRAIS A, Raschke W, Maher P
     CMS121, a Novel Drug Candidate for the Treatment of Alzheimer's Disease and Age-Related Dementia.
     J Alzheimers Dis. 2024;101.
     PubMed     Abstract available
     
     
     
701. THITILERTDECHA P, Brimson JM
     CT1812, a Small Molecule Sigma-2 Receptor Antagonist for Alzheimer's Disease Treatment: A Systematic Review of Available Clinical Data.
     J Alzheimers Dis. 2024;101.
     PubMed     Abstract available
     
     
     
702. MORRONI F, Caccamo A
     Advances and Challenges in Gene Therapy for Alzheimer's Disease.
     J Alzheimers Dis. 2024;101.
     PubMed     Abstract available
     
     
     
703. STEINBACH MJ, Denburg NL
     Melatonin in Alzheimer's Disease: Literature Review and Therapeutic Trials.
     J Alzheimers Dis. 2024;101.
     PubMed     Abstract available
     
     
     
704. EYOB E, Shaw JS, Bakker A, Munro C, et al
     A Randomized-Controlled Trial Targeting Cognition in Early Alzheimer's Disease by Improving Sleep with Trazodone (REST).
     J Alzheimers Dis. 2024;101.
     PubMed     Abstract available
     
     
     
705. VASHISTH K, Sharma S, Ghosh S, Babu MA, et al
     Immunotherapy in Alzheimer's Disease: Current Status and Future Directions.
     J Alzheimers Dis. 2024;101.
     PubMed     Abstract available
     
     
     
706. BENUSSI A, Borroni B
     Brain Stimulation in Alzheimer's Disease Trials.
     J Alzheimers Dis. 2024;101.
     PubMed     Abstract available
     
     
     December 2023
707. AHMED T, Zhang P, Kumar K
     Equilibrium of Dietary Patterns Between Alzheimer's Disease Patients and Healthy People: A Comprehensive Analysis Using Multiple Factor Analysis and Classification Modeling.
     J Alzheimers Dis. 2023 Dec 30. doi: 10.3233/JAD-230634.
     PubMed     Abstract available
     
     
     
708. RICCI F, Martorana A, Bonomi CG, Serafini C, et al
     Effect of Vascular Risk Factors on Blood-Brain Barrier and Cerebrospinal Fluid Biomarkers Along the Alzheimer's Disease Continuum: A Retrospective Observational Study.
     J Alzheimers Dis. 2023 Dec 29. doi: 10.3233/JAD-230792.
     PubMed     Abstract available
     
     
     
709. ALMKVIST O, Larsson M, Graff C
     Odor Identification Across Time in Mutation Carriers and Non-Carriers in Autosomal-Dominant Alzheimer's Disease.
     J Alzheimers Dis. 2023 Dec 29. doi: 10.3233/JAD-230618.
     PubMed     Abstract available
     
     
     
710. ZHANG E, Dai F
     Diagnostic Model for Alzheimer's Disease Based on PANoptosis-Related Genes.
     J Alzheimers Dis. 2023 Dec 28. doi: 10.3233/JAD-231103.
     PubMed     Abstract available
     
     
     
711. WEINBERG MS, He Y, Kivisakk P, Arnold SE, et al
     Effect of Metformin on Plasma and Cerebrospinal Fluid Biomarkers in Non-Diabetic Older Adults with Mild Cognitive Impairment Related to Alzheimer's Disease.
     J Alzheimers Dis. 2023 Dec 27. doi: 10.3233/JAD-230899.
     PubMed     Abstract available
     
     
     
712. FAN X, Li H, Liu L, Zhang K, et al
     Early Diagnosing and Transformation Prediction of Alzheimer's Disease Using Multi-Scaled Self-Attention Network on Structural MRI Images with Occlusion Sensitivity Analysis.
     J Alzheimers Dis. 2023 Dec 27. doi: 10.3233/JAD-230705.
     PubMed     Abstract available
     
     
     
713. MIYANO T, Ayukawa Y, Anada T, Takahashi I, et al
     Association Between Reduced Posterior Occlusal Contact and Alzheimer's Disease Onset in Older Japanese Adults: Results from the LIFE Study.
     J Alzheimers Dis. 2023 Dec 27. doi: 10.3233/JAD-230449.
     PubMed     Abstract available
     
     
     
714. MORIN P, Aguilar BJ, Li X, Chen J, et al
     Alzheimer's Disease Stage Transitions Among United States Veterans.
     J Alzheimers Dis. 2023 Dec 23. doi: 10.3233/JAD-230850.
     PubMed     Abstract available
     
     
     
715. MAHZARNIA A, Lutz MW, Badea A
     A Continuous Extension of Gene Set Enrichment Analysis Using the Likelihood Ratio Test Statistics Identifies Vascular Endothelial Growth Factor as a Candidate Pathway for Alzheimer's Disease via ITGA5.
     J Alzheimers Dis. 2023 Dec 23. doi: 10.3233/JAD-230934.
     PubMed     Abstract available
     
     
     
716. GE Y, AlObaidi AS, Kuchel GA, Bartley JM, et al
     Dysfunctional Bladder Morphology and Functional Impairments Are Identified in the Alzheimer's Disease APPNL-G-F/NL-G-F Murine Model.
     J Alzheimers Dis. 2023 Dec 23. doi: 10.3233/JAD-230547.
     PubMed     Abstract available
     
     
     
717. ROBINSON CG, Coleman T, Buciuc M, Singh NA, et al
     Behavioral and Neuropsychiatric Differences Across Two Atypical Alzheimer's Disease Variants: Logopenic Progressive Aphasia and Posterior Cortical Atrophy.
     J Alzheimers Dis. 2023 Dec 22. doi: 10.3233/JAD-230652.
     PubMed     Abstract available
     
     
     
718. EL HAFFAF LM, Ronat L, Cannizzaro A, Hanganu A, et al
     Associations Between Hyperactive Neuropsychiatric Symptoms and Brain Morphology in Mild Cognitive Impairment and Alzheimer's Disease.
     J Alzheimers Dis. 2023 Dec 22. doi: 10.3233/JAD-220857.
     PubMed     Abstract available
     
     
     
719. LI KY, Lin BT, Hsu ST, Chien CF, et al
     Quetiapine Oral Solution in Alzheimer's Disease: Efficacy and Dosage Insights from a Real-World Retrospective Study.
     J Alzheimers Dis. 2023 Dec 20. doi: 10.3233/JAD-231007.
     PubMed     Abstract available
     
     
     
720. LOJO-RAMIREZ JA, Guerra-Gomez M, Marin-Cabanas AM, Fernandez-Rodriguez P, et al
     Correlation Between Amyloid PET Imaging and Discordant Cerebrospinal Fluid Biomarkers Results in Patients with Suspected Alzheimer's Disease.
     J Alzheimers Dis. 2023 Dec 19. doi: 10.3233/JAD-230744.
     PubMed     Abstract available
     
     
     
721. KEIZER HG, Brands R, Oosting RS, Seinen W, et al
     The Carnitine Palmitoyl-Transferase 2 Cascade Hypothesis for Alzheimer's Disease.
     J Alzheimers Dis. 2023 Dec 18. doi: 10.3233/JAD-230991.
     PubMed     Abstract available
     
     
     
722. PARK YS, Joo HJ, Jang YS, Jeon H, et al
     Socioeconomic Status and Dementia Risk Among Intensive Care Unit Survivors: Using National Health Insurance Cohort in Korea.
     J Alzheimers Dis. 2023 Dec 18. doi: 10.3233/JAD-230715.
     PubMed     Abstract available
     
     
     
723. BAPAT R, Ma D, Duong TQ
     Predicting Four-Year's Alzheimer's Disease Onset Using Longitudinal Neurocognitive Tests and MRI Data Using Explainable Deep Convolutional Neural Networks.
     J Alzheimers Dis. 2023 Dec 16. doi: 10.3233/JAD-230893.
     PubMed     Abstract available
     
     
     
724. JANG YJ, Choi MG, Yoo BJ, Lee KJ, et al
     Interaction Between a High-Fat Diet and Tau Pathology in Mice: Implications for Alzheimer's Disease.
     J Alzheimers Dis. 2023 Dec 11. doi: 10.3233/JAD-230927.
     PubMed     Abstract available
     
     
     
725. MALOTAUX V, Colmant L, Quenon L, Huyghe L, et al
     Suspecting Non-Alzheimer's Pathologies and Mixed Pathologies: A Comparative Study Between Brain Metabolism and Tau Images.
     J Alzheimers Dis. 2023 Dec 11. doi: 10.3233/JAD-230696.
     PubMed     Abstract available
     
     
     
726. UKRAINTSEVA S, Duan H, Holmes R, Bagley O, et al
     Patterns of Aging Changes in Bodyweight May Predict Alzheimer's Disease.
     J Alzheimers Dis. 2023 Dec 11. doi: 10.3233/JAD-220998.
     PubMed     Abstract available
     
     
     
727. ANSCHUETZ A, Schwab K, Harrington CR, Wischik CM, et al
     A Meta-Analysis on Presynaptic Changes in Alzheimer's Disease.
     J Alzheimers Dis. 2023 Dec 8. doi: 10.3233/JAD-231034.
     PubMed     Abstract available
     
     
     
728. DA X, Hempel E, Ou Y, Rowe OE, et al
     Noninvasive Gamma Sensory Stimulation May Reduce White Matter and Myelin Loss in Alzheimer's Disease.
     J Alzheimers Dis. 2023 Dec 8. doi: 10.3233/JAD-230506.
     PubMed     Abstract available
     
     
     
729. NGUYEN SA, Oughli HA, Lavretsky H
     Use of Complementary and Integrative Medicine for Alzheimer's Disease and Cognitive Decline.
     J Alzheimers Dis. 2023 Dec 7. doi: 10.3233/JAD-230710.
     PubMed     Abstract available
     
     
     
730. SCHMUED L, Maloney B, Schmued C, Lahiri DK, et al
     Treatment with 1, 10 Phenanthroline-5-Amine Reduced Amyloid Burden in a Mouse Model of Alzheimer's Disease.
     J Alzheimers Dis. 2023 Dec 7. doi: 10.3233/JAD-221285.
     PubMed     Abstract available
     
     
     November 2023
731. HAO N, Bai X, Hu A, Zhao G, et al
     Assessing the Global, Regional, and National Impact of High Body Mass Index on Alzheimer's Disease and Other Dementias Between 1990 and 2019.
     J Alzheimers Dis. 2023 Nov 30. doi: 10.3233/JAD-230827.
     PubMed     Abstract available
     
     
     
732. LI Y, Chen X, Zhou M, Feng S, et al
     Microglial TLR4/NLRP3 Inflammasome Signaling in Alzheimer's Disease.
     J Alzheimers Dis. 2023 Nov 30. doi: 10.3233/JAD-230273.
     PubMed     Abstract available
     
     
     
733. CARPI M, Fernandes M, Mercuri NB, Liguori C, et al
     Sleep Biomarkers for Predicting Cognitive Decline and Alzheimer's Disease: A Systematic Review of Longitudinal Studies.
     J Alzheimers Dis. 2023 Nov 29. doi: 10.3233/JAD-230933.
     PubMed     Abstract available
     
     
     
734. WANG Y, Jiang R, Li M, Wang Z, et al
     Characteristics of T Cells in Single-Cell Datasets of Peripheral Blood and Cerebrospinal Fluid in Alzheimer's Disease Patients.
     J Alzheimers Dis. 2023 Nov 27. doi: 10.3233/JAD-230784.
     PubMed     Abstract available
     
     
     
735. ZHANG X, Wu P, Zhao Y
     COVID-19 in Relation to Alzheimer's Disease: Mendelian Randomization Analyses Add to Multiple Lines of Evidence.
     J Alzheimers Dis. 2023 Nov 24. doi: 10.3233/JAD-231151.
     PubMed     Abstract available
     
     
     
736. CHU C, Low YLC, Ma L, Wang Y, et al
     How Can We Use Mathematical Modeling of Amyloid-beta in Alzheimer's Disease Research and Clinical Practices?
     J Alzheimers Dis. 2023 Nov 24. doi: 10.3233/JAD-230938.
     PubMed     Abstract available
     
     
     
737. KAWARABAYASHI T, Nakamura T, Miyashita K, Segawa T, et al
     Clinical Evaluation of Cerebrospinal Fluid p217tau and Neurofilament Light Chain Levels in Patients with Alzheimer's Disease or Other Neurological Diseases.
     J Alzheimers Dis. 2023 Nov 23. doi: 10.3233/JAD-230419.
     PubMed     Abstract available
     
     
     
738. MELENDEZ JC, Satorres E, Pitarque A, Escudero J, et al
     Transcranial Direct Current Stimulation Intervention in Alzheimer's Disease and Its Follow-Up.
     J Alzheimers Dis. 2023 Nov 22. doi: 10.3233/JAD-230826.
     PubMed     Abstract available
     
     
     
739. WANG X, Huang R, Huang B, Li X, et al
     S1PR2 Regulates Autophagy Through the AKT/mTOR Pathway to Promote Pathological Damage in Alzheimer's Disease.
     J Alzheimers Dis. 2023 Nov 22. doi: 10.3233/JAD-230533.
     PubMed     Abstract available
     
     
     
740. JOHNSON CE, Duncan MJ, Murphy MP
     Sex and Sleep Disruption as Contributing Factors in Alzheimer's Disease.
     J Alzheimers Dis. 2023 Nov 22. doi: 10.3233/JAD-230527.
     PubMed     Abstract available
     
     
     
741. SPAMPINATO MV, Ulber JL, Fayyaz H, Sullivan A, et al
     Neuropsychiatric Symptoms and In Vivo Alzheimer's Biomarkers in Mild Cognitive Impairment.
     J Alzheimers Dis. 2023 Nov 22. doi: 10.3233/JAD-220835.
     PubMed     Abstract available
     
     
     
742. WHITE JP, Schembri A, Prenn-Gologranc C, Ondrus M, et al
     Sensitivity of Individual and Composite Test Scores from the Cogstate Brief Battery to Mild Cognitive Impairment and Dementia Due to Alzheimer's Disease.
     J Alzheimers Dis. 2023 Nov 21. doi: 10.3233/JAD-230352.
     PubMed     Abstract available
     
     
     
743. LEWIS JE, McDaniel HR, Woolger JM, Khan SA, et al
     The Characterization of the Th1/Th2 Ratio in Moderate-Severe Alzheimer's Disease Patients and Its Response to an Aloe Polymannose-Based Dietary Supplement.
     J Alzheimers Dis. 2023 Nov 20. doi: 10.3233/JAD-230659.
     PubMed     Abstract available
     
     
     
744. MONLLOR P, Kumar P, Lloret MA, Ftara A, et al
     Multifactorial Causation of Alzheimer's Disease Due to COVID-19.
     J Alzheimers Dis. 2023 Nov 20. doi: 10.3233/JAD-230396.
     PubMed     Abstract available
     
     
     
745. EL KADIRI W, Perrignon-Sommet M, Delpont B, Graber M, et al
     Changes in Taste Perception in Patients with Minor and Major Cognitive Impairment Linked to Alzheimer's Disease Recorded by Gustatory Evoked Potentials.
     J Alzheimers Dis. 2023 Nov 20. doi: 10.3233/JAD-230270.
     PubMed     Abstract available
     
     
     
746. TETZLOFF KA, Duffy JR, Clark HM, Pham NTT, et al
     Amyloid and Tau PET Positivity in Progressive Agrammatic Aphasia and Apraxia of Speech.
     J Alzheimers Dis. 2023 Nov 20. doi: 10.3233/JAD-230912.
     PubMed     Abstract available
     
     
     
747. ZHANG F, Petersen M, Johnson L, Hall J, et al
     Comorbidities Incorporated to Improve Prediction for Prevalent Mild Cognitive Impairment and Alzheimer's Disease in the HABS-HD Study.
     J Alzheimers Dis. 2023 Nov 18. doi: 10.3233/JAD-230755.
     PubMed     Abstract available
     
     
     
748. DING P, Gurney M, Perry G, Xu R, et al
     Association of COVID-19 with Risk and Progression of Alzheimer's Disease: Non-Overlapping Two-Sample Mendelian Randomization Analysis of 2.6 Million Subjects.
     J Alzheimers Dis. 2023 Nov 18. doi: 10.3233/JAD-230632.
     PubMed     Abstract available
     
     
     
749. GIUNTI E, Collu R, Daley S, Querfurth H, et al
     Reduction of Phosphorylated Tau in Alzheimer's Disease Induced Pluripotent Stem Cell-Derived Neuro-Spheroids by Rho-Associated Coiled-Coil Kinase Inhibitor Fasudil.
     J Alzheimers Dis. 2023 Nov 18. doi: 10.3233/JAD-230551.
     PubMed     Abstract available
     
     
     
750. LIU YB, Wang XJ, Tan L, Tan CC, et al
     PICALM Variation Moderates the Relationships of APOE varepsilon4 with Alzheimer's Disease Cerebrospinal Biomarkers and Memory Function Among Non-Demented Population.
     J Alzheimers Dis. 2023 Nov 18. doi: 10.3233/JAD-230516.
     PubMed     Abstract available
     
     
     
751. LAI D, Zhang M, Li R, Zhang C, et al
     Identifying Genes Associated with Alzheimer's Disease Using Gene-Based Polygenic Risk Score.
     J Alzheimers Dis. 2023 Nov 18. doi: 10.3233/JAD-230510.
     PubMed     Abstract available
     
     
     
752. BOZKURT AS, Yilmaz SG
     Ferroptotic Potency of ISM1 Expression in the Drug-Induced Alzheimer's Disease-Like Phenotype Under the Influence of Betulin.
     J Alzheimers Dis. 2023 Nov 17. doi: 10.3233/JAD-230940.
     PubMed     Abstract available
     
     
     
753. LI JQ, Zhong XL, Song JH, Chi S, et al
     Associations Between TREML2 Gene Variants and Alzheimer's Disease: Biomarkers, Neuroimage, and Cognition.
     J Alzheimers Dis. 2023 Nov 17. doi: 10.3233/JAD-230936.
     PubMed     Abstract available
     
     
     
754. LOPES BOSCHETTI JC, Soares KL, Carvalho GR, Filho ACV, et al
     CGAs-Rich Conilon Coffee Consumption Improves Cognition and Reduces Oxidative Stress in Elderly with Alzheimer's Disease: A Pilot Study.
     J Alzheimers Dis. 2023 Nov 17. doi: 10.3233/JAD-230843.
     PubMed     Abstract available
     
     
     
755. YANG Z, Banks SJ, Ritter AR, Cummings JL, et al
     Microglial Imaging in Alzheimer's Disease and Its Relationship to Brain Amyloid: A Human 18F-GE180 PET Study.
     J Alzheimers Dis. 2023 Nov 17. doi: 10.3233/JAD-230631.
     PubMed     Abstract available
     
     
     
756. WU W, Shen A, Lee I, Miranda-Morales EG, et al
     Changes of tRNA-Derived Fragments by Alzheimer's Disease in Cerebrospinal Fluid and Blood Serum.
     J Alzheimers Dis. 2023 Nov 17. doi: 10.3233/JAD-230412.
     PubMed     Abstract available
     
     
     
757. ZENG XX, Zeng JB
     Systems Medicine as a Strategy to Deal with Alzheimer's Disease.
     J Alzheimers Dis. 2023 Nov 16. doi: 10.3233/JAD-230739.
     PubMed     Abstract available
     
     
     
758. TAO S, Fan W, Liu J, Wang T, et al
     NLRP3 Inflammasome: An Emerging Therapeutic Target for Alzheimer's Disease.
     J Alzheimers Dis. 2023 Nov 16. doi: 10.3233/JAD-230567.
     PubMed     Abstract available
     
     
     
759. CERNOTOVA D, Hruzova K, Levcik D, Svoboda J, et al
     Linking Social Cognition, Parvalbumin Interneurons, and Oxytocin in Alzheimer's Disease: An Update.
     J Alzheimers Dis. 2023 Nov 16. doi: 10.3233/JAD-230333.
     PubMed     Abstract available
     
     
     
760. SNYTNIKOVA O, Telegina D, Savina E, Tsentalovich Y, et al
     Quantitative Metabolomic Analysis of the Rat Hippocampus: Effects of Age and of the Development of Alzheimer's Disease-Like Pathology.
     J Alzheimers Dis. 2023 Nov 13. doi: 10.3233/JAD-230706.
     PubMed     Abstract available
     
     
     
761. FERNANDO MG, Silva R, Fernando WMADB, de Silva HA, et al
     Effect of Virgin Coconut Oil Supplementation on Cognition of Individuals with Mild-to-Moderate Alzheimer's Disease in Sri Lanka (VCO-AD Study): A Randomized Placebo-Controlled Trial.
     J Alzheimers Dis. 2023 Nov 13. doi: 10.3233/JAD-230670.
     PubMed     Abstract available
     
     
     
762. MATSUMOTO H, Tagai K, Endo H, Matsuoka K, et al
     Association of Tooth Loss with Alzheimer's Disease Tau Pathologies Assessed by Positron Emission Tomography.
     J Alzheimers Dis. 2023 Nov 11. doi: 10.3233/JAD-230581.
     PubMed     Abstract available
     
     
     
763. FREDERIKSEN KS, Lanctot KL, Weidner W, Hahn-Pedersen JH, et al
     A Literature Review on the Burden of Alzheimer's Disease on Care Partners.
     J Alzheimers Dis. 2023 Nov 11. doi: 10.3233/JAD-230487.
     PubMed     Abstract available
     
     
     
764. SHINAGAWA H, Ohuchi K, Goto Y, Hashimoto K, et al
     Vacuolar Protein-Sorting Proteins Are Reduced Even Before Cognitive Decline in a Mouse Model of Alzheimer's Disease.
     J Alzheimers Dis. 2023 Nov 10. doi: 10.3233/JAD-230686.
     PubMed     Abstract available
     
     
     
765. AZAMI H, Daftarifard E, Humeau-Heurtier A, Fernandez A, et al
     Assessment and Comparison of Nonlinear Measures in Resting-State Magnetoencephalograms in Alzheimer's Disease and Mild Cognitive Impairment.
     J Alzheimers Dis. 2023 Nov 10. doi: 10.3233/JAD-230544.
     PubMed     Abstract available
     
     
     
766. LY M, Yu GZ, Chwa WJ, Raji CA, et al
     Paving the Way for Alzheimer's Disease Prevention: A Systematic Review of Global Open-Access Neuroimaging Datasets in Healthy Individuals.
     J Alzheimers Dis. 2023 Nov 6. doi: 10.3233/JAD-230738.
     PubMed     Abstract available
     
     
     
767. LI K, Rashid T, Li J, Honnorat N, et al
     Postmortem Brain Imaging in Alzheimer's Disease and Related Dementias: The South Texas Alzheimer's Disease Research Center Repository.
     J Alzheimers Dis. 2023 Nov 6. doi: 10.3233/JAD-230389.
     PubMed     Abstract available
     
     
     
768. MANI S, Dubey R, Lai IC, Babu MA, et al
     Oxidative Stress and Natural Antioxidants: Back and Forth in the Neurological Mechanisms of Alzheimer's Disease.
     J Alzheimers Dis. 2023 Nov 2. doi: 10.3233/JAD-220700.
     PubMed     Abstract available
     
     
     
769. PERRON J, Scramstad C, Hyun Ko J
     Analysis of Costs for Imaging-Assisted Pharmaceutical Intervention in Alzheimer's Disease with Lecanemab: Snapshot of the First 3 Years.
     J Alzheimers Dis. 2023 Nov 1. doi: 10.3233/JAD-230633.
     PubMed     Abstract available
     
     
     October 2023
770. FUJISAWA C, Umegaki H, Sugimoto T, Nakashima H, et al
     Relationship Between Non-Cognitive Intrinsic Capacity and Activities of Daily Living According to Alzheimer's Disease Stage.
     J Alzheimers Dis. 2023 Oct 30. doi: 10.3233/JAD-230786.
     PubMed     Abstract available
     
     
     
771. YANG J, Shi X, Wang Y, Ma M, et al
     Multi-Target Neuroprotection of Thiazolidinediones on Alzheimer's Disease via Neuroinflammation and Ferroptosis.
     J Alzheimers Dis. 2023 Oct 30. doi: 10.3233/JAD-230593.
     PubMed     Abstract available
     
     
     
772. SALHI L, Al Taep Y, Salmon E, Van Hede D, et al
     How Periodontitis or Periodontal Bacteria Can Influence Alzheimer's Disease Features? A Systematic Review of Pre-Clinical Studies.
     J Alzheimers Dis. 2023 Oct 30. doi: 10.3233/JAD-230478.
     PubMed     Abstract available
     
     
     
773. GRANT WB, Blake SM
     Diet's Role in Modifying Risk of Alzheimer's Disease: History and Present Understanding.
     J Alzheimers Dis. 2023 Oct 28. doi: 10.3233/JAD-230418.
     PubMed     Abstract available
     
     
     
774. DONG Y, Hou T, Li Y, Liu R, et al
     Plasma Amyloid-beta, Total Tau, and Neurofilament Light Chain Across the Alzheimer's Disease Clinical Spectrum: A Population-Based Study.
     J Alzheimers Dis. 2023 Oct 26. doi: 10.3233/JAD-230932.
     PubMed     Abstract available
     
     
     
775. ALROUJI M, Majrashi TA, Alhumaydhi FA, Zari A, et al
     Unveiling Phytoconstituents with Inhibitory Potential Against Tyrosine-Protein Kinase Fyn: A Comprehensive Virtual Screening Approach Targeting Alzheimer's Disease.
     J Alzheimers Dis. 2023 Oct 26. doi: 10.3233/JAD-230828.
     PubMed     Abstract available
     
     
     
776. INGANNATO A, Bessi V, Chiari A, Salvatori D, et al
     GRN Missense Variants and Familial Alzheimer's Disease: Two Case Reports.
     J Alzheimers Dis. 2023 Oct 21. doi: 10.3233/JAD-230689.
     PubMed     Abstract available
     
     
     
777. BEN KHEDHER MR, Haddad M, Fulop T, Laurin D, et al
     Implication of Circulating Extracellular Vesicles-Bound Amyloid-beta42 Oligomers in the Progression of Alzheimer's Disease.
     J Alzheimers Dis. 2023 Oct 11. doi: 10.3233/JAD-230823.
     PubMed     Abstract available
     
     
     
778. HOANG MT, Kareholt I, Schon P, von Koch L, et al
     The Impact of Educational Attainment and Income on Long-Term Care for Persons with Alzheimer's Disease and Other Dementias: A Swedish Nationwide Study.
     J Alzheimers Dis. 2023 Oct 11. doi: 10.3233/JAD-230388.
     PubMed     Abstract available
     
     
     
779. TZENG IS
     Examination of Matching Methods, Sparse Effects, and Limitations in a Nationwide Database Study on Alzheimer's Disease.
     J Alzheimers Dis. 2023 Oct 9. doi: 10.3233/JAD-230701.
     PubMed     Abstract available
     
     
     
780. LEE A, Shan D, Castle D, Rajji TK, et al
     Landscape of Phase II Trials in Alzheimer's Disease.
     J Alzheimers Dis. 2023 Oct 9. doi: 10.3233/JAD-230660.
     PubMed     Abstract available
     
     
     
781. BUCHMAN AS, Leurgans SE, Kim N, Agrawal S, et al
     Alzheimer's Disease Pathology Outside of the Cerebrum Is Related to a Higher Odds of Dementia.
     J Alzheimers Dis. 2023 Oct 9. doi: 10.3233/JAD-230223.
     PubMed     Abstract available
     
     
     
782. JIANG J, Hong Y, Li W, Wang A, et al
     Chain Mediation Analysis of the Effects of Nutrition and Cognition on the Association of Apolipoprotein E varepsilon4 with Neuropsychiatric Symptoms in Alzheimer's Disease.
     J Alzheimers Dis. 2023 Oct 6. doi: 10.3233/JAD-230577.
     PubMed     Abstract available
     
     
     
783. XUE W, He W, Yan M, Zhao H, et al
     Exploring Shared Biomarkers of Myocardial Infarction and Alzheimer's Disease via Single-Cell/Nucleus Sequencing and Bioinformatics Analysis.
     J Alzheimers Dis. 2023 Oct 6. doi: 10.3233/JAD-230559.
     PubMed     Abstract available
     
     
     
784. XIA S, Chen H, Tang T
     Risk of Death from Alzheimer's Disease Associated with Brain Tumor, Glioma, and Glioblastoma.
     J Alzheimers Dis. 2023 Oct 6. doi: 10.3233/JAD-230554.
     PubMed     Abstract available
     
     
     
785. LI A, Du J, Cai Y, Chen X, et al
     Body Mass Index Decrease Has a Distinct Association with Alzheimer's Disease Pathophysiology in APOE varepsilon4 Carriers and Non-Carriers.
     J Alzheimers Dis. 2023 Oct 6. doi: 10.3233/JAD-230446.
     PubMed     Abstract available
     
     
     
786. BIAN Z, Hu X, Liu X, Yu H, et al
     Protective Effects of Rivaroxaban on White Matter Integrity and Remyelination in a Mouse Model of Alzheimer's Disease Combined with Cerebral Hypoperfusion.
     J Alzheimers Dis. 2023 Oct 6. doi: 10.3233/JAD-230413.
     PubMed     Abstract available
     
     
     
787. ROACH JC, Rapozo MK, Hara J, Glusman G, et al
     A Remotely Coached Multimodal Lifestyle Intervention for Alzheimer's Disease Ameliorates Functional and Cognitive Outcomes.
     J Alzheimers Dis. 2023 Oct 6. doi: 10.3233/JAD-230403.
     PubMed     Abstract available
     
     
     
788. KIM M, Yi D, Byun MS, Ahn H, et al
     Development of a Cognitive Composite for Preclinical Alzheimer's Disease in Korean Older Adults.
     J Alzheimers Dis. 2023 Oct 5. doi: 10.3233/JAD-230263.
     PubMed     Abstract available
     
     
     
789. AKUSHEVICH I, Yashkin A, Ukraintseva S, Yashin AI, et al
     The Construction of a Multidomain Risk Model of Alzheimer's Disease and Related Dementias.
     J Alzheimers Dis. 2023 Oct 5. doi: 10.3233/JAD-221292.
     PubMed     Abstract available
     
     
     
790. KETCHUM FB, Erickson CM, Basche KE, Chin NA, et al
     Informing Disclosure: Efficacy of a Brief Educational Intervention on Research Participants' Knowledge about Alzheimer's Disease Biomarkers.
     J Alzheimers Dis. 2023 Oct 3. doi: 10.3233/JAD-230732.
     PubMed     Abstract available
     
     
     
791. BREDESEN DE, Toups K, Hathaway A, Gordon D, et al
     Precision Medicine Approach to Alzheimer's Disease: Rationale and Implications.
     J Alzheimers Dis. 2023 Oct 3. doi: 10.3233/JAD-230467.
     PubMed     Abstract available
     
     
     
792. UKRAINTSEVA S, Duan M, Simanek AM, Holmes R, et al
     Vaccination Against Pneumonia May Provide Genotype-Specific Protection Against Alzheimer's Disease.
     J Alzheimers Dis. 2023 Oct 3. doi: 10.3233/JAD-230088.
     PubMed     Abstract available
     
     
     
793. LIU CC, Wang QH, Xin JY, Liu YH, et al
     Association of Adipokines with Alzheimer's Disease in a Chinese Cohort.
     J Alzheimers Dis. 2023 Oct 3. doi: 10.3233/JAD-220860.
     PubMed     Abstract available
     
     
     September 2023
794. BARBA L, Otto M, Abu-Rumeileh S
     The Underestimated Relevance of Alzheimer's Disease Copathology in Amyotrophic Lateral Sclerosis.
     J Alzheimers Dis. 2023 Sep 30. doi: 10.3233/JAD-230900.
     PubMed     Abstract available
     
     
     
795. GONZALEZ-MADRID A, Calfio C, Gonzalez A, Luttges V, et al
     Toward Prevention and Reduction of Alzheimer's Disease.
     J Alzheimers Dis. 2023 Sep 30. doi: 10.3233/JAD-230454.
     PubMed     Abstract available
     
     
     
796. LIU Y, Shen Y
     Applications of Nanoparticles in Alzheimer's Disease.
     J Alzheimers Dis. 2023 Sep 30. doi: 10.3233/JAD-230098.
     PubMed     Abstract available
     
     
     
797. HUANG Y, Driedonks TAP, Cheng L, Turchinovich A, et al
     Small RNA Profiles of Brain Tissue-Derived Extracellular Vesicles in Alzheimer's Disease.
     J Alzheimers Dis. 2023 Sep 28. doi: 10.3233/JAD-230872.
     PubMed     Abstract available
     
     
     
798. GUILLIOT S, Gauthier S, Touchon J, Soto ME, et al
     Lithium, a Treatment Option for Alzheimer's Disease? A Review of Existing Evidence and Discussion on Future Perspectives.
     J Alzheimers Dis. 2023 Sep 28. doi: 10.3233/JAD-230568.
     PubMed     Abstract available
     
     
     
799. POLIN C, Gelle T, Auditeau E, Adou C, et al
     Repetitive Behaviors in Alzheimer's Disease: A Systematic Review and Meta-Analysis.
     J Alzheimers Dis. 2023 Sep 28. doi: 10.3233/JAD-230380.
     PubMed     Abstract available
     
     
     
800. DALY T
     Improving Clinical Trials of Antioxidants in Alzheimer's Disease.
     J Alzheimers Dis. 2023 Sep 28. doi: 10.3233/JAD-230308.
     PubMed     Abstract available
     
     
     
801. IKANGA J, Hickle S, Schwinne M, Epenge E, et al
     Association Between Hippocampal Volume and African Neuropsychology Memory Tests in Adult Individuals with Probable Alzheimer's Disease in Democratic Republic of Congo.
     J Alzheimers Dis. 2023 Sep 28. doi: 10.3233/JAD-230206.
     PubMed     Abstract available
     
     
     
802. ROGERS JT, Cahill CM
     Iron Responsiveness to Lysosomal Disruption: A Novel Pathway to Alzheimer's Disease.
     J Alzheimers Dis. 2023 Sep 25. doi: 10.3233/JAD-230953.
     PubMed     Abstract available
     
     
     
803. BRAMEN JE, Siddarth P, Popa ES, Kress GT, et al
     Impact of Eating a Carbohydrate-Restricted Diet on Cortical Atrophy in a Cross-Section of Amyloid Positive Patients with Alzheimer's Disease: A Small Sample Study.
     J Alzheimers Dis. 2023 Sep 22. doi: 10.3233/JAD-230458.
     PubMed     Abstract available
     
     
     
804. CHOW TE, Veziris CR, Mundada N, Martinez-Arroyo AI, et al
     Medial Temporal Lobe Tau Aggregation Relates to Divergent Cognitive and Emotional Empathy Abilities in Alzheimer's Disease.
     J Alzheimers Dis. 2023 Sep 22. doi: 10.3233/JAD-230367.
     PubMed     Abstract available
     
     
     
805. QEADAN F, McCunn A, Tingey B, Price R, et al
     Exploring the Association Between Opioid Use Disorder and Alzheimer's Disease and Dementia Among a National Sample of the U.S. Population.
     J Alzheimers Dis. 2023 Sep 21. doi: 10.3233/JAD-230714.
     PubMed     Abstract available
     
     
     
806. DINNERSTEIN E
     Erratum to: The Time for Combination Therapy Research in Alzheimer's Disease is Now.
     J Alzheimers Dis. 2023 Sep 20. doi: 10.3233/JAD-239010.
     PubMed    
     
     
     
807. SUN Y, Moghekar A, Soldan A, Pettigrew C, et al
     Cerebrospinal Fluid Alzheimer's Disease Biomarker Patterns of Change Prior to the Onset of Mild Cognitive Impairment.
     J Alzheimers Dis. 2023 Sep 20. doi: 10.3233/JAD-230807.
     PubMed     Abstract available
     
     
     
808. ALKON DL, Sun MK, Tuchman AJ, Thompson RE, et al
     Advanced Alzheimer's Disease Patients Show Safe, Significant, and Persistent Benefit in 6-Month Bryostatin Trial.
     J Alzheimers Dis. 2023 Sep 19. doi: 10.3233/JAD-230868.
     PubMed     Abstract available
     
     
     
809. LEIBY AC, Scambray KA, Nguyen HL, Basith F, et al
     Characterizing Limbic-Predominant Age-Related TDP-43 Encephalopathy Without Alzheimer's Disease and Lewy Body Dementia in the Oldest Old: A Case Series.
     J Alzheimers Dis. 2023 Sep 19. doi: 10.3233/JAD-230238.
     PubMed     Abstract available
     
     
     
810. LARDELLI M, Baer L, Hin N, Allen A, et al
     The Use of Zebrafish in Transcriptome Analysis of the Early Effects of Mutations Causing Early Onset Familial Alzheimer's Disease and Other Inherited Neurodegenerative Conditions.
     J Alzheimers Dis. 2023 Sep 16. doi: 10.3233/JAD-230522.
     PubMed     Abstract available
     
     
     
811. ZHANG Y, Xue Y, Wang L, Han Z, et al
     rs56405341 Variant Associates with Expression of C4orf33 and C4orf33 Was Downregulated in Alzheimer's Disease and Progressive Supranuclear Palsy.
     J Alzheimers Dis. 2023 Sep 16. doi: 10.3233/JAD-230327.
     PubMed     Abstract available
     
     
     
812. MERLO S, Costa L, Chiechio S, Busceti CL, et al
     Increased Heat Pain Tolerance but Hyperalgesia to Tonic Inflammatory Pain in the CRND8 Mouse Model of Alzheimer's Disease.
     J Alzheimers Dis. 2023 Sep 16. doi: 10.3233/JAD-230148.
     PubMed     Abstract available
     
     
     
813. BLUSZTAJN JK, Aytan N, Rajendiran T, Mellott TJ, et al
     Cerebral Gray and White Matter Monogalactosyl Diglyceride Levels Rise with the Progression of Alzheimer's Disease.
     J Alzheimers Dis. 2023 Sep 14. doi: 10.3233/JAD-230543.
     PubMed     Abstract available
     
     
     
814. PARRENO TORRES A, Roncero-Parra C, Borja AL, Mateo-Sotos J, et al
     Inter-Hospital Advanced and Mild Alzheimer's Disease Classification Based on Electroencephalogram Measurements via Classical Machine Learning Algorithms.
     J Alzheimers Dis. 2023 Sep 14. doi: 10.3233/JAD-230525.
     PubMed     Abstract available
     
     
     
815. SAKURAI K, Kaneda D, Morimoto S, Uchida Y, et al
     Asymmetric Cerebral Peduncle Atrophy: A Simple Diagnostic Clue for Distinguishing Frontotemporal Lobar Degeneration from Alzheimer's Disease.
     J Alzheimers Dis. 2023 Sep 14. doi: 10.3233/JAD-230441.
     PubMed     Abstract available
     
     
     
816. NIK AKHTAR S, Lu Q
     RhoA-LIMK Signaling Axis Reveals Rostral-Caudal Plane and Spatial Dysregulation in the Brain of Alzheimer's Disease Mouse Models.
     J Alzheimers Dis. 2023 Sep 14. doi: 10.3233/JAD-230408.
     PubMed     Abstract available
     
     
     
817. O'BRYANT SE, Zhang F, Johnson LA, Hall J, et al
     Precision Medicine for Preventing Alzheimer's Disease: Analysis of the ADAPT Study.
     J Alzheimers Dis. 2023 Sep 14. doi: 10.3233/JAD-230317.
     PubMed     Abstract available
     
     
     
818. YANG Y, Li M, Leng B, Yao R, et al
     Alzheimer's Disease Biomarkers and Complement Proteins Mediate the Impact of Sleep Fragmentation on Cognitive Impairment in Obstructive Sleep Apnea Patients Without Dementia.
     J Alzheimers Dis. 2023 Sep 14. doi: 10.3233/JAD-221288.
     PubMed     Abstract available
     
     
     
819. TANG H, Sun Y, Fachim HA, Cheung TKD, et al
     Elevated Expression of Two Pore Potassium Channel THIK-1 in Alzheimer's Disease: An Inflammatory Mechanism.
     J Alzheimers Dis. 2023 Sep 12. doi: 10.3233/JAD-230616.
     PubMed     Abstract available
     
     
     
820. WITUCKI L, Borowczyk K, Suszynska-Zajczyk J, Warzych E, et al
     Deletion of the Homocysteine Thiolactone Detoxifying Enzyme Bleomycin Hydrolase, in Mice, Causes Memory and Neurological Deficits and Worsens Alzheimer's Disease-Related Behavioral and Biochemical Traits in the 5xFAD Model of Alzheimer's Disease.
     J Alzheimers Dis. 2023 Sep 12. doi: 10.3233/JAD-230578.
     PubMed     Abstract available
     
     
     
821. GUIEYSSE T, Lamothe R, Houot M, Razafimahatratra S, et al
     Detecting Anosognosia from the Prodromal Stage of Alzheimer's Disease.
     J Alzheimers Dis. 2023 Sep 12. doi: 10.3233/JAD-230552.
     PubMed     Abstract available
     
     
     
822. FERNANDES C, Montalvo G, Caligiuri M, Pertsinakis M, et al
     Handwriting Changes in Alzheimer's Disease: A Systematic Review.
     J Alzheimers Dis. 2023 Sep 12. doi: 10.3233/JAD-230438.
     PubMed     Abstract available
     
     
     
823. XU X, Wang H, Zhang QY, Meng XY, et al
     Dissecting Mitochondrial Mechanisms of Alzheimer's Disease Using Gene Dependency Network and Its Implications for Discovering Nutrients Combatting the Disease.
     J Alzheimers Dis. 2023 Sep 12. doi: 10.3233/JAD-230366.
     PubMed     Abstract available
     
     
     
824. LARDELLI M
     An Alternative View of Familial Alzheimer's Disease Genetics.
     J Alzheimers Dis. 2023 Sep 12. doi: 10.3233/JAD-230313.
     PubMed     Abstract available
     
     
     
825. DE LA MONTE SM
     Malignant Brain Aging: The Formidable Link Between Dysregulated Signaling Through Mechanistic Target of Rapamycin Pathways and Alzheimer's Disease (Type 3 Diabetes).
     J Alzheimers Dis. 2023 Sep 11. doi: 10.3233/JAD-230555.
     PubMed     Abstract available
     
     
     
826. FORTEL I, Zhan L, Ajilore O, Wu Y, et al
     Disrupted Excitation-Inhibition Balance in Cognitively Normal Individuals at Risk of Alzheimer's Disease.
     J Alzheimers Dis. 2023 Sep 11. doi: 10.3233/JAD-230035.
     PubMed     Abstract available
     
     
     
827. DAVIDSON S, Allenback G, Decourt B, Sabbagh MN, et al
     Type 2 Diabetes Comorbidity and Cognitive Decline in Patients with Alzheimer's Disease.
     J Alzheimers Dis. 2023 Sep 9. doi: 10.3233/JAD-230489.
     PubMed     Abstract available
     
     
     
828. FUKUDA H, Kanzaki H, Murata F, Maeda M, et al
     Disease Burden and Progression in Patients with New-Onset Mild Cognitive Impairment and Alzheimer's Disease Identified from Japanese Claims Data: Evidence from the LIFE Study.
     J Alzheimers Dis. 2023 Sep 9. doi: 10.3233/JAD-230471.
     PubMed     Abstract available
     
     
     
829. ZIYAD SR, Altulyan M, Alharbi M
     SHMAD: A Smart Health Care System to Monitor Alzheimer's Disease Patients.
     J Alzheimers Dis. 2023 Sep 9. doi: 10.3233/JAD-230402.
     PubMed     Abstract available
     
     
     
830. NAKAMURA Y, Narita K, Kim R, Nishiyama K, et al
     Long-Term Safety, Tolerability, and Efficacy of a Transdermal Donepezil Patch in Patients with Severe Alzheimer's Disease.
     J Alzheimers Dis. 2023 Sep 9. doi: 10.3233/JAD-230386.
     PubMed     Abstract available
     
     
     
831. VERDE F, Aiello EN, Adobbati L, Poletti B, et al
     Coexistence of Amyotrophic Lateral Sclerosis and Alzheimer's Disease: Case Report and Review of the Literature.
     J Alzheimers Dis. 2023 Sep 7. doi: 10.3233/JAD-230562.
     PubMed     Abstract available
     
     
     
832. DU Y, Chen X, Zhang B, Jin X, et al
     Identification of Copper Metabolism Related Biomarkers, Polygenic Prediction Model, and Potential Therapeutic Agents in Alzheimer's Disease.
     J Alzheimers Dis. 2023 Sep 5. doi: 10.3233/JAD-230565.
     PubMed     Abstract available
     
     
     
833. LEHMANN DJ, Elshorbagy A, Hurley MJ
     Many Paths to Alzheimer's Disease: A Unifying Hypothesis Integrating Biological, Chemical, and Physical Risk Factors.
     J Alzheimers Dis. 2023 Sep 5. doi: 10.3233/JAD-230295.
     PubMed     Abstract available
     
     
     
834. KOPPELMANS V, Ruitenberg MFL, Schaefer SY, King JB, et al
     Delayed and More Variable Unimanual and Bimanual Finger Tapping in Alzheimer's Disease: Associations with Biomarkers and Applications for Classification.
     J Alzheimers Dis. 2023 Sep 4. doi: 10.3233/JAD-221297.
     PubMed     Abstract available
     
     
     
835. ADEWALE BA, Coker MM, Ogunniyi A, Kalaria RN, et al
     Biomarkers and Risk Assessment of Alzheimer's Disease in Low- and Middle-Income Countries.
     J Alzheimers Dis. 2023 Sep 4. doi: 10.3233/JAD-221030.
     PubMed     Abstract available
     
     
     
836. MAKRI M, Gkioka M, Moraitou D, Fidani L, et al
     Attitudes, Motivations, and Barriers to Pre-Symptomatic Alzheimer's Disease Screening: Development and Validation of the 'Perceptions regarding pRE-symptomatic Alzheimer's Disease Screening' (PRE-ADS) Questionnaire.
     J Alzheimers Dis. 2023 Sep 1. doi: 10.3233/JAD-220954.
     PubMed     Abstract available
     
     
     August 2023
837. LI Z, Wu H, Ji Y, Shi Z, et al
     Toward Reagent-Free Discrimination of Alzheimer's Disease Using Blood Plasma Spectral Digital Biomarkers and Machine Learning.
     J Alzheimers Dis. 2023 Aug 28. doi: 10.3233/JAD-230248.
     PubMed     Abstract available
     
     
     
838. GEZEN-AK D, Dursun E
     Vitamin D, a Secosteroid Hormone and Its Multifunctional Receptor, Vitamin D Receptor, in Alzheimer's Type Neurodegeneration.
     J Alzheimers Dis. 2023 Aug 28. doi: 10.3233/JAD-230214.
     PubMed     Abstract available
     
     
     
839. ZHANG J, Liu Q, Zhang H, Dai M, et al
     Uncovering the System Vulnerability and Criticality of Human Brain Under Dynamical Neuropathological Events in Alzheimer's Disease.
     J Alzheimers Dis. 2023 Aug 28. doi: 10.3233/JAD-230027.
     PubMed     Abstract available
     
     
     
840. FAZLOLLAHI A, Lee S, Coleman F, McCann E, et al
     Increased Resolution of Structural MRI at 3T Improves Estimation of Regional Cortical Degeneration in Individual Dementia Patients Using Surface Thickness Maps.
     J Alzheimers Dis. 2023 Aug 28. doi: 10.3233/JAD-230030.
     PubMed     Abstract available
     
     
     
841. UCHIDA Y, Onda K, Hou Z, Troncoso JC, et al
     Microstructural Neurodegeneration of the Entorhinal-Hippocampus Pathway along the Alzheimer's Disease Continuum.
     J Alzheimers Dis. 2023 Aug 25. doi: 10.3233/JAD-230452.
     PubMed     Abstract available
     
     
     
842. WU Y, Eisel ULM
     Microglia-Astrocyte Communication in Alzheimer's Disease.
     J Alzheimers Dis. 2023 Aug 25. doi: 10.3233/JAD-230199.
     PubMed     Abstract available
     
     
     
843. SCHORK NJ, Elman JA
     Pathway-Specific Polygenic Risk Scores Correlate with Clinical Status and Alzheimer's Disease-Related Biomarkers.
     J Alzheimers Dis. 2023 Aug 25. doi: 10.3233/JAD-230548.
     PubMed     Abstract available
     
     
     
844. BEI J, Miranda-Morales EG, Gan Q, Qiu Y, et al
     Circulating Exosomes from Alzheimer's Disease Suppress Vascular Endothelial-Cadherin Expression and Induce Barrier Dysfunction in Recipient Brain Microvascular Endothelial Cell.
     J Alzheimers Dis. 2023 Aug 25. doi: 10.3233/JAD-230347.
     PubMed     Abstract available
     
     
     
845. SATTAROV R, Toresson H, Orbjorn C, Mattsson-Carlgren N, et al
     Direct Conversion of Fibroblast into Neurons for Alzheimer's Disease Research: A Systematic Review.
     J Alzheimers Dis. 2023 Aug 25. doi: 10.3233/JAD-230119.
     PubMed     Abstract available
     
     
     
846. HEIDARZADEH N, Ratte S
     'Eye-Tracking' with Words for Alzheimer's Disease Detection: Time Alignment of Words Enunciation with Image Regions During Image Description Tasks.
     J Alzheimers Dis. 2023 Aug 25. doi: 10.3233/JAD-220711.
     PubMed     Abstract available
     
     
     
847. LI J, Mountz EJ, Mizuno A, Shah AM, et al
     Functional Asymmetry During Working Memory and Its Association with Markers of Alzheimer's Disease in Cognitively Normal Older Adults.
     J Alzheimers Dis. 2023 Aug 24. doi: 10.3233/JAD-230379.
     PubMed     Abstract available
     
     
     
848. RAMOS C, Madrigal C, Aguirre-Acevedo DC, Giraldo-Chica M, et al
     Psychological Status of the Participants in Alzheimer's Prevention Initiative Autosomal Dominant Alzheimer's Disease Colombia.
     J Alzheimers Dis. 2023 Aug 24. doi: 10.3233/JAD-220941.
     PubMed     Abstract available
     
     
     
849. JIANG J, Wang A, Liu Y, Yao Z, et al
     Spatiotemporal Characteristics of Regional Brain Perfusion Associated with Neuropsychiatric Symptoms in Patients with Alzheimer's Disease.
     J Alzheimers Dis. 2023 Aug 23. doi: 10.3233/JAD-230499.
     PubMed     Abstract available
     
     
     
850. KIM DY, Kim JS, Seo YS, Park WY, et al
     Evaluation of Efficacy and Safety Using Low Dose Radiation Therapy with Alzheimer's Disease: A Protocol for Multicenter Phase II Clinical Trial.
     J Alzheimers Dis. 2023 Aug 23. doi: 10.3233/JAD-230241.
     PubMed     Abstract available
     
     
     
851. ABYADEH M, Yadav VK, Kaya A
     Common Molecular Signatures Between Coronavirus Infection and Alzheimer's Disease Reveal Targets for Drug Development.
     J Alzheimers Dis. 2023 Aug 22. doi: 10.3233/JAD-230684.
     PubMed     Abstract available
     
     
     
852. JANN K, Boudreau J, Albrecht D, Cen SY, et al
     FMRI Complexity Correlates with Tau-PET and Cognitive Decline in Late-Onset and Autosomal Dominant Alzheimer's Disease.
     J Alzheimers Dis. 2023 Aug 18. doi: 10.3233/JAD-220851.
     PubMed     Abstract available
     
     
     
853. MAMELAK M
     The Alzheimer's Disease Brain, Its Microvasculature, and NADPH Oxidase.
     J Alzheimers Dis. 2023 Aug 14. doi: 10.3233/JAD-230415.
     PubMed     Abstract available
     
     
     
854. KATISKO K, Kruger J, Soppela H, Hartikainen P, et al
     Psychopharmacological Medication Use in Frontotemporal Dementia at the Time of Diagnosis: Comparison with Alzheimer's Disease.
     J Alzheimers Dis. 2023 Aug 12. doi: 10.3233/JAD-230494.
     PubMed     Abstract available
     
     
     
855. KOBRO-FLATMOEN A, Hormann TM, Gouras G
     Intracellular Amyloid-beta in the Normal Rat Brain and Human Subjects and Its relevance for Alzheimer's Disease.
     J Alzheimers Dis. 2023 Aug 10. doi: 10.3233/JAD-230349.
     PubMed     Abstract available
     
     
     
856. YANG H, Wang W, Jia L, Qin W, et al
     Erratum to: The Effect of Chronic Cerebral Hypoperfusion on Blood-Brain Barrier Permeability in a Transgenic Alzheimer's Disease Mouse Model (PS1V97L).
     J Alzheimers Dis. 2023 Aug 8. doi: 10.3233/JAD-239007.
     PubMed    
     
     
     
857. WANG X, Sundermann EE, Buckley RF, Reas ET, et al
     Sex Differences in the Associations of Obesity with Tau, Amyloid PET, and Cognitive Outcomes in Preclinical Alzheimer's Disease: Cross-Sectional A4 Study.
     J Alzheimers Dis. 2023 Aug 7. doi: 10.3233/JAD-230466.
     PubMed     Abstract available
     
     
     
858. KENKPEN AK, Storey JJ, Olson ER, Guden TE, et al
     Developing Connections Between LINC00298 RNA and Alzheimer's Disease Through Mapping Its Interactome and Through Biochemical Characterization.
     J Alzheimers Dis. 2023 Aug 7. doi: 10.3233/JAD-230057.
     PubMed     Abstract available
     
     
     
859. HARRIS K, Ling Y, Bukhbinder AS, Chen L, et al
     The Impact of Routine Vaccinations on Alzheimer's Disease Risk in Persons 65 Years and Older: A Claims-Based Cohort Study using Propensity Score Matching.
     J Alzheimers Dis. 2023 Aug 7. doi: 10.3233/JAD-221231.
     PubMed     Abstract available
     
     
     
860. CONTI E, Grana D, Angiulli F, Karantzoulis A, et al
     TSPO Modulates Oligomeric Amyloid-beta-Induced Monocyte Chemotaxis: Relevance for Neuroinflammation in Alzheimer's Disease.
     J Alzheimers Dis. 2023 Aug 5. doi: 10.3233/JAD-230239.
     PubMed     Abstract available
     
     
     
861. CAI HY, Yang D, Qiao J, Yang JT, et al
     Erratum to: A GLP-1/GIP Dual Receptor Agonist DA4-JC Effectively Attenuates Cognitive Impairment and Pathology in the APP/PS1/Tau Model of Alzheimer's Disease.
     J Alzheimers Dis. 2023 Aug 2. doi: 10.3233/JAD-239006.
     PubMed    
     
     
     
862. QAISER H, Uzair M, Al-Regaiey K, Rafiq S, et al
     Role of Thioredoxin System in Regulating Cellular Redox Status in Alzheimer's Disease.
     J Alzheimers Dis. 2023 Aug 1. doi: 10.3233/JAD-230394.
     PubMed     Abstract available
     
     
     
863. MENDEZ MF
     Can Speaking More Than One Language Help Prevent Alzheimer's Disease?
     J Alzheimers Dis. 2023 Aug 1. doi: 10.3233/JAD-230285.
     PubMed     Abstract available
     
     
     
864. SONG S, Asken B, Armstrong MJ, Yang Y, et al
     Predicting Progression to Clinical Alzheimer's Disease Dementia Using the Random Survival Forest.
     J Alzheimers Dis. 2023 Aug 1. doi: 10.3233/JAD-230208.
     PubMed     Abstract available
     
     
     
865. BACHMAN SL, Blankenship JM, Busa M, Serviente C, et al
     Capturing Measures That Matter: The Potential Value of Digital Measures of Physical Behavior for Alzheimer's Disease Drug Development.
     J Alzheimers Dis. 2023 Aug 1. doi: 10.3233/JAD-230152.
     PubMed     Abstract available
     
     
     
866. BAUMARD J
     Is Shadowing Behavior Caused by Body Representation Disorders and Apraxia?
     J Alzheimers Dis. 2023 Aug 1. doi: 10.3233/JAD-230731.
     PubMed     Abstract available
     
     
     July 2023
867. LA BARBERA L, D'Amelio M
     Alzheimer's Disease and Sex-Dependent Alterations in the Striatum: A Lesson from a Mouse Model.
     J Alzheimers Dis. 2023 Jul 28. doi: 10.3233/JAD-230681.
     PubMed     Abstract available
     
     
     
868. LIN Y, Hu T, Cheng L, Chen Y, et al
     Causal Effects of Plasma Haptoglobin Levels on Alzheimer's Disease: A Two-Sample Mendelian Randomization Study.
     J Alzheimers Dis. 2023 Jul 26. doi: 10.3233/JAD-230159.
     PubMed     Abstract available
     
     
     
869. LEITAO ADG, Spencer B, Sarsoza F, Ngolab J, et al
     Hippocampal Reduction of alpha-Synuclein via RNA Interference Improves Neuropathology in Alzheimer's Disease Mice.
     J Alzheimers Dis. 2023 Jul 25. doi: 10.3233/JAD-230232.
     PubMed     Abstract available
     
     
     
870. VICENTE MC, Paneghini JL, Stabile AM, Amorim M, et al
     Inhibition of Pro-Inflammatory Microglia with Minocycline Improves Cognitive and Sleep-Wake Dysfunction Under Respiratory Stress in a Sporadic Model for Alzheimer's Disease.
     J Alzheimers Dis. 2023 Jul 25. doi: 10.3233/JAD-230151.
     PubMed     Abstract available
     
     
     
871. NADEAU PA, Jobin B, Boller B
     Diagnostic Sensitivity and Specificity of Cognitive Tests for Mild Cognitive Impairment and Alzheimer's Disease in Patients with Down Syndrome: A Systematic Review and Meta-Analysis.
     J Alzheimers Dis. 2023 Jul 25. doi: 10.3233/JAD-220991.
     PubMed     Abstract available
     
     
     
872. VOSSEL K
     Putting the Brakes on Accelerated Cognitive Decline in Alzheimer's Disease with Epileptic Activity.
     J Alzheimers Dis. 2023 Jul 24. doi: 10.3233/JAD-230613.
     PubMed     Abstract available
     
     
     
873. WHITE LR, Corrada MM, Kawas CH, Cholerton BA, et al
     Neuropathologic Changes of Alzheimer's Disease and Related Dementias: Relevance to Future Prevention.
     J Alzheimers Dis. 2023 Jul 24. doi: 10.3233/JAD-230331.
     PubMed     Abstract available
     
     
     
874. NOWRANGI MA, Outen JD, Kim J, Avramopoulos D, et al
     Neuropsychiatric Symptoms of Alzheimer's Disease: An Anatomic-Genetic Framework for Treatment Development.
     J Alzheimers Dis. 2023 Jul 24. doi: 10.3233/JAD-221247.
     PubMed     Abstract available
     
     
     
875. 
     Henning Tiemeier, MD, PhD, and Rosanne Freak-Poli, PhD, are the recipients of the 2023 Alzheimer Award.
     J Alzheimers Dis. 2023 Jul 20. doi: 10.3233/JAD-239005.
     PubMed    
     
     
     
876. LI J, Zeng Q, Luo X, Li K, et al
     Decoupling of Regional Cerebral Blood Flow and Brain Function Along the Alzheimer's Continuum.
     J Alzheimers Dis. 2023 Jul 20. doi: 10.3233/JAD-230503.
     PubMed     Abstract available
     
     
     
877. LOPEZ-MARTOS D, Brugulat-Serrat A, Canas-Martinez A, Canals-Gispert L, et al
     Reference Data for Attentional, Executive, Linguistic, and Visual Processing Tests Obtained from Cognitively Healthy Individuals with Normal Alzheimer's Disease Cerebrospinal Fluid Biomarker Levels.
     J Alzheimers Dis. 2023 Jul 20. doi: 10.3233/JAD-230290.
     PubMed     Abstract available
     
     
     
878. KILPATRICK LA, Siddarth P, Krause-Sorio B, Milillo MM, et al
     Impact of Yoga Versus Memory Enhancement Training on Hippocampal Connectivity in Older Women at Risk for Alzheimer's Disease.
     J Alzheimers Dis. 2023 Jul 19. doi: 10.3233/JAD-221159.
     PubMed     Abstract available
     
     
     
879. STALLARD E, Kociolek A, Jin Z, Ryu H, et al
     Validation of a Multivariate Prediction Model of the Clinical Progression of Alzheimer's Disease in a Community-Dwelling Multiethnic Cohort.
     J Alzheimers Dis. 2023 Jul 19. doi: 10.3233/JAD-220811.
     PubMed     Abstract available
     
     
     
880. YU Y, Xia X, Meng X, Li D, et al
     Plasma Phosphorylated Tau181 and Amyloid-beta42 in Dementia with Lewy Bodies Compared with Alzheimer's Disease and Cognitively Healthy People.
     J Alzheimers Dis. 2023 Jul 18. doi: 10.3233/JAD-230085.
     PubMed     Abstract available
     
     
     
881. HARTLEY SL, Fleming V, Schworer EK, Peven J, et al
     Timing of Alzheimer's Disease by Intellectual Disability Level in Down Syndrome.
     J Alzheimers Dis. 2023 Jul 17. doi: 10.3233/JAD-230200.
     PubMed     Abstract available
     
     
     
882. PUENTES-DIAZ N, Chaparro D, Reyes-Marquez V, Morales-Morales D, et al
     Computational Evaluation of the Potential Pharmacological Activity of Salen-Type Ligands in Alzheimer's Disease.
     J Alzheimers Dis. 2023 Jul 15. doi: 10.3233/JAD-230542.
     PubMed     Abstract available
     
     
     
883. OLMOS-VILLASENOR R, Sepulveda-Silva C, Julio-Ramos T, Fuentes-Lopez E, et al
     Phonological and Semantic Fluency in Alzheimer's Disease: A Systematic Review and Meta-Analysis.
     J Alzheimers Dis. 2023 Jul 15. doi: 10.3233/JAD-221272.
     PubMed     Abstract available
     
     
     
884. CHENG C, Yang C, Jia C, Wang Q, et al
     The Role of Cerebellum in Alzheimer's Disease: A Forgotten Research Corner.
     J Alzheimers Dis. 2023 Jul 14. doi: 10.3233/JAD-230381.
     PubMed     Abstract available
     
     
     
885. CHUM PP, Bishara MA, Solis SR, Behringer EJ, et al
     Cerebrovascular miRNAs Track Early Development of Alzheimer's Disease and Target Molecular Markers of Angiogenesis and Blood Flow Regulation.
     J Alzheimers Dis. 2023 Jul 14. doi: 10.3233/JAD-230300.
     PubMed     Abstract available
     
     
     
886. CHEN R, Morris BJ, Donlon TA, Ross GW, et al
     Incidence of Alzheimer's Disease in Men with Late-Life Hypertension Is Ameliorated by FOXO3 Longevity Genotype.
     J Alzheimers Dis. 2023 Jul 14. doi: 10.3233/JAD-230350.
     PubMed     Abstract available
     
     
     
887. XU Y, Vasiljevic E, Deming YK, Jonaitis EM, et al
     Effect of Pathway-Specific Polygenic Risk Scores for Alzheimer's Disease (AD) on Rate of Change in Cognitive Function and AD-Related Biomarkers Among Asymptomatic Individuals.
     J Alzheimers Dis. 2023 Jul 14. doi: 10.3233/JAD-230097.
     PubMed     Abstract available
     
     
     
888. TIO ES, Hohman TJ, Milic M, Bennett DA, et al
     Testing a Polygenic Risk Score for Morphological Microglial Activation in Alzheimer's Disease and Aging.
     J Alzheimers Dis. 2023 Jul 10. doi: 10.3233/JAD-230434.
     PubMed     Abstract available
     
     
     
889. KUDO S, Funayama M, Kurose S, Shimizu Y, et al
     Shadowing Behavior May Be Associated with an Inability to Recognize the External World: A Case Report of Shadowing in a Patient with Posterior Cortical Atrophy.
     J Alzheimers Dis. 2023 Jul 10. doi: 10.3233/JAD-230257.
     PubMed     Abstract available
     
     
     
890. MIGUEL L, Gervais J, Nicolas G, Lecourtois M, et al
     SorLA Protective Function Is Restored by Improving SorLA Protein Maturation in a Subset of Alzheimer's Disease-Associated SORL1 Missense Variants.
     J Alzheimers Dis. 2023 Jul 8. doi: 10.3233/JAD-230211.
     PubMed     Abstract available
     
     
     
891. YANG Y, Lv J, Bai H, Ren L, et al
     Periodontal Status and Saliva Metabolic Signature in Patients with Alzheimer's Disease.
     J Alzheimers Dis. 2023 Jul 7. doi: 10.3233/JAD-230291.
     PubMed     Abstract available
     
     
     
892. XIA ZD, Ma RX, Wen JF, Zhai YF, et al
     Pathogenesis, Animal Models, and Drug Discovery of Alzheimer's Disease.
     J Alzheimers Dis. 2023 Jul 5. doi: 10.3233/JAD-230326.
     PubMed     Abstract available
     
     
     
893. MAO M, Wang C, Hou T, Han X, et al
     Ventricular Electrocardiographic Signatures Associated with Dementia and Plasma Alzheimer's Disease Biomarkers in Older Adults: A Population-Based Study.
     J Alzheimers Dis. 2023 Jul 5. doi: 10.3233/JAD-230056.
     PubMed     Abstract available
     
     
     
894. ZHANG HQ, Chau ACM, Shea YF, Chiu PK, et al
     Disrupted Structural White Matter Network in Alzheimer's Disease Continuum, Vascular Dementia, and Mixed Dementia: A Diffusion Tensor Imaging Study.
     J Alzheimers Dis. 2023 Jul 3. doi: 10.3233/JAD-230341.
     PubMed     Abstract available
     
     
     June 2023
895. CAI HY, Hou SJ, Wen R, Feng QF, et al
     Causal Association Between mTOR-Dependent Protein Levels and Alzheimer's Disease: A Mendelian Randomization Study.
     J Alzheimers Dis. 2023 Jun 30. doi: 10.3233/JAD-230128.
     PubMed     Abstract available
     
     
     
896. AKADA K, Koyama N, Miura Y, Takahashi K, et al
     Nationwide Database Analysis of Risk Factors Associated with Decreased Activities of Daily Living in Patients with Alzheimer's Disease.
     J Alzheimers Dis. 2023 Jun 30. doi: 10.3233/JAD-230106.
     PubMed     Abstract available
     
     
     
897. HANSEN SB
     Cholesterol's Function and Origin in the Alzheimer's Disease Brain.
     J Alzheimers Dis. 2023 Jun 29. doi: 10.3233/JAD-230538.
     PubMed     Abstract available
     
     
     
898. MOBASHERI K, Zaefizadeh M, Ghobeh M, Eidi A, et al
     Synthesis of Novel Magnetic Quercetin-Neuropeptide Nanocomposite as a Smart Nano-Drug Shuttle System: Investigation of Its Effect on Behavior, Histopathological Characteristics, and Expression of MAPT and APP Genes in Alzheimer's Disease Rats.
     J Alzheimers Dis. 2023 Jun 29. doi: 10.3233/JAD-221095.
     PubMed     Abstract available
     
     
     
899. MERTEN N, Pinto AA, Paulsen AJ, Chen Y, et al
     Associations of Midlife Lifestyle and Health Factors with Long-Term Changes in Blood-Based Biomarkers of Alzheimer's Disease and Neurodegeneration.
     J Alzheimers Dis. 2023 Jun 28. doi: 10.3233/JAD-221287.
     PubMed     Abstract available
     
     
     
900. SCHAFER HACKENHAAR F, Josefsson M, Nordin Adolfsson A, Landfors M, et al
     Sixteen-Year Longitudinal Evaluation of Blood-Based DNA Methylation Biomarkers for Early Prediction of Alzheimer's Disease.
     J Alzheimers Dis. 2023 Jun 27. doi: 10.3233/JAD-230039.
     PubMed     Abstract available
     
     
     
901. CHHIMPA N, Singh N, Puri N, Kayath HP, et al
     The Novel Role of Mitochondrial Citrate Synthase and Citrate in the Pathophysiology of Alzheimer's Disease.
     J Alzheimers Dis. 2023 Jun 27. doi: 10.3233/JAD-220514.
     PubMed     Abstract available
     
     
     
902. KANG JM, Shin JH, Kim WR, Seo S, et al
     Effects of the APOEvarepsilon4 Allele on the Relationship Between Tau and Amyloid-beta in Early- and Late-Onset Alzheimer's Disease.
     J Alzheimers Dis. 2023 Jun 24. doi: 10.3233/JAD-230339.
     PubMed     Abstract available
     
     
     
903. SORRENTINO F, Fenoglio C, Sacchi L, Serpente M, et al
     Klotho Gene Expression Is Decreased in Peripheral Blood Mononuclear Cells in Patients with Alzheimer's Disease and Frontotemporal Dementia.
     J Alzheimers Dis. 2023 Jun 24. doi: 10.3233/JAD-230322.
     PubMed     Abstract available
     
     
     
904. ALVES SS, de Oliveira JAC, Lazarini-Lopes W, Servilha-Menezes G, et al
     Audiogenic Seizures in the Streptozotocin-Induced Rat Alzheimer's Disease Model.
     J Alzheimers Dis. 2023 Jun 24. doi: 10.3233/JAD-230153.
     PubMed     Abstract available
     
     
     
905. ZHANG J, Gao S, Liu W
     Bioinformatics-Based Analysis of Circadian Rhythm Regulation Mechanisms in Alzheimer's Disease.
     J Alzheimers Dis. 2023 Jun 23. doi: 10.3233/JAD-230177.
     PubMed     Abstract available
     
     
     
906. AUDRONYTE E, Pakulaite-Kazliene G, Sutnikiene V, Kaubrys G, et al
     Odor Discrimination as a Marker of Early Alzheimer's Disease.
     J Alzheimers Dis. 2023 Jun 23. doi: 10.3233/JAD-230077.
     PubMed     Abstract available
     
     
     
907. KULMINSKI AM, Feng F, Loiko E, Nazarian A, et al
     Prevailing Antagonistic Risks in Pleiotropic Associations with Alzheimer's Disease and Diabetes.
     J Alzheimers Dis. 2023 Jun 22. doi: 10.3233/JAD-230397.
     PubMed     Abstract available
     
     
     
908. JEONG SH, Cha J, Jung JH, Yun M, et al
     Occipital Amyloid Deposition Is Associated with Rapid Cognitive Decline in the Alzheimer's Disease Continuum.
     J Alzheimers Dis. 2023 Jun 22. doi: 10.3233/JAD-230187.
     PubMed     Abstract available
     
     
     
909. HAUTECLOQUE-RAYSZ G, Sellal F, Bousiges O, Phillipi N, et al
     Epileptic Prodromal Alzheimer's Disease Treated with Antiseizure Medications: Medium-Term Outcome of Seizures and Cognition.
     J Alzheimers Dis. 2023 Jun 22. doi: 10.3233/JAD-221197.
     PubMed     Abstract available
     
     
     
910. BELAN AFR, Pais MV, Camargo MVZA, Sant'Ana LCFG, et al
     Diagnostic Performance of an Eye-Tracking Assisted Visual Inference Language Test in the Assessment of Cognitive Decline due to Alzheimer's Disease.
     J Alzheimers Dis. 2023 Jun 21. doi: 10.3233/JAD-230250.
     PubMed     Abstract available
     
     
     
911. CHEN W, Lin C, Su F, Fang Y, et al
     Early Diagnosis of Mild Cognitive Impairment due to Alzheimer's Disease Using a Composite of MemTrax and Blood Biomarkers.
     J Alzheimers Dis. 2023 Jun 21. doi: 10.3233/JAD-230182.
     PubMed     Abstract available
     
     
     
912. FU XX, Wei B, Cao HM, Duan R, et al
     Telmisartan Alleviates Alzheimer's Disease-Related Neuropathologies and Cognitive Impairments.
     J Alzheimers Dis. 2023 Jun 19. doi: 10.3233/JAD-230133.
     PubMed     Abstract available
     
     
     
913. ORTI-CASAN N, Wajant H, Kuiperij HB, Hooijsma A, et al
     Activation of TNF Receptor 2 Improves Synaptic Plasticity and Enhances Amyloid-beta Clearance in an Alzheimer's Disease Mouse Model with Humanized TNF Receptor 2.
     J Alzheimers Dis. 2023 Jun 19. doi: 10.3233/JAD-221230.
     PubMed     Abstract available
     
     
     
914. BOLLINGER RM, Gabel M, Coble DW, Chen SW, et al
     Retention of Study Partners in Longitudinal Studies of Alzheimer Disease.
     J Alzheimers Dis. 2023 Jun 18. doi: 10.3233/JAD-230079.
     PubMed     Abstract available
     
     
     
915. NAKAMURA Y, Omori T, Kim R, Nishiyama K, et al
     Efficacy and Safety of a Transdermal Donepezil Patch in Patients with Mild to Moderate Alzheimer's Disease: Open-Label, Extension Study.
     J Alzheimers Dis. 2023 Jun 14. doi: 10.3233/JAD-230387.
     PubMed     Abstract available
     
     
     
916. YAN R, Wang W, Yang W, Huang M, et al
     Mitochondria-Related Candidate Genes and Diagnostic Model to Predict Late-Onset Alzheimer's Disease and Mild Cognitive Impairment.
     J Alzheimers Dis. 2023 Jun 13. doi: 10.3233/JAD-230314.
     PubMed     Abstract available
     
     
     
917. JIANG WR, Wu W, Yang LJ, Yang W, et al
     Alteration of Cognitive Function in Aging and Alzheimer's Disease Mice Is Related to Dysfunction of the Neuroimmune System.
     J Alzheimers Dis. 2023 Jun 13. doi: 10.3233/JAD-230292.
     PubMed     Abstract available
     
     
     
918. MANSOR NI, Ling KH, Rosli R, Hassan Z, et al
     Centella asiatica (L.) Urban. Attenuates Cell Damage in Hydrogen Peroxide-Induced Oxidative Stress in Transgenic Murine Embryonic Stem Cell Line-Derived Neural-Like Cells: A Preliminary Study for Potential Treatment of Alzheimer's Disease.
     J Alzheimers Dis. 2023 Jun 13. doi: 10.3233/JAD-221233.
     PubMed     Abstract available
     
     
     
919. XU GY, Liu YH, Zeng XQ, Chen DW, et al
     The Diagnostic Potential of Circulating Autoantibodies to Amyloid-beta in Alzheimer's Disease.
     J Alzheimers Dis. 2023 Jun 12. doi: 10.3233/JAD-230252.
     PubMed     Abstract available
     
     
     
920. QAISAR R, Karim A, Iqbal MS, Alkahtani SA, et al
     ACE Inhibitors Improve Skeletal Muscle by Preserving Neuromuscular Junctions in Patients with Alzheimer's Disease.
     J Alzheimers Dis. 2023 Jun 12. doi: 10.3233/JAD-230201.
     PubMed     Abstract available
     
     
     
921. PATEL S, Wei J, Shi Z, Rifkin AS, et al
     Refining Risk for Alzheimer's Disease Among Heterozygous APOEvarepsilon4 Carriers.
     J Alzheimers Dis. 2023 Jun 12. doi: 10.3233/JAD-230156.
     PubMed     Abstract available
     
     
     
922. PEAVY GM
     Can't Have One Without the Other: Study Partner Retention in Alzheimer's Disease Research.
     J Alzheimers Dis. 2023 Jun 10. doi: 10.3233/JAD-230455.
     PubMed     Abstract available
     
     
     
923. VANNINEN A, Lukkarinen H, Kokkola T, Koivisto AM, et al
     Cerebrospinal Fluid Diagnostics of Alzheimer's Disease in Patients with Idiopathic Normal Pressure Hydrocephalus.
     J Alzheimers Dis. 2023 Jun 10. doi: 10.3233/JAD-230144.
     PubMed     Abstract available
     
     
     
924. MILANO C, Hoxhaj D, Del Chicca M, Pascazio A, et al
     Alzheimer's Disease and Neurosyphilis: Meaningful Commonalities and Differences of Clinical Phenotype and Pathophysiological Biomarkers.
     J Alzheimers Dis. 2023 Jun 9. doi: 10.3233/JAD-230170.
     PubMed     Abstract available
     
     
     
925. HU D, Dong X, Wang Q, Liu M, et al
     PCP4 Promotes Alzheimer's Disease Pathogenesis by Affecting Amyloid-beta Protein Precursor Processing.
     J Alzheimers Dis. 2023 Jun 8. doi: 10.3233/JAD-230192.
     PubMed     Abstract available
     
     
     
926. ZHANG X, Liu Y, Huang M, Gunewardena S, et al
     Landscape of Double-Stranded DNA Breaks in Postmortem Brains from Alzheimer's Disease and Non-Demented Individuals.
     J Alzheimers Dis. 2023 Jun 8. doi: 10.3233/JAD-230316.
     PubMed     Abstract available
     
     
     
927. RUDGE JD
     The Lipid Invasion Model: Growing Evidence for This New Explanation of Alzheimer's Disease.
     J Alzheimers Dis. 2023 Jun 3. doi: 10.3233/JAD-221175.
     PubMed     Abstract available
     
     
     May 2023
928. SUN L, Ye KX, Wong HLK, Wang L, et al
     The Effects of Medium Chain Triglyceride for Alzheimer's Disease Related Cognitive Impairment: A Systematic Review and Meta-Analysis.
     J Alzheimers Dis. 2023 May 23. doi: 10.3233/JAD-230406.
     PubMed     Abstract available
     
     
     
929. HAZAN J, Liu K, Fox N, Howard R, et al
     Advancing Diagnostic Certainty in Alzheimer's Disease: A Synthesis of the Diagnostic Process.
     J Alzheimers Dis. 2023 May 23. doi: 10.3233/JAD-230186.
     PubMed     Abstract available
     
     
     
930. FINDLEY CA, McFadden SA, Cox MF, Sime LN, et al
     Prodromal Glutamatergic Modulation with Riluzole Impacts Glucose Homeostasis and Spatial Cognition in Alzheimer's Disease Mice.
     J Alzheimers Dis. 2023 May 23. doi: 10.3233/JAD-221245.
     PubMed     Abstract available
     
     
     
931. LI D, Yu YY, Hu N, Zhang M, et al
     Composite Indices of the Color-Picture Version of Boston Naming Test Have Better Discriminatory Power: Reliability and Validity in a Chinese Sample with Diverse Neurodegenerative Diseases.
     J Alzheimers Dis. 2023 May 23. doi: 10.3233/JAD-221227.
     PubMed     Abstract available
     
     
     
932. GONZALEZ A, Calfio C, Luttges V, Gonzalez-Madrid A, et al
     The Multifactorial Etiopathogenesis of Alzheimer's Disease: Neuroinflammation as the Major Contributor.
     J Alzheimers Dis. 2023 May 20. doi: 10.3233/JAD-230150.
     PubMed     Abstract available
     
     
     
933. LIU M, Li M, He J, He Y, et al
     Chiral Amino Acid Profiling in Serum Reveals Potential Biomarkers for Alzheimer's Disease.
     J Alzheimers Dis. 2023 May 20. doi: 10.3233/JAD-230142.
     PubMed     Abstract available
     
     
     
934. JARHOLM JA, Bjornerud A, Dalaker TO, Akhavi MS, et al
     Medial Temporal Lobe Atrophy in Predementia Alzheimer's Disease: A Longitudinal Multi-Site Study Comparing Staging and A/T/N in a Clinical Research Cohort.
     J Alzheimers Dis. 2023 May 20. doi: 10.3233/JAD-221274.
     PubMed     Abstract available
     
     
     
935. LIU J, Xie Y, Lu Y, Zhao Z, et al
     APP/PS1 Gene-Environmental Cadmium Interaction Aggravates the Progression of Alzheimer's Disease in Mice via the Blood-Brain Barrier, Amyloid-beta, and Inflammation.
     J Alzheimers Dis. 2023 May 20. doi: 10.3233/JAD-221205.
     PubMed     Abstract available
     
     
     
936. KARIMA S, Aghamollaii V, Mahmoodi Baram S, Balenci L, et al
     Boswellic Acids Improve Clinical Cognitive Scores and Reduce Systemic Inflammation in Patients with Mild to Moderate Alzheimer's Disease.
     J Alzheimers Dis. 2023 May 20. doi: 10.3233/JAD-221026.
     PubMed     Abstract available
     
     
     
937. MI Z, Abrahamson EE, Ryu AY, Malek-Ahmadi M, et al
     Vesicular Glutamate Transporter Changes in the Cortical Default Mode Network During the Clinical and Pathological Progression of Alzheimer's Disease.
     J Alzheimers Dis. 2023 May 19. doi: 10.3233/JAD-221063.
     PubMed     Abstract available
     
     
     
938. PUOYAN-MAJD S, Parnow A, Rashno M, Heidarimoghadam R, et al
     The Protective Effects of High-Intensity Interval Training Combined with Q10 Supplementation on Learning and Memory Impairments in Male Rats with Amyloid-beta-Induced Alzheimer's Disease.
     J Alzheimers Dis. 2023 May 18. doi: 10.3233/JAD-230096.
     PubMed     Abstract available
     
     
     
939. MORI H, Yoshino Y, Iga JI, Ochi S, et al
     Aberrant Expression of GABA-Related Genes in the Hippocampus of 3xTg-AD Model Mice from the Early to End Stages of Alzheimer's Disease.
     J Alzheimers Dis. 2023 May 18. doi: 10.3233/JAD-230078.
     PubMed     Abstract available
     
     
     
940. HUI HYH, Ran AR, Dai JJ, Cheung CY, et al
     Deep Reinforcement Learning-Based Retinal Imaging in Alzheimer's Disease: Potential and Perspectives.
     J Alzheimers Dis. 2023 May 18. doi: 10.3233/JAD-230055.
     PubMed     Abstract available
     
     
     
941. ELZAYAT EM, Shahien SA, El-Sherif AA, Hosney M, et al
     miRNAs and Stem Cells as Promising Diagnostic and Therapeutic Targets for Alzheimer's Disease.
     J Alzheimers Dis. 2023 May 18. doi: 10.3233/JAD-221298.
     PubMed     Abstract available
     
     
     
942. QUERRY M, Blanc F, Bousiges O, Philippi N, et al
     Memory Outcome in Prodromal and Mild Dementia with Lewy Bodies and Alzheimer's Disease: A Longitudinal Study.
     J Alzheimers Dis. 2023 May 18. doi: 10.3233/JAD-221243.
     PubMed     Abstract available
     
     
     
943. GONZALEZ C, Mimmack KJ, Amariglio RE, Becker JA, et al
     Associations of the Harvard Automated Phone Task and Alzheimer's Disease Pathology in Cognitively Normal Older Adults: Preliminary Findings.
     J Alzheimers Dis. 2023 May 18. doi: 10.3233/JAD-220885.
     PubMed     Abstract available
     
     
     
944. VOLLOCH V, Rits-Volloch S
     Effect of Lecanemab in Early Alzheimer's Disease: Mechanistic Interpretation in the Amyloid Cascade Hypothesis 2.0 Perspective.
     J Alzheimers Dis. 2023 May 16. doi: 10.3233/JAD-230164.
     PubMed     Abstract available
     
     
     
945. ORTNER M, Lanz K, Goldhardt O, Muller-Sarnowski F, et al
     Elecsys Cerebrospinal Fluid Immunoassays Accurately Detect Alzheimer's Disease Regardless of Concomitant Small Vessel Disease.
     J Alzheimers Dis. 2023 May 16. doi: 10.3233/JAD-221187.
     PubMed     Abstract available
     
     
     
946. WHEELERA CJ
     Evolutionary Selection of APOEvarepsilon4 Encourages Increased Focus on Immunity in Alzheimer's Disease.
     J Alzheimers Dis. 2023 May 13. doi: 10.3233/JAD-230390.
     PubMed     Abstract available
     
     
     
947. DINNERSETIN E
     The Time for Combination Therapy Research in Alzheimer's Disease is Now.
     J Alzheimers Dis. 2023 May 13. doi: 10.3233/JAD-230254.
     PubMed    
     
     
     
948. HIROTA Y, Sakakibara Y, Takei K, Nishijima R, et al
     Alzheimer's Disease-Related Phospho-Tau181 Signals Are Localized to Demyelinated Axons of Parvalbumin-Positive GABAergic Interneurons in an App Knock-In Mouse Model of Amyloid-beta Pathology.
     J Alzheimers Dis. 2023 May 13. doi: 10.3233/JAD-230121.
     PubMed     Abstract available
     
     
     
949. WHITE LR
     If Midlife Brain Injury Is a Risk Factor for Alzheimer's Disease and Related Dementias, What Is the Neuropathologic Mechanism?
     J Alzheimers Dis. 2023 May 12. doi: 10.3233/JAD-230332.
     PubMed     Abstract available
     
     
     
950. TOPPING M, Kim J, Fletcher J
     Area-Level Infant Mortality Exposure in Early Life and Alzheimer's Disease Mortality: Examining Variation Based on Age, Sex, and Place of Birth.
     J Alzheimers Dis. 2023 May 12. doi: 10.3233/JAD-230086.
     PubMed     Abstract available
     
     
     
951. BALIETTI M, Casoli T, Giorgetti B, Colangeli R, et al
     Generation and Characterization of the First Murine Model of Alzheimer's Disease with Mutated AbetaPP Inserted in a BALB/c Background (C.B6/J-APPswe).
     J Alzheimers Dis. 2023 May 11. doi: 10.3233/JAD-230195.
     PubMed     Abstract available
     
     
     
952. CARLOS AF, Machulda MM, Rutledge MH, Nguyen AT, et al
     Comparison of Clinical, Genetic, and Pathologic Features of Limbic and Diffuse Transactive Response DNA-Binding Protein 43 Pathology in Alzheimer's Disease Neuropathologic Spectrum.
     J Alzheimers Dis. 2023 May 11. doi: 10.3233/JAD-221094.
     PubMed     Abstract available
     
     
     
953. EIKELBOOM WS, van den Berg E, Coesmans M, Goudzwaard JA, et al
     Effects of the DICE Method to Improve Timely Recognition and Treatment of Neuropsychiatric Symptoms in Early Alzheimer's Disease at the Memory Clinic: The BEAT-IT Study.
     J Alzheimers Dis. 2023 May 10. doi: 10.3233/JAD-230116.
     PubMed     Abstract available
     
     
     
954. LIN H, Pan T, Wang M, Ge J, et al
     Metabolic Asymmetry Relates to Clinical Characteristics and Brain Network Abnormalities in Alzheimer's Disease.
     J Alzheimers Dis. 2023 May 10. doi: 10.3233/JAD-221258.
     PubMed     Abstract available
     
     
     
955. YAN Y, Wu Y, Xiao G, Wang L, et al
     White Matter Changes as an Independent Predictor of Alzheimer's Disease.
     J Alzheimers Dis. 2023 May 9. doi: 10.3233/JAD-221037.
     PubMed     Abstract available
     
     
     
956. CHENG J, Zheng H, Liu C, Jin J, et al
     Age-Associated UBE2O Reduction Promotes Neuronal Death in Alzheimer's Disease.
     J Alzheimers Dis. 2023 May 6. doi: 10.3233/JAD-221143.
     PubMed     Abstract available
     
     
     
957. LI Y, Chang J, Chen X, Liu J, et al
     Advances in the Study of APOE and Innate Immunity in Alzheimer's Disease.
     J Alzheimers Dis. 2023 May 5. doi: 10.3233/JAD-230179.
     PubMed     Abstract available
     
     
     
958. VIG V, Garg I, Tuz-Zahra F, Xu J, et al
     Vitreous Humor Biomarkers Reflect Pathological Changes in the Brain for Alzheimer's Disease and Chronic Traumatic Encephalopathy.
     J Alzheimers Dis. 2023 May 5. doi: 10.3233/JAD-230167.
     PubMed     Abstract available
     
     
     
959. SACCHI L, Contarino VE, Siggillino S, Carandini T, et al
     Banks of the Superior Temporal Sulcus in Alzheimer's Disease: A Pilot Quantitative Susceptibility Mapping Study.
     J Alzheimers Dis. 2023 May 5. doi: 10.3233/JAD-230095.
     PubMed     Abstract available
     
     
     
960. BLUSZTAJN JK, Slack BE
     Accelerated Breakdown of Phosphatidylcholine and Phosphatidylethanolamine Is a Predominant Brain Metabolic Defect in Alzheimer's Disease.
     J Alzheimers Dis. 2023 May 5. doi: 10.3233/JAD-230061.
     PubMed     Abstract available
     
     
     
961. ABBATE C
     The Adult Neurogenesis Theory of Alzheimer's Disease.
     J Alzheimers Dis. 2023 May 5. doi: 10.3233/JAD-221279.
     PubMed     Abstract available
     
     
     
962. HUGGINS LKL, Min SH, Kaplan S, Wei J, et al
     Meta-Analysis of Variations in Association between APOE varepsilon4 and Alzheimer's Disease and Related Dementias Across Hispanic Regions of Origin.
     J Alzheimers Dis. 2023 May 5. doi: 10.3233/JAD-221167.
     PubMed     Abstract available
     
     
     
963. MOYAERT P, Beun S, Achten E, Clement P, et al
     Effect of Acetylcholinesterase Inhibitors on Cerebral Perfusion and Cognition: A Systematic Review.
     J Alzheimers Dis. 2023 May 5. doi: 10.3233/JAD-221125.
     PubMed     Abstract available
     
     
     
964. BEADELL AV, Zhang Z, Capuano AW, Bennett DA, et al
     Genome-Wide Mapping Implicates 5-Hydroxymethylcytosines in Diabetes Mellitus and Alzheimer's Disease.
     J Alzheimers Dis. 2023 May 5. doi: 10.3233/JAD-221113.
     PubMed     Abstract available
     
     
     April 2023
965. HSIAO WW, Angela S, Le TN, Ku CC, et al
     Evolution of Detecting Early Onset of Alzheimer's Disease: From Neuroimaging to Optical Immunoassays.
     J Alzheimers Dis. 2023 Apr 28. doi: 10.3233/JAD-221202.
     PubMed     Abstract available
     
     
     
966. PRESS DZ, Musaeus CS, Zhao L, Breton J, et al
     Levetiracetam Increases Hippocampal Blood Flow in Alzheimer's Disease as Measured by Arterial Spin Labelling MRI.
     J Alzheimers Dis. 2023 Apr 26. doi: 10.3233/JAD-220614.
     PubMed     Abstract available
     
     
     
967. ZHANG K, Du X, Gao Y, Liu S, et al
     Mesenchymal Stem Cells for Treating Alzheimer's Disease: Cell Therapy and Chemical Reagent Pretreatment.
     J Alzheimers Dis. 2023 Apr 21. doi: 10.3233/JAD-221253.
     PubMed     Abstract available
     
     
     
968. LIU R, Zhang L, You H
     Insulin Resistance and Impaired Branched-Chain Amino Acid Metabolism in Alzheimer's Disease.
     J Alzheimers Dis. 2023 Apr 21. doi: 10.3233/JAD-221147.
     PubMed     Abstract available
     
     
     
969. LIEW Y, Retinasamy T, Arulsamy A, Ali I, et al
     Neuroinflammation: A Common Pathway in Alzheimer's Disease and Epilepsy.
     J Alzheimers Dis. 2023 Apr 17. doi: 10.3233/JAD-230059.
     PubMed     Abstract available
     
     
     
970. LIANG J, LeFleur B, Hussainy S, Perry G, et al
     Gene Co-Expression Analysis of Multiple Brain Tissues Reveals Correlation of FAM222A Expression with Multiple Alzheimer's Disease-Related Genes.
     J Alzheimers Dis. 2023 Apr 17. doi: 10.3233/JAD-221241.
     PubMed     Abstract available
     
     
     
971. OTOKI Y, Yu D, Shen Q, Sahlas DJ, et al
     Quantitative Lipidomic Analysis of Serum Phospholipids Reveals Dissociable Markers of Alzheimer's Disease and Subcortical Cerebrovascular Disease.
     J Alzheimers Dis. 2023 Apr 17. doi: 10.3233/JAD-220795.
     PubMed     Abstract available
     
     
     
972. SINGH M, Jindal D, Kumar R, Pancham P, et al
     Molecular Docking and Network Pharmacology Interaction Analysis of Gingko Biloba (EGB761) Extract with Dual Target Inhibitory Mechanism in Alzheimer's Disease.
     J Alzheimers Dis. 2023 Apr 12. doi: 10.3233/JAD-221222.
     PubMed     Abstract available
     
     
     
973. WILLIAMS E, Mutlu-Smith M, Alex A, Chin XW, et al
     Mid-Adulthood Cognitive Training Improves Performance in a Spatial Task but Does Not Ameliorate Hippocampal Pathology in a Mouse Model of Alzheimer's Disease.
     J Alzheimers Dis. 2023 Apr 12. doi: 10.3233/JAD-221185.
     PubMed     Abstract available
     
     
     
974. STARK J, Hiersche KJ, Yu JC, Hasselbach AN, et al
     Partial Least Squares Regression Analysis of Alzheimer's Disease Biomarkers, Modifiable Health Variables, and Cognitive Change in Older Adults with Mild Cognitive Impairment.
     J Alzheimers Dis. 2023 Apr 12. doi: 10.3233/JAD-221084.
     PubMed     Abstract available
     
     
     
975. HENDRIE HC
     Screening and Assessment for Alzheimer's Disease in the Days of Biological Biomarkers.
     J Alzheimers Dis. 2023 Apr 10. doi: 10.3233/JAD-230215.
     PubMed     Abstract available
     
     
     
976. TIAN J, Stucky C, Wang T, Muma NA, et al
     Mitochondrial Dysfunction Links to Impaired Hippocampal Serotonin Release in a Mouse Model of Alzheimer's Disease.
     J Alzheimers Dis. 2023 Apr 10. doi: 10.3233/JAD-230072.
     PubMed     Abstract available
     
     
     
977. ZHAO Z, Wang J, Wang Y, Liu X, et al
     18F-AV45 PET and MRI Reveal the Influencing Factors of Alzheimer's Disease Biomarkers in Subjective Cognitive Decline Population.
     J Alzheimers Dis. 2023 Apr 10. doi: 10.3233/JAD-221251.
     PubMed     Abstract available
     
     
     
978. EITHZ N, Sorensen J, Sopina L
     Healthcare Costs in the Year Before and After Alzheimer's Disease Diagnosis: A Danish Register-Based Matched Cohort Study.
     J Alzheimers Dis. 2023 Apr 10. doi: 10.3233/JAD-220821.
     PubMed     Abstract available
     
     
     
979. JIA J, Zhang Y, Shi Y, Yina X, et al
     Erratum to: A 19-Year-Old Adolescent with Probable Alzheimer's Disease.
     J Alzheimers Dis. 2023 Apr 5. doi: 10.3233/JAD-239001.
     PubMed    
     
     
     
980. MAO C, You H, Hou B, Chu S, et al
     Differentiation of Alzheimer's Disease from Frontotemporal Dementia and Mild Cognitive Impairment Based on Arterial Spin Labeling Magnetic Resonance Imaging: A Pilot Cross-Sectional Study from PUMCH Dementia Cohort.
     J Alzheimers Dis. 2023 Apr 4. doi: 10.3233/JAD-221023.
     PubMed     Abstract available
     
     
     
981. SULHEIM E, WiderOe M, Back M, Nilsson KPR, et al
     Contrast Enhanced Magnetic Resonance Imaging of Amyloid-beta Plaques in a Murine Alzheimer's Disease Model.
     J Alzheimers Dis. 2023 Apr 3. doi: 10.3233/JAD-220198.
     PubMed     Abstract available
     
     
     
982. QIAN L, Bian W, Wang D, Ming Z, et al
     Adeno-Associated Virus-Mediated Immunotherapy Based on Bispecific Tandem scFv for Alzheimer's Disease.
     J Alzheimers Dis. 2023 Apr 1. doi: 10.3233/JAD-221088.
     PubMed     Abstract available
     
     
     
983. NAGARAJA N, Wang WE, Duara R, DeKosky ST, et al
     Mediation of Reduced Hippocampal Volume by Cerebral Amyloid Angiopathy in Pathologically Confirmed Patients with Alzheimer's Disease.
     J Alzheimers Dis. 2023 Apr 1. doi: 10.3233/JAD-220624.
     PubMed     Abstract available
     
     
     March 2023
984. SAKURAI K, Kaneda D, Morimoto S, Uchida Y, et al
     Voxel-Based and Surface-Based Morphometry Analysis in Patients with Pathologically Confirmed Argyrophilic Grain Disease and Alzheimer's Disease.
     J Alzheimers Dis. 2023 Mar 25. doi: 10.3233/JAD-230068.
     PubMed     Abstract available
     
     
     
985. RAHMANI F, Ghezzi L, Tosti V, Liu J, et al
     Twelve Weeks of Intermittent Caloric Restriction Diet Mitigates Neuroinflammation in Midlife Individuals with Multiple Sclerosis: A Pilot Study with Implications for Prevention of Alzheimer's Disease.
     J Alzheimers Dis. 2023 Mar 25. doi: 10.3233/JAD-221007.
     PubMed     Abstract available
     
     
     
986. ZIYAD SR, Alharbi M, Altulyan M
     Artificial Intelligence Model for Alzheimer's Disease Detection with Convolution Neural Network for Magnetic Resonance Images.
     J Alzheimers Dis. 2023 Mar 23. doi: 10.3233/JAD-221250.
     PubMed     Abstract available
     
     
     
987. SUN Y, Hu HY, Hu H, Huang LY, et al
     Cerebral Small Vessel Disease Burden Predicts Neurodegeneration and Clinical Progression in Prodromal Alzheimer's Disease.
     J Alzheimers Dis. 2023 Mar 23. doi: 10.3233/JAD-221207.
     PubMed     Abstract available
     
     
     
988. FORTEA J, Garcia-Arcelay E, Terrancle A, Galvez B, et al
     Attitudes of Neurologists Toward the Use of Biomarkers in the Diagnosis of Early Alzheimer's Disease.
     J Alzheimers Dis. 2023 Mar 23. doi: 10.3233/JAD-221160.
     PubMed     Abstract available
     
     
     
989. WIDJAYA MA, Cheng YJ, Kuo YM, Liu CH, et al
     Transcriptomic Analyses of Exercise Training in Alzheimer's Disease Cerebral Cortex.
     J Alzheimers Dis. 2023 Mar 23. doi: 10.3233/JAD-221139.
     PubMed     Abstract available
     
     
     
990. NAKAMURA T, Kawarabayashi T, Ueda T, Shimomura S, et al
     Plasma ApoE4 Levels Are Lower than ApoE2 and ApoE3 Levels, and Not Associated with Plasma Abeta 40/42 Ratio as a Biomarker of Amyloid-beta Amyloidosis in Alzheimer's Disease.
     J Alzheimers Dis. 2023 Mar 23. doi: 10.3233/JAD-220996.
     PubMed     Abstract available
     
     
     
991. HOOK G, Kindy M, Hook V
     Cathepsin B Deficiency Improves Memory Deficits and Reduces Amyloid-beta in hAbetaPP Mouse Models Representing the Major Sporadic Alzheimer's Disease Condition.
     J Alzheimers Dis. 2023 Mar 21. doi: 10.3233/JAD-221005.
     PubMed     Abstract available
     
     
     
992. FILLENBAUM GG, Mohs R
     CERAD (Consortium to Establish a Registry for Alzheimer's Disease) Neuropsychology Assessment Battery: 35 Years and Counting.
     J Alzheimers Dis. 2023 Mar 13. doi: 10.3233/JAD-230026.
     PubMed     Abstract available
     
     
     
993. BAYAT S, Roe CM, Schindler S, Murphy SA, et al
     Everyday Driving and Plasma Biomarkers in Alzheimer's Disease: Leveraging Artificial Intelligence to Expand Our Diagnostic Toolkit.
     J Alzheimers Dis. 2023 Mar 13. doi: 10.3233/JAD-221268.
     PubMed     Abstract available
     
     
     
994. DOLCET-NEGRE MM, Imaz Aguayo L, de Eulate RG, Marti-Andres G, et al
     Predicting Conversion from Subjective Cognitive Decline to Mild Cognitive Impairment and Alzheimer's Disease Dementia Using Ensemble Machine Learning.
     J Alzheimers Dis. 2023 Mar 13. doi: 10.3233/JAD-221002.
     PubMed     Abstract available
     
     
     
995. MOON SW, Byun MS, Yi D, Kim MJ, et al
     Low Ankle-Brachial Index Relates to Alzheimer-Signature Cerebral Glucose Metabolism in Cognitively Impaired Older Adults.
     J Alzheimers Dis. 2023 Mar 13. doi: 10.3233/JAD-220911.
     PubMed     Abstract available
     
     
     
996. MAN S, Chen B, Zhang Y, Xu H, et al
     The Associations Between Cataracts and Alzheimer's Disease: A Bidirectional Two-Sample Mendelian Randomization Study.
     J Alzheimers Dis. 2023 Mar 10. doi: 10.3233/JAD-221137.
     PubMed     Abstract available
     
     
     
997. GOLAS AC, Salwierz P, Rajji TK, Bowie CR, et al
     Assessing the Role of Past Depression in Patients with Mild Cognitive Impairment, with and without Biomarkers for Alzheimer's Disease.
     J Alzheimers Dis. 2023 Mar 10. doi: 10.3233/JAD-221097.
     PubMed     Abstract available
     
     
     
998. HE Y, Li J, Yi L, Li X, et al
     Octadecaneuropeptide Ameliorates Cognitive Impairments Through Inhibiting Oxidative Stress in Alzheimer's Disease Models.
     J Alzheimers Dis. 2023 Mar 6. doi: 10.3233/JAD-221115.
     PubMed     Abstract available
     
     
     
999. HOLLENBENDERS Y, Pobiruchin M, Reichenbach A
     Two Routes to Alzheimer's Disease Based on Differential Structural Changes in Key Brain Regions.
     J Alzheimers Dis. 2023 Mar 6. doi: 10.3233/JAD-221061.
     PubMed     Abstract available
     
     
     
1000. BONOMI CG, Assogna M, Di Donna MG, Bernocchi F, et al
      Cerebrospinal Fluid sTREM-2, GFAP, and beta-S100 in Symptomatic Sporadic Alzheimer's Disease: Microglial, Astrocytic, and APOE Contributions Along the Alzheimer's Disease Continuum.
      J Alzheimers Dis. 2023 Mar 6. doi: 10.3233/JAD-221010.
      PubMed     Abstract available
      
      
      
1001. XU S, Xie L, Zhang Y, Wu X, et al
      Inferior Frontal Sulcal Hyperintensity on FLAIR Is Associated with Small Vessel Disease but not Alzheimer's Disease Pathology.
      J Alzheimers Dis. 2023 Mar 6. doi: 10.3233/JAD-220843.
      PubMed     Abstract available
      
      
      
1002. XU Y, Zheng F, Zhong Q, Zhu Y, et al
      Ketogenic Diet as a Promising Non-Drug Intervention for Alzheimer's Disease: Mechanisms and Clinical Implications.
      J Alzheimers Dis. 2023 Mar 4. doi: 10.3233/JAD-230002.
      PubMed     Abstract available
      
      
      
1003. GARCIA-ESCOBAR G, Puig-Pijoan A, Puente-Periz V, Fernandez-Lebrero A, et al
      NEURONORMA Cognitive Battery Associations with Cerebrospinal Fluid Amyloid-beta and Tau Levels in the Continuum of Alzheimer's Disease.
      J Alzheimers Dis. 2023 Mar 4. doi: 10.3233/JAD-220930.
      PubMed     Abstract available
      
      
      
1004. SHAH J, Rahman Siddiquee MM, Krell-Roesch J, Syrjanen JA, et al
      Neuropsychiatric Symptoms and Commonly Used Biomarkers of Alzheimer's Disease: A Literature Review from a Machine Learning Perspective.
      J Alzheimers Dis. 2023 Mar 3. doi: 10.3233/JAD-221261.
      PubMed     Abstract available
      
      
      
1005. LIU H, Reynolds GP, Wei X
      The Influence of Agricultural Work and Plasma Uric Acid on Hospital Admission for Alzheimer's Disease.
      J Alzheimers Dis. 2023 Mar 2. doi: 10.3233/JAD-221226.
      PubMed     Abstract available
      
      
      February 2023
1006. LOUGHMAN A, Adler C, Macpherson H
      Unlocking Modifiable Risk Factors for Alzheimer's Disease: Does the Oral Microbiome Hold Some of the Keys?
      J Alzheimers Dis. 2023 Feb 27. doi: 10.3233/JAD-220760.
      PubMed     Abstract available
      
      
      
1007. SOTO-MERCADO V, Mendivil-Perez M, Velez-Pardo C, Jimenez-Del-Rio M, et al
      Neuroprotective Effect of Combined Treatment with Epigallocatechin 3-Gallate and Melatonin on Familial Alzheimer's Disease PSEN1 E280A Cerebral Spheroids Derived from Menstrual Mesenchymal Stromal Cells.
      J Alzheimers Dis. 2023 Feb 24. doi: 10.3233/JAD-220903.
      PubMed     Abstract available
      
      
      
1008. ATWOOD CS, Perry G
      Russian Roulette with Alzheimer's Disease Patients: Do the Cognitive Benefits of Lecanemab Outweigh the Risk of Edema and Stroke?
      J Alzheimers Dis. 2023 Feb 22. doi: 10.3233/JAD-230040.
      PubMed     Abstract available
      
      
      
1009. WALKER JM, Gonzales MM, Goette W, Farrell K, et al
      Cognitive and Neuropsychological Profiles in Alzheimer's Disease and Primary Age-Related Tauopathy and the Influence of Comorbid Neuropathologies.
      J Alzheimers Dis. 2023 Feb 21. doi: 10.3233/JAD-230022.
      PubMed     Abstract available
      
      
      
1010. DEMARSHALL CA, Viviano J, Emrani S, Thayasivam U, et al
      Early Detection of Alzheimer's Disease-Related Pathology Using a Multi-Disease Diagnostic Platform Employing Autoantibodies as Blood-Based Biomarkers.
      J Alzheimers Dis. 2023 Feb 21. doi: 10.3233/JAD-221091.
      PubMed     Abstract available
      
      
      
1011. ACOSTA-BAENA N, Lopera-Gomez CM, Jaramillo-Elorza MC, Velilla-Jimenez L, et al
      Early Depressive Symptoms Predict Faster Dementia Progression in Autosomal-Dominant Alzheimer's Disease.
      J Alzheimers Dis. 2023 Feb 18. doi: 10.3233/JAD-221294.
      PubMed     Abstract available
      
      
      
1012. YIN W, Wan K, Zhu W, Zhou X, et al
      Bilateral Hippocampal Volume Mediated the Relationship Between Plasma BACE1 Concentration and Memory Function in the Early Stage of Alzheimer's Disease: A Cross-Sectional Study.
      J Alzheimers Dis. 2023 Feb 18. doi: 10.3233/JAD-221174.
      PubMed     Abstract available
      
      
      
1013. DING P, Gorenflo MP, Zhu X, Xu R, et al
      Aspirin Use and Risk of Alzheimer's Disease: A 2-Sample Mendelian Randomization Study.
      J Alzheimers Dis. 2023 Feb 18. doi: 10.3233/JAD-220787.
      PubMed     Abstract available
      
      
      January 2023
1014. MASCARENHAS FONSECA L, Sage Chaytor N, Olufadi Y, Buchwald D, et al
      Intraindividual Cognitive Variability and Magnetic Resonance Imaging in Aging American Indians: Data from the Strong Heart Study.
      J Alzheimers Dis. 2023;91:1395-1407.
      PubMed     Abstract available
      
      
      
1015. SACRIPANTE R, Girtler N, Doglione E, Nobili F, et al
      Forgetting Rates of Prose Memory in Mild Cognitive Impairment.
      J Alzheimers Dis. 2023;91:1385-1394.
      PubMed     Abstract available
      
      
      
1016. HAYS WEEKS CC, Zlatar ZZ, Meloy MJ, Shin DD, et al
      APOE Genotype Modifies the Association of Fusiform Gyrus Cerebral Metabolic Rate of Oxygen Consumption and Object Naming Performance.
      J Alzheimers Dis. 2023;91:1371-1383.
      PubMed     Abstract available
      
      
      
1017. JANSE A, van de Rest O, de Groot LCPGM, Witkamp RF, et al
      The Association of Vitamin D Status with Mild Cognitive Impairment and Dementia Subtypes: A Cross-Sectional Analysis in Dutch Geriatric Outpatients.
      J Alzheimers Dis. 2023;91:1359-1369.
      PubMed     Abstract available
      
      
      
1018. MARIN-MARIN L, Miro-Padilla A, Costumero V
      Structural But Not Functional Connectivity Differences within Default Mode Network Indicate Conversion to Dementia.
      J Alzheimers Dis. 2023;91:1483-1494.
      PubMed     Abstract available
      
      
      
1019. LIU C, Lee SH, Loewenstein DA, Galvin JE, et al
      Early Amnestic Mild Cognitive Impairment Is Associated with Reduced Total Cerebral Blood Flow with no Brain Tissue Loss.
      J Alzheimers Dis. 2023;91:1313-1322.
      PubMed     Abstract available
      
      
      
1020. HUQUE H, Eramudugolla R, Chidiac B, Ee N, et al
      Could Country-Level Factors Explain Sex Differences in Dementia Incidence and Prevalence? A Systematic Review and Meta-Analysis.
      J Alzheimers Dis. 2023;91:1231-1241.
      PubMed     Abstract available
      
      
      
1021. BOUGES S, Fischer BL, Norton DL, Wyman MF, et al
      Effect of Metabolic Syndrome Risk Factors on Processing Speed and Executive Function in Three Racialized Groups.
      J Alzheimers Dis. 2023;92:285-294.
      PubMed     Abstract available
      
      
      
1022. YOSHIDA M, Uemura T, Mizoi M, Waragai M, et al
      Urinary Amino Acid-Conjugated Acrolein and Taurine as New Biomarkers for Detection of Dementia.
      J Alzheimers Dis. 2023;92:361-369.
      PubMed     Abstract available
      
      
      
1023. BAEZ S, Trujillo-Llano C, de Souza LC, Lillo P, et al
      Moral Emotions and Their Brain Structural Correlates Across Neurodegenerative Disorders.
      J Alzheimers Dis. 2023;92:153-169.
      PubMed     Abstract available
      
      
      
1024. HUANG Z
      A Function of Amyloid-beta in Mediating Activity-Dependent Axon/Synapse Competition May Unify Its Roles in Brain Physiology and Pathology.
      J Alzheimers Dis. 2023;92:29-57.
      PubMed     Abstract available
      
      
      
1025. GRASSET L, Power MC, Crivello F, Tzourio C, et al
      How Traumatic Brain Injury History Relates to Brain Health MRI Markers and Dementia Risk: Findings from the 3C Dijon Cohort.
      J Alzheimers Dis. 2023;92:183-193.
      PubMed     Abstract available
      
      
      
1026. CORRERO II AN, Gauthreaux K, Perales-Puchalt J, Chen YC, et al
      Cognitive Aging with Dementia, Mild Cognitive Impairment, or No Impairment: A Comparison of Same- and Mixed-Sex Couples.
      J Alzheimers Dis. 2023;92:109-128.
      PubMed     Abstract available
      
      
      
1027. MOEBIUS HJ, Church KJ
      The Case for a Novel Therapeutic Approach to Dementia: Small Molecule Hepatocyte Growth Factor (HGF/MET) Positive Modulators.
      J Alzheimers Dis. 2023;92:1-12.
      PubMed     Abstract available
      
      
      
1028. YANG M, Qi R, Liu Y, Shen X, et al
      Casein Kinase 1delta Phosphorylates TDP-43 and Suppresses Its Function in Tau mRNA Processing.
      J Alzheimers Dis. 2023;91:1527-1539.
      PubMed     Abstract available
      
      
      
1029. ONO R, Sakurai T, Sugimoto T, Uchida K, et al
      Mortality Risks and Causes of Death by Dementia Types in a Japanese Cohort with Dementia: NCGG-STORIES.
      J Alzheimers Dis. 2023;92:487-498.
      PubMed     Abstract available
      
      
      
1030. GABRIELLI AP, Weidling I, Ranjan A, Wang X, et al
      Mitochondria Profoundly Influence Apolipoprotein E Biology.
      J Alzheimers Dis. 2023;92:591-604.
      PubMed     Abstract available
      
      
      
1031. TAN YJ, Siow I, Saffari SE, Ting SKS, et al
      Plasma Soluble ST2 Levels Are Higher in Neurodegenerative Disorders and Associated with Poorer Cognition.
      J Alzheimers Dis. 2023;92:573-580.
      PubMed     Abstract available
      
      
      
1032. ROYALL DR, Palmer RF
      Multiple Adipokines Predict Dementia Severity as Measured by delta: Replication Across Biofluids and Cohorts.
      J Alzheimers Dis. 2023;92:639-652.
      PubMed     Abstract available
      
      
      
1033. MANN FD, Clouston SAP, Cuevas A, Waszczuk MA, et al
      Genetic Liability, Exposure Severity, and Post-Traumatic Stress Disorder Predict Cognitive Impairment in World Trade Center Responders.
      J Alzheimers Dis. 2023;92:701-712.
      PubMed     Abstract available
      
      
      
1034. TANG M, Su N, Zhang D, Dai Y, et al
      The Differential Effects of APOEvarepsilon4 on Cerebral Volumetric Structures in Different Lifespan in Community-Dwelling Populations.
      J Alzheimers Dis. 2023;92:691-700.
      PubMed     Abstract available
      
      
      
1035. GYLLENHAMMAR M, Rennie A, Padilla DF, Wallert J, et al
      The Association Between Temporal Atrophy and Episodic Memory Is Moderated by Education in a Multi-Center Memory Clinic Sample.
      J Alzheimers Dis. 2023;92:605-614.
      PubMed     Abstract available
      
      
      
1036. JOHNSON CN, McCoin CS, Kueck PJ, Hawley AG, et al
      Relationship of Muscle Apolipoprotein E Expression with Markers of Cellular Stress, Metabolism, and Blood Biomarkers in Cognitively Healthy and Impaired Older Adults.
      J Alzheimers Dis. 2023;92:1027-1035.
      PubMed     Abstract available
      
      
      
1037. TARAWNEH HY, Jayakody DMP, Verma S, Dore V, et al
      Auditory Event-Related Potentials in Older Adults with Subjective Memory Complaints.
      J Alzheimers Dis. 2023;92:1093-1109.
      PubMed     Abstract available
      
      
      
1038. KANIA B, Sotelo A, Ty D, Wisco JJ, et al
      The Prevention of Inflammation and the Maintenance of Iron and Hepcidin Homeostasis in the Gut, Liver, and Brain Pathologies.
      J Alzheimers Dis. 2023;92:769-789.
      PubMed     Abstract available
      
      
      
1039. LI QY, Li XM, Hu HY, Ma YH, et al
      Associations of Lung Function Decline with Risks of Cognitive Impairment and Dementia: A Meta-Analysis and Systematic Review.
      J Alzheimers Dis. 2023;92:853-873.
      PubMed     Abstract available
      
      
      
1040. WELBERRY HJ, Chau T, Heffernan M, San Jose JC, et al
      Factors Associated with Participation in a Multidomain Web-Based Dementia Prevention Trial: Evidence from Maintain Your Brain (MYB).
      J Alzheimers Dis. 2023;92:959-974.
      PubMed     Abstract available
      
      
      
1041. KIM BS, Jun S, Kim H
      Cognitive Trajectories and Associated Biomarkers in Patients with Mild Cognitive Impairment.
      J Alzheimers Dis. 2023;92:803-814.
      PubMed     Abstract available
      
      
      
1042. ZHANG F, Niu L, Zhong R, Li S, et al
      Chronic Sleep Disturbances Alters Sleep Structure and Tau Phosphorylation in AbetaPP/PS1 AD Mice and Their Wild-Type Littermates.
      J Alzheimers Dis. 2023;92:1341-1355.
      PubMed     Abstract available
      
      
      
1043. BUKHBINDER AS, Hinojosa M, Harris K, Li X, et al
      Population-Based Mini-Mental State Examination Norms in Adults of Mexican Heritage in the Cameron County Hispanic Cohort.
      J Alzheimers Dis. 2023;92:1323-1339.
      PubMed     Abstract available
      
      
      
1044. KAWAKATSU S, Kobayashi R
      Towards Improved Clinical Diagnosis of Argyrophilic Grain Disease Using Brain Imaging.
      J Alzheimers Dis. 2023;93:389-392.
      PubMed     Abstract available
      
      
      
1045. PARKA A, Volbracht C, Hall B, Bastlund JF, et al
      Visual Evoked Potentials as an Early-Stage Biomarker in the rTg4510 Tauopathy Mouse Model.
      J Alzheimers Dis. 2023;93:247-262.
      PubMed     Abstract available
      
      
      
1046. GAO Y, Liu Y, Zhang Y, Wang Y, et al
      Olfactory Threshold Test as a Quick Screening Tool for Cognitive Impairment: Analysis of Two Independent Cohorts.
      J Alzheimers Dis. 2023;93:169-178.
      PubMed     Abstract available
      
      
      
1047. TETLOW AM, Jackman BM, Alhadidy MM, Perumal V, et al
      Influence of Host Age on Intracranial AAV9 TauP301L Induced Tauopathy.
      J Alzheimers Dis. 2023;93:365-378.
      PubMed     Abstract available
      
      
      
1048. RODRIGUES MARTINS D, Vandermeeren M, Van Kolen K, Brepoels E, et al
      Development and Characterization of Mouse-Specific Anti-Tau Monoclonal Antibodies: Relevance for Analysis of Murine Tau in Cerebrospinal Fluid.
      J Alzheimers Dis. 2023;93:151-167.
      PubMed     Abstract available
      
      
      
1049. LV X, Chu M, Liu Y, Jing D, et al
      Neurofunctional Correlates of Activities of Daily Living in Patients with Posterior Cortical Atrophy.
      J Alzheimers Dis. 2023;93:295-305.
      PubMed     Abstract available
      
      
      
1050. JANG S, Chorna N, Rodriguez-Graciani KM, Inyushin M, et al
      The Effects of Amyloid-beta on Metabolomic Profiles of Cardiomyocytes and Coronary Endothelial Cells.
      J Alzheimers Dis. 2023;93:307-319.
      PubMed     Abstract available
      
      
      
1051. LANOOIJ SD, Eisel ULM, van der Zee EA, Kas MJH, et al
      Variation in Group Composition Alters an Early-Stage Social Phenotype in hAPP-Transgenic J20 Mice.
      J Alzheimers Dis. 2023;93:211-224.
      PubMed     Abstract available
      
      
      
1052. UMFLEET LG, Bilder RM, Loring DW, Thames A, et al
      The Future of Cognitive Screening in Neurodegenerative Diseases.
      J Alzheimers Dis. 2023;93:47-59.
      PubMed     Abstract available
      
      
      
1053. KREBS C, Brill E, Minkova L, Federspiel A, et al
      Investigating Compensatory Brain Activity in Older Adults with Subjective Cognitive Decline.
      J Alzheimers Dis. 2023;93:107-124.
      PubMed     Abstract available
      
      
      
1054. WEIDUNG B, Lovheim H, Littbrand H, Wahlin J, et al
      Temporal Dementia and Cognitive Impairment Trends in the Very Old in the 21st Century.
      J Alzheimers Dis. 2023;93:61-74.
      PubMed     Abstract available
      
      
      
1055. GRISANTI SG, Massa F, Chincarini A, Pretta S, et al
      Discrepancy Between Patient and Caregiver Estimate of Apathy Predicts Dementia in Patients with Amnestic Mild Cognitive Impairment.
      J Alzheimers Dis. 2023;93:75-86.
      PubMed     Abstract available
      
      
      
1056. FLETCHER E
      Multifactorial Modeling of Cognitive Trajectories Using an Advanced Regression Technique: Improving Our Understanding of Biomarkers and Modifiable Variables that Support Cognition.
      J Alzheimers Dis. 2023;93:815-819.
      PubMed     Abstract available
      
      
      
1057. CASTELLANI RJ, Shanes ED, McCord M, Reish NJ, et al
      Neuropathology of Anti-Amyloid-beta Immunotherapy: A Case Report.
      J Alzheimers Dis. 2023;93:803-813.
      PubMed     Abstract available
      
      
      
1058. XIAO Y, Liao L, Huang K, Yao S, et al
      Coupling Between Hippocampal Parenchymal Fraction and Cortical Grey Matter Atrophy at Different Stages of Cognitive Decline.
      J Alzheimers Dis. 2023;93:791-801.
      PubMed     Abstract available
      
      
      
1059. HICKEY M, Hueg TK, Priskorn L, Uldbjerg CS, et al
      Depression in Mid- and Later-Life and Risk of Dementia in Women: A Prospective Study within the Danish Nurses Cohort.
      J Alzheimers Dis. 2023;93:779-789.
      PubMed     Abstract available
      
      
      
1060. CHEN CD, Ponisio MR, Lang JA, Flores S, et al
      Comparing Tau PET Visual Interpretation with Tau PET Quantification, Cerebrospinal Fluid Biomarkers, and Longitudinal Clinical Assessment.
      J Alzheimers Dis. 2023;93:765-777.
      PubMed     Abstract available
      
      
      
1061. HATTORI Y, Saito S, Nakaoku Y, Ogata S, et al
      Taxifolin for Cognitive Preservation in Patients with Mild Cognitive Impairment or Mild Dementia.
      J Alzheimers Dis. 2023;93:743-754.
      PubMed     Abstract available
      
      
      
1062. ZHANG LY, Wang DZ, Wang J, Guo L, et al
      Associations of Serum Antimicrobial Peptide LL-37 with Longitudinal Cognitive Decline and Neurodegeneration Among Older Adults with Memory Complaints.
      J Alzheimers Dis. 2023;93:595-603.
      PubMed     Abstract available
      
      
      
1063. AGUILAR-BARBERA M, Soler-Girabau P, Tabuenca-Martin AI, Prieto-Del Val L, et al
      Fortasyn Connect Improves Neuropsychiatric Symptoms in Patients with Mild Cognitive Impairment and Dementia: Results from a Retrospective Real-World Study.
      J Alzheimers Dis. 2023;93:621-631.
      PubMed     Abstract available
      
      
      
1064. SIBLE IJ, Nation DA
      Visit-to-Visit Blood Pressure Variability and Cognitive Decline in Apolipoprotein varepsilon4 Carriers versus Apolipoprotein varepsilon3 Homozygotes.
      J Alzheimers Dis. 2023;93:533-543.
      PubMed     Abstract available
      
      
      
1065. BISWAS R, Kawas C, Montine TJ, Bukhari SA, et al
      Superior Global Cognition in Oldest-Old Is Associated with Resistance to Neurodegenerative Pathologies: Results from The 90+ Study.
      J Alzheimers Dis. 2023;93:561-575.
      PubMed     Abstract available
      
      
      
1066. BROOK ES, D'Alonzo ZJ, Lam V, Chan DC, et al
      Plasma Amyloid-beta Homeostasis Is Associated with Body Mass Index and Weight Loss in People with Overweight and Obesity.
      J Alzheimers Dis. 2023;93:653-664.
      PubMed     Abstract available
      
      
      
1067. RHYU JM, Park J, Shin BS, Kim YE, et al
      A Novel c.800G>C Variant of the ITM2B Gene in Familial Korean Dementia.
      J Alzheimers Dis. 2023;93:403-409.
      PubMed     Abstract available
      
      
      
1068. DUFF K, Wan L, Embree L, Hoffman JM, et al
      Change in the Quick Dementia Rating System Across Time in Older Adults with and without Cognitive Impairment.
      J Alzheimers Dis. 2023;93:449-457.
      PubMed     Abstract available
      
      
      
1069. ZHANG J, Zhang T, Wang Y, Yao L, et al
      Galpha13-Mediated Signaling Cascade Is Related to the Tau Pathology Caused by Anesthesia and Surgery in 5XFAD Transgenic Mice.
      J Alzheimers Dis. 2023;93:545-560.
      PubMed     Abstract available
      
      
      
1070. IMAI A, Matsuoka T, Narumoto J
      Emotional Dysregulation in Mild Behavioral Impairment Is Associated with Reduced Cortical Thickness in the Right Supramarginal Gyrus.
      J Alzheimers Dis. 2023;93:521-532.
      PubMed     Abstract available
      
      
      
1071. ZHENG YB, Sun J, Shi L, Su SZ, et al
      Association of Caffeine Consumption and Brain Amyloid Positivity in Cognitively Normal Older Adults.
      J Alzheimers Dis. 2023;93:483-493.
      PubMed     Abstract available
      
      
      
1072. NOBLE JM, Papapanou PN
      With Teeth, Broken, or Fixed: The Challenges of Linking Periodontitis, Neuroepidemiology, and Biomarkers of Disease.
      J Alzheimers Dis. 2023;93:991-994.
      PubMed     Abstract available
      
      
      
1073. GOLLOP C, Zingel R, Jacob L, Smith L, et al
      Incidence of Newly-Diagnosed Dementia After COVID-19 Infection versus Acute Upper Respiratory Infection: A Retrospective Cohort Study.
      J Alzheimers Dis. 2023;93:1033-1040.
      PubMed     Abstract available
      
      
      
1074. FAN J, Zhu Z, Chen Y, Yang C, et al
      SORL1 rs1699102 Moderates the Effect of Sex on Language Network.
      J Alzheimers Dis. 2023;93:1051-1063.
      PubMed     Abstract available
      
      
      
1075. WU J, Su Y, Chen Y, Zhu W, et al
      A Surface-Based Federated Chow Test Model for Integrating APOE Status, Tau Deposition Measure, and Hippocampal Surface Morphometry.
      J Alzheimers Dis. 2023;93:1153-1168.
      PubMed     Abstract available
      
      
      
1076. JIANG C, Wang Y, Dong Y, Liu R, et al
      Associations of Microvascular Dysfunction with Mild Cognitive Impairment and Cognitive Function Among Rural-Dwelling Older Adults in China.
      J Alzheimers Dis. 2023;93:1111-1124.
      PubMed     Abstract available
      
      
      
1077. MARSHALL AJ, Gaubert A, Kapoor A, Tan A, et al
      Blood-Derived Progenitor Cells Are Depleted in Older Adults with Cognitive Impairment: A Role for Vascular Resilience?
      J Alzheimers Dis. 2023;93:1041-1050.
      PubMed     Abstract available
      
      
      
1078. NIJSKENS C, Henstra M, Rhodius-Meester H, Yasar S, et al
      Cardiovascular Risk Management in Persons with Dementia.
      J Alzheimers Dis. 2023;93:879-889.
      PubMed     Abstract available
      
      
      
1079. GIBBONS LE, Power MC, Walker RL, Kumar RG, et al
      Association of Traumatic Brain Injury with Late Life Neuropathological Outcomes in a Community-Based Cohort.
      J Alzheimers Dis. 2023;93:949-961.
      PubMed     Abstract available
      
      
      
1080. SMITH CJ, Ashford JW
      Apolipoprotein varepsilon4-Associated Protection Against Pediatric Enteric Infections Is a Survival Advantage in Pre-Industrial Populations.
      J Alzheimers Dis. 2023;93:907-918.
      PubMed     Abstract available
      
      
      
1081. BAUERNSCHMIDT D, Hirt J, Langer G, Meyer G, et al
      Technology-Based Counselling for People with Dementia and Their Informal Carers: A Systematic Review and Meta-Analysis.
      J Alzheimers Dis. 2023;93:891-906.
      PubMed     Abstract available
      
      
      
1082. PILONIETA G, Pisu M, Martin RC, Shan L, et al
      Specialist Availability and Drug Adherence in Older Adults with Dementia Across Regions of the United States.
      J Alzheimers Dis. 2023;93:927-937.
      PubMed     Abstract available
      
      
      
1083. XIANG Q, Andersen SL, Sweigart B, Gunn S, et al
      Signatures of Neuropsychological Test Results in the Long Life Family Study: A Cluster Analysis.
      J Alzheimers Dis. 2023;93:1457-1469.
      PubMed     Abstract available
      
      
      
1084. BEST MN, Lim Y, Ferenc NN, Kim N, et al
      Extracellular Tau Oligomers Damage the Axon Initial Segment.
      J Alzheimers Dis. 2023;93:1425-1441.
      PubMed     Abstract available
      
      
      
1085. XU S, Ren Y, Liu R, Li Y, et al
      Prevalence and Progression of Subjective Cognitive Decline Among Rural Chinese Older Adults: A Population-Based Study.
      J Alzheimers Dis. 2023;93:1355-1368.
      PubMed     Abstract available
      
      
      
1086. YANG F, Yang L, Fang X, Deng Y, et al
      Increased Cerebrospinal Fluid Levels of Soluble Triggering Receptor Expressed on Myeloid Cells 2 and Chitinase-3-Like Protein 1 in Idiopathic Normal-Pressure Hydrocephalus.
      J Alzheimers Dis. 2023;93:1341-1354.
      PubMed     Abstract available
      
      
      
1087. NALLAPU BT, Petersen KK, Lipton RB, Grober E, et al
      Association of Alcohol Consumption with Cognition in Older Population: The A4 Study.
      J Alzheimers Dis. 2023;93:1381-1393.
      PubMed     Abstract available
      
      
      
1088. ANDERSSON MJ, Stone J
      Best Medicine for Dementia: The Life-Long Defense of the Brain.
      J Alzheimers Dis. 2023;94:51-66.
      PubMed     Abstract available
      
      
      
1089. DI J, Nelson RS, Jicha GA, Moga DC, et al
      Urinary Incontinence in a Community-Based Autopsy Cohort Is Associated with Limbic Predominant Age-Related TDP-43 Encephalopathy Neuropathologic Changes.
      J Alzheimers Dis. 2023;94:333-346.
      PubMed     Abstract available
      
      
      
1090. MEDURI G, Guillemeau K, Daguinot C, Dounane O, et al
      Concomitant Neuronal Tau Deposition and FKBP52 Decrease Is an Early Feature of Different Human and Experimental Tauopathies.
      J Alzheimers Dis. 2023;94:313-331.
      PubMed     Abstract available
      
      
      
1091. SINHA N, Fausto BA, Mander B, Gluck MA, et al
      High-Quality Sleep Mitigates ABCA7-Related Generalization Deficits in Healthy Older African Americans.
      J Alzheimers Dis. 2023;94:281-290.
      PubMed     Abstract available
      
      
      
1092. BUAWANGPONG N, Pinyopornpanish K, Phinyo P, Jiraporncharoen W, et al
      Effect of Comorbidities on Ten-Year Survival in Patients with Dementia.
      J Alzheimers Dis. 2023;94:163-175.
      PubMed     Abstract available
      
      
      
1093. DE ANDA-DURAN I, Kolachalama VB, Carmichael OT, Hwang PH, et al
      Midlife Neuropsychological Profiles and Associated Vascular Risk: The Bogalusa Heart Study.
      J Alzheimers Dis. 2023;94:101-113.
      PubMed     Abstract available
      
      
      
1094. LOUGHREY DG, Leroi I
      Understanding the Association Between Sensory Impairment and Dementia: Toward Informing Future Research and Health Policy.
      J Alzheimers Dis. 2023;94:597-599.
      PubMed     Abstract available
      
      
      
1095. OLIVEIRA FF
      Looking Behind the Curtain: Patient Stratification According to Genetic or Demographic Factors May Yield Unexpected Results in Studies of Neurodegenerative Diseases.
      J Alzheimers Dis. 2023;94:777-780.
      PubMed     Abstract available
      
      
      
1096. CURTIS ME, Smith T, Nenov M, Blass BE, et al
      Retromer Stabilization Improves Cognitive Function and Synaptic Plasticity in a Mouse Model of Down Syndrome.
      J Alzheimers Dis. 2023;94:513-518.
      PubMed     Abstract available
      
      
      
1097. LI B, Shi K, Ren C, Kong M, et al
      Detection of Tau-PET Positivity in Clinically Diagnosed Mild Cognitive Impairment with Multidimensional Features.
      J Alzheimers Dis. 2023;94:627-640.
      PubMed     Abstract available
      
      
      
1098. TOCCACELI BLASI M, Valletta M, Trebbastoni A, D'Antonio F, et al
      Sundowning in Patients with Dementia: Identification, Prevalence, and Clinical Correlates.
      J Alzheimers Dis. 2023;94:601-610.
      PubMed     Abstract available
      
      
      
1099. WANG J, Wang M, Ren S, Huang L, et al
      The Effect of Gender and APOE varepsilon4 Status on Brain Amyloid-beta Deposition in Different Age Groups of Mild Cognitively Impaired Individuals: A PET-CT Study.
      J Alzheimers Dis. 2023;94:763-775.
      PubMed     Abstract available
      
      
      
1100. FARINA FR, Booi L, Occhipinti JA, Quoidbach V, et al
      Young Adult Brain Capital: A New Opportunity for Dementia Prevention.
      J Alzheimers Dis. 2023;94:415-423.
      PubMed     Abstract available
      
      
      
1101. MAURER A, Himmel G, Lange C, Mathies F, et al
      Individualized Summary Assessment of Detailed Neuropsychological Testing for the Etiological Diagnosis of Newly Detected Cognitive Impairment in Hospitalized Geriatric Patients.
      J Alzheimers Dis. 2023;94:559-584.
      PubMed     Abstract available
      
      
      
1102. EDWARDS L, Thomas KR, Weigand AJ, Edmonds EC, et al
      White Matter Hyperintensity Volume and Amyloid-PET Synergistically Impact Memory Independent of Tau-PET in Older Adults Without Dementia.
      J Alzheimers Dis. 2023;94:695-707.
      PubMed     Abstract available
      
      
      
1103. CHOU OHI, Zhou J, Li L, Chan JSK, et al
      The Association Between Neutrophil-Lymphocyte Ratio and Variability with New-Onset Dementia: A Population-Based Cohort Study.
      J Alzheimers Dis. 2023;94:547-557.
      PubMed     Abstract available
      
      
      
1104. LI T, Pappas C, Klinedinst B, Pollpeter A, et al
      Associations Between Insulin-Like Growth Factor-1 and Resting-State Functional Connectivity in Cognitively Unimpaired Midlife Adults.
      J Alzheimers Dis. 2023;94.
      PubMed     Abstract available
      
      
      
1105. KOSTEV K
      Sex-Related Differences in the Association Between Body Mass Index and Dementia Risk.
      J Alzheimers Dis. 2023;94:961-962.
      PubMed     Abstract available
      
      
      
1106. CASTELBLANCO-TORO SM, Jurado-Delgado J, Meneses-Bernal JF, Santacruz-Escudero JM, et al
      Fear of Falling as a Behavioral Symptom in Neurocognitive Impaired Patients: Evidence from an Underrepresented Population.
      J Alzheimers Dis. 2023;94:1197-1207.
      PubMed     Abstract available
      
      
      
1107. CUBERO-PLAZAS L, Sancho-Cantus D, de la Rubia Orti JE, Prieto-Contreras L, et al
      Impact of Family Function on the Quality of Life and Health Perception of Non-Institutionalized Dementia Patients.
      J Alzheimers Dis. 2023;94:963-975.
      PubMed     Abstract available
      
      
      
1108. PANZA F, Solfrizzi V, Sardone R, Dibello V, et al
      Depressive and Biopsychosocial Frailty Phenotypes: Impact on Late-life Cognitive Disorders.
      J Alzheimers Dis. 2023;94:879-898.
      PubMed     Abstract available
      
      
      
1109. BAYRAM E, Holden SK, Fullard M, Armstrong MJ, et al
      Race and Ethnicity in Lewy Body Dementia: A Narrative Review.
      J Alzheimers Dis. 2023;94:861-878.
      PubMed     Abstract available
      
      
      
1110. WANG G, Li DY, Vance DE, Li W, et al
      Alcohol Use Disorder as a Risk Factor for Cognitive Impairment.
      J Alzheimers Dis. 2023;94:899-907.
      PubMed     Abstract available
      
      
      
1111. CAILLAUD M, Maltezos S, Hudon C, Mellah S, et al
      Hippocampal Volume and Episodic Associative Memory Identify Memory Risk in Subjective Cognitive Decline Individuals in the CIMA-Q Cohort, Regardless of Cognitive Reserve Level and APOE4 Status.
      J Alzheimers Dis. 2023;94:1047-1056.
      PubMed     Abstract available
      
      
      
1112. CHWA WJ, Lopez OL, Longstreth WT, Dai W, et al
      Longitudinal Patterns of Brain Changes in a Community Sample in Relation to Aging and Cognitive Status.
      J Alzheimers Dis. 2023;94:1035-1045.
      PubMed     Abstract available
      
      
      
1113. SANDISON H, Callan NGL, Rao RV, Phipps J, et al
      Observed Improvement in Cognition During a Personalized Lifestyle Intervention in People with Cognitive Decline.
      J Alzheimers Dis. 2023;94:993-1004.
      PubMed     Abstract available
      
      
      
1114. LI D, Yang H, Lyu M, Wang J, et al
      Acupuncture Therapy on Dementia: Explained with an Integrated Analysis on Therapeutic Targets and Associated Mechanisms.
      J Alzheimers Dis. 2023;94.
      PubMed     Abstract available
      
      
      
1115. GOTTSCHALK WK, Mahon S, Hodgson D, Barrera J, et al
      The APOE-TOMM40 Humanized Mouse Model: Characterization of Age, Sex, and PolyT Variant Effects on Gene Expression.
      J Alzheimers Dis. 2023;94:1563-1576.
      PubMed     Abstract available
      
      
      
1116. SUSAC J, Vukojevic J, Debogovic S, Bajic Z, et al
      Share of and Absolute Costs of Informal Care in Five Subpopulations of Outpatients with Dementia in Croatia: A Latent Profile Analysis.
      J Alzheimers Dis. 2023;94:1417-1430.
      PubMed     Abstract available
      
      
      
1117. BAYER TA, Jiang L, Erqou S, Kunicki ZJ, et al
      Incidence of New Dementia Diagnosis in Veterans Admitted to Nursing Homes After Heart Failure Hospitalization.
      J Alzheimers Dis. 2023;94:1397-1404.
      PubMed     Abstract available
      
      
      
1118. LANSDELL TA, Xu H, Galligan JJ, Dorrance AM, et al
      Effects of Striatal Amyloidosis on the Dopaminergic System and Behavior: A Comparative Study in Male and Female 5XFAD Mice.
      J Alzheimers Dis. 2023;94:1361-1375.
      PubMed     Abstract available
      
      
      
1119. YABUUCHI K, Kimura N, Masuda T, Matsubara E, et al
      Comparison of Brain Amyloid Deposition and Cortical Glucose Metabolism Between Clinic- and Community-Based Cohort.
      J Alzheimers Dis. 2023;95:299-306.
      PubMed     Abstract available
      
      
      
1120. HUANG L, Li Y, Wu J, Chen N, et al
      Shanghai Cognitive Screening: A Mobile Cognitive Assessment Tool Using Voice Recognition to Detect Mild Cognitive Impairment and Dementia in the Community.
      J Alzheimers Dis. 2023;95:227-236.
      PubMed     Abstract available
      
      
      
1121. CASTILLO C, Bravo-Arrepol G, Wendt A, Saez-Orellana F, et al
      Neuroprotective Properties of Eudesmin on a Cellular Model of Amyloid-beta Peptide Toxicity.
      J Alzheimers Dis. 2023;94.
      PubMed     Abstract available
      
      
      
1122. NORRIS CM
      Is It Time to Repurpose Calcineurin Inhibitors for the Treatment of Cognitive Impairment and Dementia?
      J Alzheimers Dis. 2023;95:599-602.
      PubMed     Abstract available
      
      
      
1123. PANIKKAR D, Vivek S, Crimmins E, Faul J, et al
      Pre-Analytical Variables Influencing Stability of Blood-Based Biomarkers of Neuropathology.
      J Alzheimers Dis. 2023;95:735-748.
      PubMed     Abstract available
      
      
      
1124. PASSMORE SR, Longhurst C, Gerbitz A, Green-Harris G, et al
      "I Want to Know Everything ... ": The Return of Research Results and the Importance of Transparency in the Acceptability of Lumbar Punctures for African American Older Adults.
      J Alzheimers Dis. 2023;95:663-675.
      PubMed     Abstract available
      
      
      
1125. ROSALES-LAGARDE A, Cubero-Rego L, Menendez-Conde F, Rodriguez-Torres EE, et al
      Dissociation of Arousal Index Between REM and NREM Sleep in Elderly Adults with Cognitive Impairment, No Dementia: A Pilot Study.
      J Alzheimers Dis. 2023;95:477-491.
      PubMed     Abstract available
      
      
      
1126. VOLGMAN AS, Engelstein E, Aggarwal NT
      Vascular Cognitive Impairment: A Little Bit of Good News for Women or Bad News for Men?
      J Alzheimers Dis. 2023;95:407-409.
      PubMed     Abstract available
      
      
      
1127. MIYAWAKI CE, McClellan A, Bouldin ED, Brohard C, et al
      Feasibility and Efficacy of Life Review Delivered by Virtually-Trained Family Caregivers.
      J Alzheimers Dis. 2023;95:573-583.
      PubMed     Abstract available
      
      
      
1128. MACYCZKO JR, Wang N, Lu W, Jeevaratnam S, et al
      Upregulation of sFRP1 Is More Profound in Female than Male 5xFAD Mice and Positively Associated with Amyloid Pathology.
      J Alzheimers Dis. 2023;95:399-405.
      PubMed     Abstract available
      
      
      
1129. BOGDAN A, Fabre R, Desmidt T, Golebiowski J, et al
      Different Trajectories of Apathy and Depression Among Subjective Cognitive Impairment Individuals with or without Conversion to Dementia: Results from the Memento Cohort in France.
      J Alzheimers Dis. 2023;95:415-426.
      PubMed     Abstract available
      
      
      
1130. GUEVARA JE, Kurniadi NE, Duff K
      Assessing Longitudinal Cognitive Change in Mild Cognitive Impairment Using Estimated Standardized Regression-Based Formulas.
      J Alzheimers Dis. 2023;95:509-521.
      PubMed     Abstract available
      
      
      
1131. NG PY, Zhang C, Li H, Baker DJ, et al
      Senescent Microglia Represent a Subset of Disease-Associated Microglia in P301S Mice.
      J Alzheimers Dis. 2023;95:493-507.
      PubMed     Abstract available
      
      
      
1132. LOPES DAS NEVES P, Duraes J, Silva-Spinola A, Lima M, et al
      Serum Neurofilament Light Chain in the Diagnostic Evaluation of Patients with Cognitive Symptoms in the Neurological Consultation of a Tertiary Center.
      J Alzheimers Dis. 2023;95:391-397.
      PubMed     Abstract available
      
      
      
1133. DALY T
      JAD: A Forum for Philosophy in Science.
      J Alzheimers Dis. 2023;95:411-413.
      PubMed     Abstract available
      
      
      
1134. HUA S, Peters BA, Lee S, Fitzgerald K, et al
      Gut Microbiota and Cognitive Function Among Women Living with HIV.
      J Alzheimers Dis. 2023;95:1147-1161.
      PubMed     Abstract available
      
      
      
1135. COSTA T, Premi E, Liloia D, Cauda F, et al
      Unleashing the Power of Bayesian Re-Analysis: Enhancing Insights into Lecanemab (Clarity AD) Phase III Trial Through Informed t-Test.
      J Alzheimers Dis. 2023;95:1059-1065.
      PubMed     Abstract available
      
      
      
1136. POZZI FE, Appollonio I, Ferrarese C, Tremolizzo L, et al
      Can Traditional Board Games Prevent or Slow Down Cognitive Impairment? A Systematic Review and Meta-Analysis.
      J Alzheimers Dis. 2023;95:829-845.
      PubMed     Abstract available
      
      
      
1137. AL-LAHHAM R, Mendez N
      Tau Loss of Function, by Deletion or Aggregation, Contributes to Peripheral Insulin Resistance.
      J Alzheimers Dis. 2023;95:1041-1058.
      PubMed     Abstract available
      
      
      
1138. VASSILAKI M, Fu S, Christenson LR, Garg M, et al
      Characterizing Performance Gaps of a Code-Based Dementia Algorithm in a Population-Based Cohort of Cognitive Aging.
      J Alzheimers Dis. 2023;95:931-940.
      PubMed     Abstract available
      
      
      
1139. DI GIOIA C, Santonico M, Zompanti A, Sabatini A, et al
      Detecting Dementia by Saliva Analysis: A Fingerprinting Unobtrusive Method Based on a Fast and Cheap Sensor System.
      J Alzheimers Dis. 2023;95:1067-1075.
      PubMed     Abstract available
      
      
      
1140. FLEISCHMAN DA, Arfanakis K, Zhang S, Leurgans SE, et al
      Acculturation in Context and Brain Health in Older Latino Adults: A Diffusion Tensor Imaging Study.
      J Alzheimers Dis. 2023;95:1585-1595.
      PubMed     Abstract available
      
      
      
1141. WANG S, Liu S, Ke S, Zhou W, et al
      APOEvarepsilon4 Status and Plasma p-tau181 Levels May Influence Memory and Executive Function Decline in Older Adults Without Dementia.
      J Alzheimers Dis. 2023;95:1509-1518.
      PubMed     Abstract available
      
      
      
1142. WATTS A, Haneline S, Welsh-Bohmer KA, Wu J, et al
      TOMM40 '523 Genotype Distinguishes Patterns of Cognitive Improvement for Executive Function in APOEvarepsilon3 Homozygotes.
      J Alzheimers Dis. 2023;95:1697-1707.
      PubMed     Abstract available
      
      
      
1143. AMOFA-HO PA, Stickel AM, Chen R, Kobayashi LC, et al
      The Mediating Roles of Neurobiomarkers in the Relationship Between Education and Late-Life Cognition.
      J Alzheimers Dis. 2023;95:1405-1416.
      PubMed     Abstract available
      
      
      
1144. MARCOLINI S, Rojczyk P, Seitz-Holland J, Koerte IK, et al
      Posttraumatic Stress and Traumatic Brain Injury: Cognition, Behavior, and Neuroimaging Markers in Vietnam Veterans.
      J Alzheimers Dis. 2023;95:1427-1448.
      PubMed     Abstract available
      
      
      
1145. WANG R, Kuang C, Guo C, Chen Y, et al
      Automatic Detection of Putative Mild Cognitive Impairment from Speech Acoustic Features in Mandarin-Speaking Elders.
      J Alzheimers Dis. 2023;95:901-914.
      PubMed     Abstract available
      
      
      
1146. DAAMEN M, Scheef L, Li S, Grothe MJ, et al
      Cortical Amyloid Burden Relates to Basal Forebrain Volume in Subjective Cognitive Decline.
      J Alzheimers Dis. 2023;95:1013-1028.
      PubMed     Abstract available
      
      
      
1147. CODY SL, Miller GH, Fazeli PL, Wang G, et al
      Preventing Neurocognitive Decline in Adults Aging with HIV: Implications for Practice and Research.
      J Alzheimers Dis. 2023;95:753-768.
      PubMed     Abstract available
      
      
      
1148. KEPP KP, Sensi SL, Johnsen KB, Barrio JR, et al
      The Anti-Amyloid Monoclonal Antibody Lecanemab: 16 Cautionary Notes.
      J Alzheimers Dis. 2023;94:497-507.
      PubMed     Abstract available
      
      
      
1149. SAJI N, Ishihara Y, Murotani K, Uchiyama A, et al
      Cross-Sectional Analysis of Periodontal Disease and Cognitive Impairment Conducted in a Memory Clinic: The Pearl Study.
      J Alzheimers Dis. 2023;96:369-380.
      PubMed     Abstract available
      
      
      
1150. DATLOW LY, King J, Leventhal M, Wallace TC, et al
      Association of Pork Intake with Cognitive Performance in Older Adults Enrolled in the National Health and Nutrition Examination Survey (NHANES), 2011-2014 Data Cycles.
      J Alzheimers Dis. 2023;96:351-358.
      PubMed     Abstract available
      
      
      
1151. PACHECO PACHADO M, Casas AI, Elbatreek MH, Nogales C, et al
      Re-Addressing Dementia by Network Medicine and Mechanism-Based Molecular Endotypes.
      J Alzheimers Dis. 2023;96:47-56.
      PubMed     Abstract available
      
      
      
1152. CHEN S, Huang W, He T, Zhang M, et al
      Exploring the Causality Between Plasma Brain-Derived Neurotrophic Factor and Neurological Diseases: A Mendelian Randomization Study.
      J Alzheimers Dis. 2023;96:135-148.
      PubMed     Abstract available
      
      
      
1153. UTZ J, Olm P, Jablonowski J, Siegmann EM, et al
      Reconceptualization of the Erlangen Score for the Assessment of Dementia Risk: The ERlangen Score.
      J Alzheimers Dis. 2023;96:265-275.
      PubMed     Abstract available
      
      
      
1154. HAMMERS DB, Lin JH, Polsinelli AJ, Logan PE, et al
      Criterion Validation of Tau PET Staging Schemes in Relation to Cognitive Outcomes.
      J Alzheimers Dis. 2023;96:197-214.
      PubMed     Abstract available
      
      
      
1155. DING H, Mandapati A, Hamel AP, Karjadi C, et al
      Multimodal Machine Learning for 10-Year Dementia Risk Prediction: The Framingham Heart Study.
      J Alzheimers Dis. 2023;96:277-286.
      PubMed     Abstract available
      
      
      
1156. LINDH-RENGIFO M, Jonasson SB, Ullen S, Palmqvist S, et al
      Effects of Brain Pathologies on Spatiotemporal Gait Parameters in Patients with Mild Cognitive Impairment.
      J Alzheimers Dis. 2023;96:161-171.
      PubMed     Abstract available
      
      
      
1157. CAVUOTO MG, Robinson SR, O'Donoghue FJ, Barnes M, et al
      Associations Between Amyloid Burden, Hypoxemia, Sleep Architecture, and Cognition in Obstructive Sleep Apnea.
      J Alzheimers Dis. 2023;96:149-159.
      PubMed     Abstract available
      
      
      
1158. SMITH GS, Kuwabara H, Yan H, Nassery N, et al
      Serotonin Degeneration and Amyloid-beta Deposition in Mild Cognitive Impairment: Relationship to Cognitive Deficits.
      J Alzheimers Dis. 2023;96:215-227.
      PubMed     Abstract available
      
      
      
1159. 
      Erratum to: Medial Temporal Lobe Atrophy in Predementia Alzheimer's Disease: A Longitudinal Multi-Site Study Comparing Staging and A/T/N in a Clinical Research Cohort.
      J Alzheimers Dis. 2023;96:859-860.
      PubMed    
      
      
      
1160. BAHRANI AA, Abner EL, DeCarli CS, Barber JM, et al
      Multi-Site Cross-Site Inter-Rater and Test-Retest Reliability and Construct Validity of the MarkVCID White Matter Hyperintensity Growth and Regression Protocol.
      J Alzheimers Dis. 2023;96:683-693.
      PubMed     Abstract available
      
      
      
1161. KARJADI C, Xue C, Cordella C, Kiran S, et al
      Fusion of Low-Level Descriptors of Digital Voice Recordings for Dementia Assessment.
      J Alzheimers Dis. 2023;96:507-514.
      PubMed     Abstract available
      
      
      
1162. LI J, Weiss J, Rajadhyaksha A, Acosta D, et al
      Dementia Attributable Healthcare Utilizations in the Caribbean versus United States.
      J Alzheimers Dis. 2023;96:801-811.
      PubMed     Abstract available
      
      
      
1163. MICHOPOULOU S, Prosser A, Dickson J, Guy M, et al
      Perfusion Imaging and Inflammation Biomarkers Provide Complementary Information in Alzheimer's Disease.
      J Alzheimers Dis. 2023;96:1317-1327.
      PubMed     Abstract available
      
      
      
1164. ZHOU J, Wang ZB, Sun Y, Fu Y, et al
      Cerebrospinal Fluid Complement 4 Levels Were Associated with Alzheimer's Disease Pathology and Cognition in Non-Demented Elderly.
      J Alzheimers Dis. 2023;96:1071-1081.
      PubMed     Abstract available
      
      
      
1165. CHWA WJ, Raji CA, Toups K, Hathaway A, et al
      Longitudinal White and Gray Matter Response to Precision Medicine-Guided Intervention for Alzheimer's Disease.
      J Alzheimers Dis. 2023;96:1051-1058.
      PubMed     Abstract available
      
      
      
1166. TU MC, Chung HW, Hsu YH, Yang JJ, et al
      Neurovascular Correlates of Cobalamin, Folate, and Homocysteine in Dementia.
      J Alzheimers Dis. 2023;96:1329-1338.
      PubMed     Abstract available
      
      
      
1167. BROSENS N, Samouil D, Stolker S, Katsika EV, et al
      Early Life Stress Enhances Cognitive Decline and Alters Synapse Function and Interneuron Numbers in Young Male APP/PS1 Mice.
      J Alzheimers Dis. 2023;96:1097-1113.
      PubMed     Abstract available
      
      
      
1168. ZHU Y, Olchanski N, Cohen JT, Freund KM, et al
      Life-Sustaining Treatments Among Medicare Beneficiaries with and without Dementia at the End of Life.
      J Alzheimers Dis. 2023;96:1183-1193.
      PubMed     Abstract available
      
      
      
1169. BERNARDES C, Lima M, Duro D, Silva-Spinola A, et al
      Montreal Cognitive Assessment in Mild Cognitive Impairment: Relationship with Cerebrospinal Fluid Biomarkers and Conversion to Dementia.
      J Alzheimers Dis. 2023;96:1173-1182.
      PubMed     Abstract available
      
      
      
1170. NAISMITH SL, Michaelian JC, Santos C, Mehrani I, et al
      Tackling Dementia Together via The Australian Dementia Network (ADNeT): A Summary of Initiatives, Progress and Plans.
      J Alzheimers Dis. 2023;96:913-925.
      PubMed     Abstract available
      
      
      
1171. KOULOUSAKIS P, Willems E, Schepers M, Rombaut B, et al
      Exogenous Oxytocin Administration Restores Memory in Female APP/PS1 Mice.
      J Alzheimers Dis. 2023;96:1207-1219.
      PubMed     Abstract available
      
      
      
1172. HEALY E
      Impact of the MIND Diet on Cognition in Individuals with Dementia.
      J Alzheimers Dis. 2023;96:967-977.
      PubMed     Abstract available
      
      
      
1173. ZHAO B, Ou YN, Zhang XY, Fu Y, et al
      Differential Associations of APOEvarepsilon2 and APOEvarepsilon4 Genotypes with Cerebrospinal Fluid Biomarkers of Alzheimer's Disease in Individuals Without Dementia.
      J Alzheimers Dis. 2023;96:1813-1825.
      PubMed     Abstract available
      
      
      
1174. ROBINSON MJ, Newbury S, Singh K, Leonenko Z, et al
      The Interplay Between Cholesterol and Amyloid-beta on HT22 Cell Viability, Morphology, and Receptor Tyrosine Kinase Signaling.
      J Alzheimers Dis. 2023;96:1663-1683.
      PubMed     Abstract available
      
      
      
1175. TIAN J, Du E, Jia K, Wang T, et al
      Elevated Ghrelin Promotes Hippocampal Ghrelin Receptor Defects in Humanized Amyloid-beta Knockin Mice During Aging.
      J Alzheimers Dis. 2023;96:1579-1592.
      PubMed     Abstract available
      
      
      
1176. SLUGGETT JK, Air T, Cations M, Caughey GE, et al
      Clinical Quality Indicators for Monitoring Hospitalizations Among Older People with Dementia Accessing Aged Care Services.
      J Alzheimers Dis. 2023;96:1747-1758.
      PubMed     Abstract available
      
      
      
1177. GAO Y, Duan X, Li W, Zhang X, et al
      Elevated Homocysteine Levels and Hypertension Relate to Cognitive Impairment via Increased White Matter Hyperintensity Volume.
      J Alzheimers Dis. 2023;96:1739-1746.
      PubMed     Abstract available
      
      
      
1178. YOON J, Sasaki K, Tateoka K, Arai T, et al
      Evaluation of Cognitive and Physical Function Among Older Adults by Their Physical Activity: A Cross-Sectional Kasama Study, Japan.
      J Alzheimers Dis. 2023;96:1801-1812.
      PubMed     Abstract available
      
      
      
1179. SOLIS-URRA P, Rodriguez-Ayllon M, Alvarez-Ortega M, Molina-Hidalgo C, et al
      Physical Performance and Amyloid-beta in Humans: A Systematic Review and Meta-Analysis of Observational Studies.
      J Alzheimers Dis. 2023;96:1427-1439.
      PubMed     Abstract available
      
      
      
1180. GARCIA-ALBERCA JM, de la Rosa MD, Solo de Zaldivar P, Ledesma M, et al
      Effect of Nordic Sensi(R) Chair on Behavioral and Psychological Symptoms of Dementia in Nursing Homes Residents: A Randomized Controlled Trial.
      J Alzheimers Dis. 2023;96:1609-1622.
      PubMed     Abstract available
      
      
      
1181. SHORT MI, Fohner AE, Skjellegrind HK, Beiser A, et al
      Proteome Network Analysis Identifies Potential Biomarkers for Brain Aging.
      J Alzheimers Dis. 2023;96:1767-1780.
      PubMed     Abstract available
      
      
      
1182. BRICENO EM, Dhakal U, Sharma U, Adhikari N, et al
      Neuropsychological Assessment of Older Adults in Nepal for Population-Based Dementia Ascertainment: Needs, Challenges, and Opportunities.
      J Alzheimers Dis. 2023;96:1339-1352.
      PubMed     Abstract available
      
      
      
1183. AXELSSON ANDREN E, Kettunen P, Bjerke M, Rolstad S, et al
      Diagnostic Performance of Cerebrospinal Fluid Neurofilament Light Chain and Soluble Amyloid-beta Protein Precursor beta in the Subcortical Small Vessel Type of Dementia.
      J Alzheimers Dis. 2023;96:1515-1528.
      PubMed     Abstract available
      
      
      
1184. AGARWAL P, Ford CN, Leurgans SE, Beck T, et al
      Dietary Sugar Intake Associated with a Higher Risk of Dementia in Community-Dwelling Older Adults.
      J Alzheimers Dis. 2023;95:1417-1425.
      PubMed     Abstract available